The fate of antibiotic resistance genes during treatment and disposal of residual municipal wastewater solids by Burch, Tucker Ramsey
  
 
 
THE FATE OF ANTIBIOTIC RESISTANCE GENES DURING 
TREATMENT AND DISPOSAL OF RESIDUAL MUNICIPAL 
WASTEWATER SOLIDS 
 
A DISSERTATION SUBMITTED TO THE FACULTY OF THE UNIVERSITY OF 
MINNESOTA BY 
 
TUCKER RAMSEY BURCH 
 
IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF 
DOCTOR OF PHILOSOPHY 
 
Timothy M. LaPara, Advisor 
 
December 2013 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
© Tucker R. Burch 2013 
 
 
 
 
 
 
 
 
 
 
i 
 
Acknowledgements 
 This work would not have been possible without the contributions of many 
individuals who provided me with their time, energy, and thoughts. 
 I must thank my committee members, all of whom have provided valuable insight 
and suggestions that have improved the overall quality of my thesis.  I must also thank 
the numerous fellow graduate students and other colleagues that have attended classes, 
shared offices, and shared lab space with me.  Among these, Patrick McNamara (now at 
Marquette University, Milwaukee, WI) deserves special mention.  He has always had 
great questions that forced me to confront my own thinking regarding my research, and 
he was also a frequent voice of reason that helped keep me on the straight and narrow 
when I became frustrated with my work. 
My advisor, Tim LaPara, has both challenged and supported me.  He has always 
been personally invested in my success, and he has been a unique and irreplaceable 
influence on my professional development.  Tim taught me two valuable lessons: 1) 
always spend time with my family and 2) do everything in triplicate. 
My mom and dad have supported me in all ways imaginable, and I appreciate all 
the hard work they have put into placing me in a position to succeed.  
Finally, I must thank my lovely wife, Jennifer.  Her love, patience, and grace have 
seemed inexhaustible for the nearly 10 years that I have known her.  Recently, she has 
put up with some very long nights and me neglecting to shave for most of the month of 
November.  She has also shouted timely and much appreciated updates on football games 
from the other room while I have been writing. 
ii 
 
This work was supported by National Science Foundation Award 0967176, a 
University of Minnesota Sommerfeld Fellowship, and the Minnesota Environment and 
Natural Resources Trust Fund. 
  
iii 
 
Dedication 
This work is dedicated to great teachers and mentors.  Tom Zimmerman 
(Columbus Catholic High School, Marshfield, WI) taught me to appreciate details and 
solve problems.  John Katers (University of Wisconsin – Green Bay, Green Bay, WI) 
inspired me to solve environmental problems, gave me my first job in research, and told 
me I should be an engineer.  Daniel Zitomer (Marquette University, Milwaukee, WI) 
gave me my second job in research and seemed to be a great example of someone who 
thoroughly enjoyed what he did for a living.  The opportunity he provided me heavily 
influenced my decision to pursue graduate education.  Finally, Tim LaPara has been 
completely candid with me from the first time we spoke.  The fact that I can ask him any 
question, no matter how stupid it sounds in my head beforehand, has been a defining 
feature of our relationship.  Without these individuals, I would probably be handling 
manure instead of sewage for a living, and I would be far less qualified to do so.   
 It is also dedicated to my family, for their inexhaustible patience and support and 
the countless ways in which they have shaped my life: Mom, Dad, Grandma and Grandpa 
Mallo, Grandma and Grandpa Burch, and my lovely wife Jennifer.  Without these people, 
I simply would not be me. 
  
iv 
 
Abstract 
The development of resistance to antibiotics among pathogens is a global public 
health dilemma with significant consequences for the length and quality of human life.  
As a result, the bacterial antibiotic resistance genes (ARGs) that confer resistance are 
increasingly regarded as environmental contaminants.  A significant body of knowledge 
has been generated that catalogues the occurrence of ARGs in numerous environmental 
reservoirs, among which residual municipal wastewater solids are one of the largest.  
Only a handful of studies, however, make the critical paradigm shift to considering 
treatment technologies and management strategies intended to reduce the quantities of 
ARGs in those reservoirs.  The objective of the work presented here was to evaluate 
various treatment technologies and management strategies for reducing the quantity of 
ARGs discharged from the municipal wastewater treatment process during treatment and 
disposal of residual solids.  Aerobic digestion, air drying, and hyperthermophilic (≥ 
60°C) anaerobic digestion were evaluated for their abilities to reduce ARG quantities in 
residual municipal wastewater solids using laboratory-scale treatment units.  The 
technologies were compared among each other and to mesophilic (40°C) and 
thermophilic (56°C) anaerobic digestion on the basis of the kinetics of ARG removal 
from residual solids.  While all technologies were effective, hyperthermophilic anaerobic 
digestion tended to exhibit the fastest kinetics.  In addition, class 1 integrons were 
identified as a candidate design gene, and batch or semi-batch flow configurations were 
demonstrated to be a potential means of optimizing the removal of ARGs from residual 
solids during aerobic digestion, thermophilic anaerobic digestion, and hyperthermophilic 
v 
 
anaerobic digestion.  The fate of ARGs in soil following simulated disposal was also 
investigated by applying treated residual solids from full-scale treatment facilities and 
from numerous laboratory-scale treatment units to soil microcosms.  ARGs from residual 
solids treated at typical full-scale treatment facilities persisted in soil at high 
concentrations for relatively long periods of time, with half-lives on the order of months.  
Alkali stabilization, thermophilic anaerobic digestion, hyperthermophilic anaerobic 
digestion, and pasteurization, however, caused drastic decreases in ARG quantities in soil 
within one month.  The results presented here can be used to optimize and design the 
residual municipal wastewater solids treatment and disposal process to remove ARGs.        
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Chapter 1: Introduction 
Antibiotics are a critical tool for modern medicine.  The beginning of the 
antibiotic age in the mid-20th century marked the beginning of a vast improvement in the 
medical community’s ability to protect human health (1).  Diseases once known to be 
virulent and deadly were rendered common and harmless.  However, the development of 
resistance to antibiotics among pathogens is a serious threat to their sustainable use. 
The medical community has undertaken several strategies to circumvent and 
manage the development of antibiotic resistance, including developing new antibiotics, 
limiting frivolous antibiotic use, and prescribing cocktails of multiple antibiotics to 
individual patients.  However, resistance is now becoming more difficult to manage with 
these strategies alone.  The rate at which new antibiotics are deployed for public use has 
slowed considerably since the mid-20
th
 century (2).  Furthermore, the rise of multiply 
resistant pathogens and pathogens resistant to even the most state-of-the-art antibiotics is 
beginning to stretch the limits of the existing antibiotic arsenal (3,4).  It is becoming clear 
that complimentary strategies for managing the proliferation of antibiotic resistance will 
be required in the near future. 
One such new strategy relies on identifying bacterial antibiotic resistance genes 
(ARGs) as environmental contaminants (5).  ARGs are a convenient focus in this context 
for two reasons.  They can be readily detected and quantified using analytical 
biochemistry, and they are also the fundamental mechanism by which resistance is 
conveyed from one microorganism to another and through the natural environment.  The 
ultimate goal of this strategy is to identify environmental reservoirs of ARGs in order to 
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reduce the quantity of ARGs that they contain.  This perspective has, in fact, led to the 
identification of numerous environmental reservoirs of ARGs, including surface waters, 
aquaculture facilities, and agricultural waste (5–20).  The municipal wastewater treatment 
process is one of the most significant reservoirs of ARGs (5,10,21–32), and within this 
process, the residual municipal wastewater solids contain the vast majority of ARGs that 
are discharged to the environment (27).   
While residual municipal wastewater solids have been identified as an important 
environmental reservoir of ARGs, significant additional work is needed to investigate 
potential strategies for mitigating the size of this reservoir.  That is, further work is 
needed to assess potential treatment and management strategies for ARGs in residual 
municipal wastewater solids.  The global hypothesis underlying this work is that the 
residual municipal wastewater solids treatment process can be designed to intentionally 
reduce the quantity of ARGs it discharges to the natural environment.  Designing this 
process to destroy ARGs would provide an antibiotic resistance management strategy that 
is complimentary to existing strategies. 
Residual municipal wastewater solids are currently treated using an infrastructure 
that could be optimized and upgraded to reduce the number of ARGs it discharges to the 
environment.  There is currently a critical lack of knowledge related to achieving this 
goal, however, despite the obvious significance of residual municipal wastewater solids 
as an environmental reservoir of ARGs.  For instance, the degree to which some existing 
residual solids treatment technologies (e.g. air drying) can remove ARGs from residual 
municipal wastewater solids has not been assessed.  Furthermore, while other 
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technologies have been investigated (e.g. anaerobic digestion), the degree to which they 
can continue to be optimized for ARG removal from residual solids is not well 
understood, and few design criteria related to ARG removal (e.g. kinetic decay 
coefficients) are available.  We also currently lack a rational basis upon which to 
compare and select among alternative treatment technologies.  Finally, the fate of ARGs 
in treated residual solids following disposal (i.e. land-application) is unknown.  
The objective of this work was to address some of these gaps in the existing body 
of knowledge related to designing the residual municipal wastewater solids treatment and 
disposal process for ARG removal.  The following chapters investigate several 
technologies that have not previously been considered for their ability to remove ARGs 
from residual municipal wastewater solids.  Two of these technologies, air drying and 
alkali (i.e. lime) stabilization, are either used at a large number of municipal wastewater 
treatment plants or are applied to a large fraction of the treated residual solids produced 
in the United States each year (Chapter 4 and Chapter 7).  A third technology (anaerobic 
digestion at temperatures greater than or equal to 60°C) holds promise based on the 
observation that increasing temperatures in anaerobic digesters may increase the rate and 
extent of ARG removal in residual municipal wastewater solids (Chapter 5).  This work 
also presents detailed kinetic analyses of several technologies and residual solids disposal 
practices that contribute to our ability to select among alternative treatment technologies 
for removing ARGs from residual solids (Chapter 3, Chapter 4, Chapter 5, Chapter 6, and 
Chapter 7).  Two chapters provide evidence that operating treatment units in batch 
configurations, rather than as continuous-flow reactors, may improve the removal of 
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ARGs from residual solids (Chapter 3 and Chapter 5).  Two chapters also illustrate 
selection for ARGs in some treatment technologies based on how their presumed 
ecological niches relate to the treatment environments (Chapter 3 and Chapter 4).  
Furthermore, class 1 integrons are identified throughout this work as an early, promising 
candidate for consideration as a design gene (Chapter 3, Chapter 4, Chapter 5, Chapter 6, 
and Chapter 7).  Finally, this work illustrates the general fate of ARGs in treated residual 
solids applied to soil (Chapter 6) and presents an initial investigation into how the 
selection of residual solids treatment technologies in the treatment plant can affect the 
fate of ARGs following application to soil (Chapter 7). 
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Chapter 2: The Role of Municipal Wastewater Treatment in Mitigating 
the Spread of Antibiotic Resistance 
2.1 Antibiotics 
Antibiotics are widely used and critical tools for protecting human health.  First 
discovered and developed for widespread use between 1929 and 1940 (33,34), our 
original arsenal of sulphanilamide and penicillin has now grown to include over 90 
individual drugs in more than a dozen major classes (35).  Between 1940 and 1950, the 
crude death rate due to infectious disease dropped from approximately 200 deaths per 
100,000 persons to about 100 deaths per 100,000 persons (1).  A large portion of this 
decline was due to widespread use of antibiotics, along with improved hygiene and 
sanitation and the development of vaccines to prevent viral diseases (36).    
Definitions for the term “antibiotic” are often nebulous at best.  A frequently cited 
definition is “a chemical substance produced by a microorganism that kills or inhibits the 
growth of another microorganism” (37).  Under this definition, antibiotics are often 
considered to be a subset of antimicrobials, which are generally regarded as any 
chemicals that kill microorganisms (including bacteria, fungi, and protozoa) or inhibit 
their growth (37,38).  However, this definition excludes the large number of widely used 
synthetic and semi-synthetic drugs that are also, paradoxically, referred to as “antibiotics” 
in common practice.  This exclusion is due to the somewhat arbitrary specification that 
antibiotics must be “produced by a microorganism”.  Synthetic and semi-synthetic 
antibiotics are not direct products of natural microbial biosynthetic pathways and 
therefore more closely fit the definition of antimicrobial, though they behave and are 
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commonly referred to as antibiotics.  However, if the “produced by a microorganism” 
specification is dropped from the definition of “antibiotic”, a new specification must be 
added.  Antibiotics must work at relatively low concentrations, so as to exclude 
substances like organic acids, hydrogen peroxide, and ethanol (all of which are 
antimicrobial) that are not practical for internal application to higher organisms, 
particularly humans and animals (34).  Thus, from a strictly anthropocentric point of 
view, antibiotics – both “natural” and “synthetic” – may be most thoroughly defined as 
low molecular weight (< 1000 Daltons) organic compounds that inhibit or kill 
prokaryotes specifically and at dilute concentrations (38–40). 
Traditionally, natural antibiotics are viewed as an evolutionary adaptation 
conferring a competitive advantage to their producers in diverse ecosystems (41).  While 
an antibiotic-producing microorganism will generally not be sensitive to the compound or 
compounds that it produces, its neighbors in a mixed microbial community may be.  As a 
result, the antibiotic producer can inhibit or eliminate other microorganisms with which it 
is competing (e.g. for carbon, nitrogen, etc.) by releasing antibiotic compounds into its 
local environment (42).  This concept originated with initial discoveries of antibiotic 
compounds, including Alexander Fleming’s seminal (and accidental) discovery of 
penicillin.  Fleming observed that a compound released by a colony of Penicillium 
contaminating petri dishes in his lab caused nearby Staphylococcus cells to lyse (33).  
Other early researchers found that microbial communities in soil environments contained 
a large variety of microorganisms capable of producing substances that inhibited the 
growth of other microorganisms (43).  Thus it was concluded that antibiotic compounds 
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served as agents of intercellular chemical warfare in natural environments, and the 
properties that made them useful in that regard were subsequently exploited with great 
success for application to human needs (39,43). 
Today, antibiotics are used for treating microbial infections and prophylaxis in 
human and veterinary medicine, as well as for growth promotion in agriculture.  Direct 
treatment of bacterial infections in human hosts was the first and is still the most critical 
task to which antibiotics may be applied, and their use for this purpose provides obvious 
human health benefits (34,39,44).  Antibiotics are useful for the same purpose in 
agricultural animals, which can increase overall productivity in agricultural operations 
(45).  Antibiotics can also be used for prophylaxis (i.e. disease prevention), often at lower 
concentrations than what would be used for treatment of an actual infection (45,46).  
Though prophylaxis can be (and frequently is) practiced in human medicine (e.g. 
antibiotics administered to prevent infection during surgery or in patients with immune 
deficiencies), antibiotics employed for this purpose are also quite common in agriculture 
and aquaculture (46,47).  Antibiotics used in agriculture for prophylaxis often serve a 
second purpose of growth promotion.  Agricultural use of antibiotics for prophylaxis and 
growth promotion is highly controversial – and has even been banned in the European 
Union – due to evidence that it contributes to the development of antibiotic resistance in 
human pathogens (45,48).  Thus, while application in agriculture makes up a very large 
(≥ 70%) portion of their overall use by mass (35,49), antibiotics are still most critical for 
treating microbial infections in humans.   
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Antibiotics inhibit microbial growth via one of three primary mechanisms, and 
each major class of antibiotics exhibits one of these mechanisms exclusively.  Antibiotics 
may block cell wall biosynthesis, protein synthesis (i.e. inhibit translation), or nucleic 
acid synthesis (i.e. DNA replication and repair or transcription).  Major classes of 
antibiotics that block cell wall biosynthesis include β-lactams and glycopeptides, while 
antibiotics inhibiting protein synthesis include the macrolides, tetracyclines, and 
aminoglycosides (50,51).  Common molecular targets associated with the inhibition of 
cell wall biosynthesis include transpeptidases and the D-Ala-D-Ala termini of 
peptidoglycan, while peptidyltransferase is a common target associated with the 
inhibition of protein synthesis (51).  Sulfonamides block nucleic acid synthesis by 
targeting nucleic acid precursors (folic acids), while quinolones are known to uniquely 
halt nucleic acid synthesis by targeting enzymes associated with those functions (e.g. 
ciprofloxacin and nalidixic acid both target the α subunit of DNA gyrase) (3,50,51). 
The development of modern, clinically useful antibiotics – both natural and 
synthetic – began in the first half of the 20th century with sulfonamides and penicillin.  
Sulfonamides, synthetic drugs that were developed in the 1930s, were the first 
compounds widely used as antibiotics (34).  These drugs were successfully applied to the 
treatment of some previously common and deadly infectious diseases just before the start 
of World War II.  For instance, use of sulphanilamide and sulphapyridine to treat 
puerperal pyrexia, an extremely high fever associated with childbirth and caused by 
hemolytic streptococci, led to a decrease in the disease’s mortality rate by a factor of 
more than 3 between 1935 and 1940 (34).  However, the sulfa drugs could not control all 
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infectious diseases, resulting in a need for more effective and broad-spectrum antibiotic 
agents (37).  Penicillin would prove to be a first step in meeting this need.  Though it was 
discovered somewhat earlier than the first sulfonamides (1928-1929), penicillin was not 
successfully extracted from culture media and developed for clinical use until 1940 
(33,34).  During World War II, penicillin was found to be highly effective for treating 
staphylococcal and pneumococcal infections among members of the military.  It was also 
superior to the sulfa drugs for treating streptococcal infections, and at the conclusion of 
the war, penicillin was made available to the general public (37).    
The success of penicillin led to substantial concerted research efforts aimed at 
discovering new compounds with similar useful properties.  Thus, the 1940s and 1950s 
saw a number of new natural antibiotics made available, including the first 
aminoglycoside (streptomycin), the first tetracyclines (chlortetracycline and 
oxytetracycline), the first macrolide (erythromycin), and the first glycopeptide 
(vancomycin) (Table 2.1).  It was also found that the chemical structure of these natural 
compounds could be manipulated to adjust their effectiveness, specificity towards target 
organisms, or to reduce unwanted side-effects (34).  As a result, numerous analogs of 
many of the original natural antibiotic compounds were developed, such that many 
antibiotics now in common use are often semi-synthetic derivatives of some natural 
antibiotic discovered in the mid-20
th
 century (51).
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Table 2.1.  A timeline detailing the development and/or discovery of important antibiotic compounds.  Data are compiled from 
Reference 34 and references noted in right-most column. 
Drug Class Type Year Reference 
Penicillin β-lactam: Penicillins Natural 1929/1940 (52) 
Sulphanilamide Sulfonamide Synthetic 1932 (53) 
Sulphapyridine Sulfonamide Synthetic 1938 (53) 
Streptomycin Aminoglycoside Natural 1944 (54) 
Chloramphenicol Chloramphenicol Natural 1947 (55) 
Cephalosporin β-lactam: Cephalosporins Natural 1948 (56) 
Chlortetracycline Tetracycline Natural 1948 (57) 
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Oxytetracycline Tetracycline Natural 1950 (57) 
Erythromycin Macrolide Natural 1952 (58) 
Vancomycin Glycopeptide Natural 1956 (59) 
Kanamycin Aminoglycoside Natural 1957 (54) 
Rifamycin Ansamycin Natural 1957 (60) 
Methicillin β-lactam: Penicillins Semi-synthetic 1960 (52,61) 
Ampicillin β-lactam: Penicillins Semi-synthetic 1961 (52,61) 
Spectinomycin Aminoglycoside Natural 1961 (54) 
Lincomycin Lincosamide Natural 1962 (62) 
Naladixic acid Quinolone Synthetic 1962 (63) 
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Gentamicin Aminoglycoside Natural 1963 (54) 
Tobramycin Aminoglycoside Natural 1964 (54) 
Norfloxacin 
Quinolone: 
Fluoroquinolones 
Synthetic 1980-1984 (63) 
Ciprofloxacin 
Quinolone: 
Fluoroquinolones 
Synthetic 1987-1989 (63) 
Clarithromycin Macrolide Semi-synthetic 1991 (58) 
Linezolid Oxazolidinones Synthetic 2000 (64) 
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Exceptions to this trend obviously include synthetic antibiotics.  While the 
original antibiotic drugs (i.e. the sulfonamide drugs) were in fact synthetic, advances in 
producing new synthetic antibiotics have been sparse compared to those associated with 
natural and semi-synthetic compounds (see Table 2.1).  After a dry spell in the 
development of synthetic antibiotics following the sulfa drugs, the first quinolone, 
nalidixic acid, was made available in 1962.  Further refinements of this class of 
compounds, specifically the addition of fluorine groups at various positions on their dual-
ring structure, have led to the development of important drugs like ciprofloxacin and 
norfloxacin (63).  So-called fluoroquinolone antibiotics are now among the most widely 
used in clinical practice (51). 
Antibiotics are now used on a scale that would have likely been difficult to 
foresee for those involved in their early development and application.  In the United 
States, more than 90 antibiotic compounds, including natural, semi-synthetic, and 
synthetic species, are sold for use in human and/or veterinary medicine (35,49).  Of the 
many compounds used in both fields of medicine, antibiotics in the tetracycline class 
make up the largest fraction of U.S. sales by mass (5.8×10
6
 kg in 2011, 98% for food-
producing animals), followed by penicillins (2.3×10
6
 kg in 2011, 38% for food-producing 
animals) (35,49).  Other important antibiotic classes used in both human and veterinary 
medicine include sulfonamides (850,000 kg in 2011, 44% for food-producing animals), 
macrolides (750,000 kg in 2011, 78% for food-producing animals), and cephalosporins 
(520,000 kg in 2011, 5% for food-producing animals) (35,49).  In total, the United States 
uses approximately 15×10
6
 kg of antibiotics every year, although this value includes 
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approximately 4×10
6
 kg yr
-1
 of ionophores, which are used exclusively for food-
producing animals (35,49).  Total global antibiotic use has been estimated to be on the 
order of 90 to 180 million kg yr
-1
 (Kümmerer 2009).  This widespread use results in 
many tangible benefits that increase the overall quality of human life, but it has also led 
to a new problem: bacterial resistance to antibiotics. 
2.2 Antibiotic Resistance 
Resistance to antibiotics, which develops as an inevitable consequence of 
antibiotic use, is widespread and has significant consequences.  In the United States, 
antibiotic resistant infections now account for at least two million illnesses and 23,000 
deaths each year (65).  This number of deaths is on par with those due to Parkinson’s 
disease in 2010 (approximately 22,000) and represents a conservative estimate, as it does 
not include the many additional deaths from other conditions complicated by antibiotic-
resistant infections (65,66).  Antibiotic-resistant infections have been shown to be 
associated with attributable costs of between $19,000 and $29,000 per patient and to 
increase death rates 2-fold relative to antibiotic-sensitive infections (67).  The frequency 
with which resistance to individual antibiotics is encountered also often increases with 
time (68), which renders older antibiotics less effective and creates an “arms race” 
between rates of antibiotic development and rates of bacterial adaptation to new 
antibiotics. 
A straightforward definition for “resistance” to an antibiotic is “continued growth 
of microorganisms in the presence of [what should be] cytotoxic concentrations of 
antibiotics” (69).  The distinction between antibiotic-susceptible and antibiotic-resistant 
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microorganisms, however, is not as clear as it may initially seem based on this definition.  
Resistance is quantified for individual combinations of antibiotic and microorganism 
using disc diffusion assays, and the results are expressed as minimum inhibitory 
concentrations (MICs).  MICs vary, sometimes widely, based on both the microorganism 
and the antibiotic (Table 2.2).  Furthermore, MICs do not represent neat dividing lines 
between susceptible and resistant microorganisms, but rather, the centers of occasionally 
wide distributions of inhibitory antibiotic concentrations (70).  MICs have been defined 
for numerous combinations of different antibiotics and specific pathogens, but are usually 
undefined for environmental microorganisms, so the concept of “resistance” in a strict 
sense is vaguer with respect to these microorganisms.
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Table 2.2.  Median minimum inhibitory concentrations (MIC) of major antibiotic classes for a model gram-negative 
microorganism (Escherichia coli) and a model gram-positive microorganism (Staphylococcus aureus). 
Class Drug 
Median MIC (mg/L) 
Reference 
E. coli S. aureus 
Aminoglycosides Gentamicin 0.5 0.25 (54) 
 
Streptomycin 8 4 
 
 
Spectinomycin 8 64 
 
β-lactams: cephalosporins Cefalotin 4 - 8 0.25 - 0.5 (56) 
β-lactams: penicillins Amoxicillin 4 0.1 (52) 
 
Ampicillin 4 0.06 - 1 
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Benzylpenicillin 64 0.03 
 
 
Methicillin ≥ 128 1 
 
Chloramphenicols Chloramphenicol 2 - 8 2 - 8 (55) 
Diaminopyrimidines Trimethoprim 0.05 - > 64 0.2 - 2 (71) 
Glycopeptides Vancomycin > 32 1 - 2 (59) 
Lincosamides Lincomycin > 64 0.5 - 2 (62) 
Macrolides Erythromycin 8 - 32 0.1 - 1 (58) 
Oxazolidinones Linezolid > 32 0.06 - 4 (64) 
Quinolones Nalidixic acid 4 - 8 ≥ 64 (63) 
Quinolones: Fluoroquinolones Ciprofloxacin ≥ 0.06 0.25 - 1 (63) 
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Norfloxacin 0.25 1 
 
Rifamycins Rifampicin 8 - 16 0.008 - 0.06 (60) 
Sulfonamides Sulfamethoxazole 4 - 8 4 - 32 (53) 
Tetracyclines Chlortetracycline 8 - 16 0.5 - > 32 (57) 
 
Oxytetracycline 2 - 16 2 - > 32 
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The mechanisms of antibiotic resistance are fairly well understood, and generally 
fall into one of three broad categories.  These include efflux pumps, enzymatic 
modification, and ribosomal protection proteins (68,69).  Efflux pumps are proteins 
embedded in the bacterial cell membrane that actively transport antibiotics and other 
compounds from the cytoplasm to the cell’s surrounding environment (69).  Enzymatic 
modification includes modification of either the molecular target of an antibiotic or the 
modification of the antibiotic itself, while ribosomal protection proteins bind to bacterial 
ribosomes to block the active sites some antibiotics are designed to take advantage of 
(69,72).     
Despite this small number of general antibiotic resistance mechanisms, the 
biochemical diversity of the specific cellular processes and structures that fall into these 
categories is significant (69), and the antibiotic resistance genes (ARGs) that form the 
genetic basis for antibiotic resistance are correspondingly numerous.  Some individual 
ARGs are specific to particular antibiotics, while others provide resistance to multiple 
antibiotics.  Efflux pumps in particular are frequently found to be relatively non-specific 
with regard to what compounds they are able to interact with (69).  ARGs have been 
discovered for nearly every antibiotic in existence, and some antibiotics are associated 
with relatively large numbers of different ARGs (73,74).  For some antibiotics, ARGs 
have been found corresponding to every resistance mechanism (73,74).  For example, at 
least 45 ARGs are known to encode resistance to the group of macrolide, lincosamides, 
and streptogramin B antibiotics (74).  This group of 45 ARGs includes 10 putative efflux 
pumps (ATP-binding transporters and major facilitators), 14 putative enzymatic 
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modification mechanisms (esterases, hydrolases, phosphorylases, and transferases), and 
21 putative ribosomal protection proteins (rRNA methyltransferases).  Similarly, there 
are at least 32 known tetracycline resistance genes, with 20 encoding putative efflux 
pumps, one encoding a putative enzymatic modification mechanism, and nine encoding 
putative ribosomal protection proteins (two of the 32 genes code for unknown products) 
(73).          
The incidence of ARGs in pathogens was once assumed to be the result of random 
point mutations in homologous genes.  However, we now know that ARGs are ancient 
relative to human time scales, and many probably originate from environmental – not 
pathogenic – microorganisms (75–78).  Thus, a substantial amount of modern resistance 
is likely to be due to the horizontal exchange of existing ARGs themselves (79).  There 
are three mechanisms by which horizontal gene transfer occurs: conjugation, 
transduction, and transformation (79).  Conjugation is the direct sharing of genetic 
material between two prokaryotic microorganisms, via the extension of a pilus from one 
microorganism to the other (80).  Transduction occurs when bacteriophages randomly 
pack host genetic material into new phages, and those phages infect a new host, thereby 
transferring genetic material from one prokaryotic microorganism to another (80,81).  
Finally, transformation is the uptake of exogenous genetic material into the cell 
cytoplasm (80).   
The mechanisms of horizontal gene transfer are at least partially facilitated by 
mobile genetic elements.  In addition to bacteriophages, important examples of mobile 
genetic elements include plasmids, transposons, and integrons (79).  Plasmids are 
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circular, double-stranded and closed segments of DNA that carry non-essential genes 
(80).  They can be transformed, although conjugal transfer is frequently thought of as the 
most significant horizontal gene transfer mechanism for plasmids (79).  Transposons are 
recombinant DNA sequences that can transfer among different sites on chromosomes 
and/or plasmids using non-homologous recombination (80).  Transposons can be 
transduced and transformed, although conjugal transfer is frequently thought of as the 
most significant horizontal gene transfer mechanism for them as well (79).  The critical 
components of an integron include an integrase gene from the tyrosine-recombinase 
family, a primary recombination site, and an outward-oriented promoter (82).  Integrons 
are of particular interest because they convert exogenous open reading frames (ORFs, i.e. 
potential “new” genes) to functional genes.  The integrase gene recombines circularized 
ORFs (a.k.a. “gene cassettes”) at the primary recombination site downstream from the 
promoter in order to integrate them into a cell’s genetic regulatory system (82).  Integrons 
are frequently found on plasmids and transposons, and transposons themselves can be 
found on plasmids (3,79).  Whether combined or not, integrons, plasmids, and 
transposons also enable the accumulation of multiple ARGs by an individual bacterium, 
thereby contributing to the incidence of multiple antibiotic resistance (69).  Thus, mobile 
genetic elements enable ARGs to spread relatively quickly through mixed microbial 
communities via horizontal gene transfer and also potentially facilitate the development 
and maintenance of multiply-resistant genotypes.   
The historical development of resistance to antibiotics has closely paralleled the 
development of antibiotics themselves (Table 2.3).  Resistance has developed to virtually 
22 
 
all classes of antibiotics, and it tends to develop rapidly.  For antibiotics listed in both 
Table 2.1 and Table 2.3, the time span between the development of an antibiotic and the 
first report of resistance to that antibiotic is frequently on the order of 10 years.  The 
antibiotic resistance threats currently identified as the most “urgent” by the Centers for 
Disease Control and Prevention include carbapenem-resistant Enterobacteriaceae and 
Neisseria gonorrheae resistant to any of cefixime, ceftriaxone, azithromycin, or 
tetracycline (65).  These two threats are followed closely by a group of 12 “serious” 
threats that includes methicillin-resistant Staphylococcus aureus (MRSA), 
Mycobacterium tuberculosis resistant to individual or multiple antibiotics, and two multi-
drug resistant microorganisms (Acinetobacter and Pseudomonas aeruginosa) (65).  
MRSA is an opportunistic pathogen that is frequently community acquired (i.e. acquired 
outside the hospital), resistant to multiple antibiotics in addition to methicillin, and has 
probably acquired resistance through horizontal gene transfer (83,84).  M. tuberculosis 
was in decline as a cause of morbidity and mortality in the U.S. until the late 20
th
 century, 
but it has once again become a serious public health challenge since acquiring resistance 
to antibiotics (85).  Multi-drug resistant microorganisms, which have developed with 
increasing frequency in the last 15 years, are particularly expensive and difficult to treat 
in practice because many alternative antibiotics are often ineffective against them (3).  
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Table 2.3.  A timeline outlining the development of antibiotic resistance.  Data are 
adapted and compiled from References 61 and 65.  Microorganisms were not 
identified for Reference 61. 
Antibiotic Microorganism Year Reference 
Sulfonamides 
 
1940s (61) 
Penicillin Staphylococcus 1940 (65) 
Tetracycline 
 
1953 (61) 
Chloramphenicol 
 
1959 (61) 
Streptomycin 
 
1959 (61) 
Tetracycline Shigella 1959 (65) 
Methicillin Staphylococcus 1962 (65) 
Penicillin Pneumococcus 1965 (65) 
Erythromycin Streptococcus 1968 (65) 
Cephalosporins 
 
late 1960s (61) 
Ampicillin 
 
1973 (61) 
Gentamicin Enterococcus 1979 (65) 
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Ceftazidime Enterobacteriaceae 1987 (65) 
Erythromycin 
 
1988 (61) 
Vancomycin Enterococcus 1988 (65) 
Levofloxacin Pneumococcus 1996 (65) 
Imipenem Enterobacteriaceae 1998 (65) 
MDR
a
 Tuberculosis 2000 (65) 
Linezolid Staphylococcus 2001 (65) 
Vancomycin Staphylococcus 2002 (65) 
MDR
a
 Acinetobacter 2004 (65) 
MDR
a
 Pseudomonas 2005 (65) 
Ceftriaxone Neisseria gonorrheae 2009 (65) 
MDR
a
 Enterobacteriaceae 2009 (65) 
Ceftaroline Staphylococcus 2011 (65) 
aMDR indicates “multi-drug resistant” microorganisms. 
The current strategy for dealing with antibiotic resistance consists of multiple 
complementary components.  These components include developing new antibiotics, 
developing alternatives to antibiotics (e.g. bacteriophage therapy), prescribing multiple 
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antibiotic cocktails for individual infections, cycling antibiotics over time scales of 
decades, and reducing or eliminating the use of antibiotics for purposes other than human 
medicine (e.g. as growth promoters in agriculture) (2,3,69,86–90).  Many of these 
components, however, are currently working minimally or not at all.  For instance, the 
rate at which new antibiotics are developed and deployed has slowed considerably in 
recent years, largely due to economic pressures in the pharmaceutical industry (2,91).  
Furthermore, the research underlying our understanding of potential alternatives to 
antibiotics is still at such a fundamental level that results along these lines seem unlikely 
to appear in the immediate future.  The use of multiple antibiotics to treat individual 
infections can work well, although it still relies, in part, on the efficacy of individual 
antibiotics and is also hampered by the development of multi-drug resistant pathogens.  
Antibiotic cycling holds promise, but its benefits can be undone by compensatory 
mutations, co-selection of ARGs that are not under selective pressure with ARGs or other 
traits that are under selective pressure, and ARGs that carry either minimal fitness costs 
or that provide a fitness advantage even in the absence of antibiotic selective pressure 
(69).  Finally, the reduction or elimination of antibiotic use for purposes other than 
human medicine seems prudent (92) and there is evidence for the effectiveness of 
policies intended to achieve reduced frequency of antibiotic resistance among bacteria 
isolated from humans (93).  However, such measures have so far proven to be politically 
difficult to enact in the U.S.  Antibiotic resistance will continue to require a prolonged, 
multi-component strategy to overcome it, but the complications and shortcomings of the 
existing strategies are such that new additions complementing them are needed.  
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Members of the environmental science and engineering community have offered one 
such promising new addition, which is based on the consideration of ARGs as 
environmental contaminants.   
2.3 Antibiotic Resistance Genes as Environmental Contaminants 
The consideration of ARGs as environmental contaminants (5) is based on two 
attributes of ARGs.  First, as outlined in the previous section, ARGs are responsible for 
adverse human health outcomes.  Second, the distribution of ARGs in the environment 
provides the opportunity for human exposure to them.  The ultimate source of ARGs 
circulating in the environment is likely to be the gastrointestinal tract of humans and 
food-producing animals undergoing antibiotic treatment.  These ARGs then enter the 
environment in feces.  (A substantial body of literature is concerned with transmission of 
antibiotic resistance from food-producing animals via meat; while this route of exposure 
is likely important, it is beyond the scope of this work).  In the United States and many 
other countries, fecal wastes are disposed of via direct land-disposal (in the case of food-
producing animals) or are treated in a municipal wastewater treatment plants (in the case 
of humans) prior to land-disposal of the treated solids and discharge of the treated liquid 
fraction to surface waters.  Thus, ARGs have been reported in agricultural waste and 
aquaculture facilities (5,6,11,12,16,19,20,94–116), as well as in sewage and all stages of 
the municipal wastewater treatment process, even in treated wastewater after undergoing 
“best available” treatment practices (5,10,15,21–32,99,103,112,117–147).  Furthermore, 
as a result of current disposal practices for agricultural waste and human sewage, ARGs 
have been found in soil (including on vegetables at harvest) (11,78,99,104,124,135,148–
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158), surface water environments (including beaches, sediments, biofilms, and “pristine” 
environments presumably unaffected by anthropogenic activities) (5,7–10,13–
15,17,18,21,99,103,108,112,117,119,124,136,159–165) groundwater (including in 
aquifers recharged with treated wastewater) (6,94,101,102,152,166), aerosols (167), and 
even the drinking water treatment process (including finished plant water and tap water) 
(5,15,168).  The ARGs catalogued in these reports encode resistance to virtually all 
antibiotic classes, are distributed in numerous locations across the globe, and have been 
found in a large variety of bacterial genera.   
The wide distribution of ARGs in the environment is the result of traditional fate 
and transport processes for both organic chemicals (as would be the case for extracellular 
DNA) and microorganisms.  Organic chemical fate and transport mechanisms relevant to 
extracellular ARGs would seem to include biodegradation, hydrolysis, oxidation, 
photolysis, and sorption, along with physical transport of dissolved ARGs in water or 
sorbed ARGs with airborne or waterborne particulate matter (169).  Potential fate and 
transport mechanisms for ARGs contained within bacterial cells would seem to include 
cell division, endogenous decay, and sorption, along with physical transport of bacterial 
cells in water and air and physical transport of sorbed bacterial cells with airborne or 
waterborne particulate matter.  These fate and transport mechanisms, whether for 
extracellular or intracellular ARGs, seem reasonable, and important evidence linking 
human activities to the occurrence of ARGs in natural environments provides indirect 
support for their significance (14,18,112).  However, explicit investigation of their effects 
has occurred in only a handful of studies (100,115,170).   
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The fate and transport mechanisms for extracellular and intracellular ARGs are 
complicated by the additional fate and transport mechanisms presented by the 
mechanisms of horizontal gene transfer.  For instance, because transformation enables the 
uptake of extracellular DNA by microorganisms, it enables a “state change” that 
determines whether an ARG is subject to fate and transport mechanisms for organic 
chemicals or fate and transport mechanisms for microorganisms.  Similarly, because 
conjugation and transduction both enable the transfer of ARGs between microorganisms 
with, potentially, different abilities to survive in specific environments, ARGs could 
conceivably be transferred from pathogens lacking the ability to survive in, for example, 
surface water, to environmental microorganisms that can easily survive in surface water.  
In such a case, the environmental microorganisms may serve as a temporary reservoir of 
ARGs that carries them through the environment until coming in contact with pathogens 
and transferring the ARGs back.  Bacteriophages themselves may also act as temporary 
carriers of ARGs through environments that are hostile to other hosts.   
Like ARGs themselves, the mobile genetic elements that enable horizontal gene 
transfer are distributed widely in the environment.  They have been identified in 
agricultural waste and aquaculture facilities (including bacteriophages carrying ARGs) 
(20,96,97,99,104,106,108–110,171), as well as in sewage and all stages of the municipal 
wastewater treatment process (including multi-resistance plasmids, multi-resistance 
integrons, and integron-borne plasmids) (10,24,32,99,120,121,123,124,126,130–
134,136–139,141–147,171–178).  Mobile genetic elements enabling horizontal gene 
transfer have also been described in soil (including plasmids and transposons associated 
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with multiple ARGs) (99,104,124,151–153,155–158,171,179), surface water 
environments (including sediments and biofilms and including multi-resistance plasmids) 
(7,10,99,108,136,141,159,160,164,172,173,177,178,180–183), groundwater (152), and 
aerosols (167).  As with ARGs, the mobile genetic elements catalogued in these reports 
carry resistance genes for virtually all antibiotic classes, are distributed in numerous 
locations across the globe, and have been found in a large variety of bacterial genera.        
The ultimate goal of identifying the distribution of ARGs and ARG-associated 
mobile genetic elements in the environment is to inform management strategies to reduce 
human exposure to ARGs.  This assumes, of course, that reduced exposure to ARGs will 
result in reduced antibiotic resistant infections and thereby preserve the efficacy of our 
existing antibiotic arsenal.  We currently lack strong evidence that reducing 
environmental exposure to ARGs results in a reduction in the frequency with which 
antibiotic resistant infections occur.  However, the strategy of reducing the number of 
ARGs circulating in the environment (and potentially exposed to humans) could be 
pursued as a method of disease prevention based on the precautionary principle.  This 
requires the identification of the largest reservoirs of ARGs and subsequent reduction of 
their size.  The municipal wastewater treatment process is undoubtedly among the largest 
reservoirs of ARGs.  Furthermore, the bulk of the biomass, and as a result, the bulk of the 
ARGs that exit the municipal wastewater treatment process do so in the residual 
municipal wastewater solids (27).  Thus, residual municipal wastewater solids treatment 
may be a highly effective point at which to control the number of anthropogenic ARGs 
circulating in the environment. 
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2.4 Treatment of Residual Municipal Wastewater Solids as an 
Opportunity to Mitigate the Spread of Antibiotic Resistance  
Treatment of residual municipal wastewater solids takes place within an existing 
infrastructure that holds promise for being upgraded and optimized to reduce the number 
of ARGs discharged to the environment.  The primary goals of residual solids treatment 
are to reduce the water, organic carbon, and pathogen content of untreated residual 
municipal wastewater solids (184).  Achieving these goals makes treated residual solids 
easier to dispose of, less offensive, less attractive to disease vectors, and safer for humans 
that happen to come in direct contact with them.  Residual solids treatment technologies, 
termed Processes to Significantly Reduce Pathogens (PSRPs), include aerobic digestion 
between 15°C and 20°C, air drying at ambient temperatures above 0°C, anaerobic 
digestion between 20°C and 55°C, composting at temperatures above 40°C, and lime 
stabilization (185).  Following treatment in a PSRP, treated residual solids are typically 
disposed of in landfills or are land-applied to agricultural fields (186).  In the United 
States, approximately 50% of treated residual solids are land-applied to agricultural fields 
(186).  Additionally, treatment technologies termed Processes to Further Reduce 
Pathogens (PFRPs) can be used as alternatives to PSRPs when treated residual solids are 
more likely to come in direct contact with humans (e.g. when treated residual solids are 
sold as garden fertilizers) and must be treated to a higher standard (184).  PFRPs include 
aerobic digestion at temperatures between 55°C and 60°C, beta ray irradiation, 
composting at temperatures above 55°C, gamma ray irradiation, heat drying at 
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temperatures above 80°C, heat treatment at temperatures above 180°C, and pasteurization 
at temperatures above 70°C (185).       
Because PSRPs and PFRPs are largely intended to “stabilize” (i.e. kill) 
microorganisms in residual municipal wastewater solids, they should also reduce ARG 
quantities in residual solids.  Previous work has shown laboratory-scale aerobic digestion 
(between 22°C and 55°C) to be largely ineffective at removing ARGs from residual 
solids (121).  However, full-scale anaerobic digestion (between 50°C and 60°C) has been 
demonstrated to reduce ARG quantities in residual solids by at least 75% (24), while 
laboratory-scale anaerobic digestion (between 35°C and 59°C) has achieved reductions of 
up to 80% to 90% (121,131).  Furthermore, one study (121) demonstrated that increasing 
the digestion temperature may increase the rate and extent of ARG removal from residual 
municipal wastewater solids in anaerobic digestion, although this effect has not been 
fully reproducible (131) and appears to depend, in part, on both the specific ARG and the 
flow configuration of the digester.  Despite these important advances, however, a number 
of critical knowledge gaps remain with regard to removing ARGs from residual 
municipal wastewater solids during residual solids treatment. 
 For instance, the full array of PSRPs and PFRPs has yet to be evaluated for its 
potential to destroy ARGs.  This is a problem, because approximately 80% of treatment 
plants in the United States use a technology other than anaerobic digestion (currently the 
most frequently investigated technology with regard to ARGs) for residual solids 
treatment (186).  Important examples of treatment technologies that should probably be 
investigated due to either the number of treatment plants that employ the technology or 
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the amount of residual solids produced with the technology include air-drying beds, 
composting, and lime stabilization.  Air-drying beds are used at approximately 30% of all 
municipal wastewater treatment plants in the United States for dewatering treated 
residual solids, while composting is used to treat approximately 21% of all residual solids 
produced in the United States (186).  Lime stabilization is used at approximately 18% of 
U.S. municipal wastewater treatment plants to treat approximately 13% of all residual 
solids produced nationally (186).  Because of their widespread use, there is a need to 
investigate the performance of these types of treatment technology for their ability to 
remove ARGs from residual municipal wastewater solids.  
Furthermore, even for the treatment technologies that have been investigated, we 
have little rational basis for selecting among alternative technologies.  For any given 
treatment objective, selection of alternative treatment technologies is typically governed 
by operating costs (e.g. energy and chemical inputs and outputs) and capital costs (e.g. 
tank size).  Understanding these costs requires detailed process design, which itself 
frequently relies on understanding the kinetics of the underlying biological, chemical, or 
physical processes.  However, only one study to date (121) has considered the kinetics of 
ARG removal during treatment of residual solids.  Thus, we must develop a more 
thorough understanding of the kinetics of ARG removal from residual solids in many 
different alternative technologies in order to select the most appropriate technology 
rationally.  Furthermore, because we cannot possibly design our residual solids treatment 
infrastructure to consider all ARGs (see Section 2.2), the identification of a “design gene” 
or a subset of design genes seems warranted.  In this context, a design gene would be a 
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genetic element related to antibiotic resistance in humans that possesses some 
combination of 1) serious human health consequences and 2) relatively slow rates of 
removal from residual solids.  Thus, understanding the kinetic behavior of a design gene 
would appropriately constrain the design of individual treatment units and the selection of 
alternative treatment technologies.    
Finally, almost no attention has been paid to the fate of ARGs following the 
treatment and ultimate disposal (i.e. land-application) of residual municipal wastewater 
solids.  This is a critical gap in our current body of knowledge, because approximately 
50% of all treated residual municipal wastewater solids in the United States are 
ultimately disposed of via land-application (186).  The potential exists for these ARGs to 
accumulate in soil (150), and whether they accumulate or not, several plausible transport 
mechanisms have been outlined (see Section 2.3) that could result in human exposure to 
ARGs originating from land-applied treated residual solids.  We must improve our 
understanding of how long, and in what quantities, ARGs from treated residual solids 
persist in soil following land-application of treated residual solids in order to guide 
decisions related to the frequency and mass loading rate of treated residual solids at 
individual field sites.     
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Chapter 3: Aerobic Digestion Reduces the Quantity of Antibiotic 
Resistance Genes in Residual Municipal Wastewater Solids 
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Numerous initiatives have been undertaken to circumvent the problem of 
antibiotic resistance, including the development of new antibiotics, the use of narrow 
spectrum antibiotics, and the reduction of inappropriate antibiotic use.  We propose an 
alternative but complimentary approach to reduce antibiotic resistant bacteria by 
implementing more stringent technologies for treating municipal wastewater, which is 
known to contain large quantities of antibiotic resistant bacteria and antibiotic resistance 
genes (ARGs).  In this study, we investigated the ability of conventional aerobic 
digestion to reduce the quantity of ARGs in untreated wastewater solids.  A bench-scale 
aerobic digestor was fed untreated wastewater solids collected from a full-scale 
municipal wastewater treatment facility.  The reactor was operated under semi-
continuous-flow conditions for more than 200 days at a residence time of approximately 
40 days.  During this time, the quantities of tet(A), tet(W), and erm(B) decreased by more 
than 90%.  In contrast, intI1 did not decrease, and tet(X) increased in quantity by a factor 
of five.  Following operation in semi-continuous-flow mode, the aerobic digestor was 
converted to batch mode to determine the first-order decay coefficients, with half-lives 
ranging from as short as 2.8 days for tet(W) to as long as 6.3 days for intI1.  These results 
demonstrated that aerobic digestion can be used to reduce the quantity of ARGs in 
untreated wastewater solids, but that rates can vary substantially depending on the reactor 
design and the specific ARG. 
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3.1 Introduction 
The resistance of pathogenic bacteria to antibiotic chemotherapy is a growing 
problem with significant consequences for public health.  In the United States, 
methicillin-resistant Staphylococcus aureus (MRSA) infections lead to more fatalities 
than the combination of HIV/AIDs, Parkinson’s disease, and homicides, and the 
estimated economic cost of antibiotic resistance ranges from $21 to 34 billion dollars per 
year (187).  In response, medical practitioners have attempted to reduce the number of 
inappropriate and unnecessary antibiotic prescriptions.  The biomedical research 
community is also focusing its research efforts to develop new antibiotics as well as 
alternatives to antibiotic chemotherapy (2,88,89).  Finally, in Sweden and Switzerland, 
the use of antibiotics in agriculture for growth promotion and prophylaxis has been 
banned (87,188).   
Despite these initiatives, a significant body of research suggests that antibiotic 
resistant bacteria (ARB) are becoming increasingly more prevalent (3,4,61).   An 
alternative, but complementary, approach to reducing the prevalence of ARB would be to 
identify pertinent reservoirs of resistance and then to implement appropriate technologies 
to ameliorate these reservoirs.  Consistent with this approach, numerous studies have 
identified untreated municipal wastewater (raw sewage) as a significant reservoir of ARB 
and antibiotic resistance genes (ARGs) (21,28,30,31,144,189–192).  Municipal 
wastewater treatment processes, therefore, should represent an important opportunity to 
mitigate the quantity of this reservoir of antibiotic resistance.    
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Although prior research has demonstrated that the treated municipal wastewater 
also contains substantial concentrations of ARB and ARGs (5,9,10,192), a mass balance 
on wastewater treatment operations suggests that > 99% of the ARB and ARGs in 
untreated municipal wastewater accumulate in the residual wastewater solids.  These are 
subsequently treated by numerous technologies to reduce their nutrient and pathogen 
content (to varying degrees) prior to their disposal on agricultural land (184).  There have 
been relatively few investigations on the different technologies used for treating residual 
wastewater solids and their associated effectiveness at mitigating ARB and ARGs.  Diehl 
and LaPara (2010) observed relatively little removal of ARGs in aerobic digestion 
processes operated at 22-55°C, but observed increasingly effective removal of ARGs in 
anaerobic digestion processes at temperature > 37°C.   In contrast, Ma et al. (2011) 
observed little benefit of increasing the temperature of anaerobic digestion beyond 37°C.   
In the present research, we undertook a detailed investigation of the effectiveness 
of a bench-scale conventional aerobic digestion process at mitigating the quantity of 
ARGs in untreated residual wastewater solids.  Although our prior research had observed 
no effect of aerobic digestion on the quantity of ARGs in wastewater solids (121), these 
previous experiments were performed in relatively small bioreactors with a mean 
hydraulic residence time of 4 days.  Assuming that ARGs decay at a relatively slow rate 
(i.e., half-lives > 4 days), this experimental design would have been insufficient to 
observe significant reductions in ARGs.  This short time period used in our prior 
experimental design is also pertinent because the United States Environmental Protection 
Agency requires that aerobic digestion processes have a mean hydraulic residence time of 
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40 days (when operated at 20°C) to qualify as a “process to significantly reduce 
pathogens” (PSRP), which must be achieved before these treated wastewater solids can 
be applied to agricultural land for their disposal (albeit with some restrictions) (184).  
This research is of considerable practical importance because numerous full-scale 
municipal wastewater treatment facilities currently utilize aerobic digestion processes to 
treat their wastewater solids, particularly those that treat less than 10 million gallons of 
wastewater each day (at higher flow rates, other technologies are considered more 
practical and economical). 
3.2 Materials and Methods 
Experimental Design.  A 10-liter aerobic digester was operated at room 
temperature with a mean residence time of 40 days and a minimum dissolved oxygen 
(DO) concentration of 2 mg/L.  The digester was inoculated with 10 liters of untreated 
residual municipal wastewater solids from a full-scale municipal wastewater treatment 
plant.  Mixing and aeration were provided by pumping atmospheric air through a stone 
diffuser located at the bottom of the reactor vessel at a rate sufficient to prevent settling 
of solids and to maintain the minimum DO concentration.  Typical operating variables, 
including temperature, DO, pH, total solids (TS), volatile solids (VS), and inert solids 
(IS) were monitored throughout the entire time period the digester was in operation (193).  
Water loss due to evaporation was monitored and replaced by adding appropriate 
volumes of deionized water to the digester.   
The digester was operated for more than 175 days while being fed on a weekly 
basis untreated residual municipal wastewater solids.  The digester was considered to 
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have reached steady-state conditions once the residence time for inert solids had been 
maintained at 41.1 ± 0.5 days (mean ± standard deviation) for a time period of 35 days.  
Once steady-state conditions had been established, the operating mode of the digester 
was shifted to better reflect continuous-flow operating conditions by feeding untreated 
residual municipal wastewater solids on a daily basis from Day 180 to Day 191.  
Following this semi-continuous flow phase, the aerobic digester was operated for an 
additional 27 days while being fed on a weekly basis untreated residual municipal 
wastewater solids.  On Day 218, half of the digester contents (i.e. 5 liters) were replaced 
with untreated residual municipal wastewater solids to allow the determination of decay 
coefficients in a batch-like reactor. 
Sample Collection and Genomic DNA Extraction and Purification.  Triplicate 
samples (100 µL) were collected from larger aliquots (50 to 300 mL) of digester contents 
to ensure accurate sample collection volumes.  Samples were then diluted with 500 µL of 
lysis buffer (120 mM sodium phosphate buffer, 5% dodecyl sulfate, pH 8.0 ± 0.1) and 
subjected to three consecutive freeze-thaw cycles followed by incubation at 70°C for 90 
minutes.  Genomic DNA was then extracted using a FastDNA Spin Kit (MP Biomedicals 
LLC, Solon, OH) according to the manufacturer’s instructions. 
Real-Time PCR.  Real-time PCR was used to quantify the concentrations of 
three different genes that encode resistance to tetracycline (tet(A), tet(W), and tet(X)), 
one gene that encodes resistance to erythromycin (erm(B)), one gene that encodes 
resistance to sulfonamides (sul1), and the integrase gene of class 1 integrons (intI1). The 
three tetracycline resistance genes were selected because they represent each of the three 
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known mechanisms of tetracycline resistance (efflux pumps, ribosomal protection 
proteins, and enzymatic modification) (73).  The erythromycin gene, erm(B), was chosen 
because it encodes an rRNA methyltransferase that confers resistance to macrolides, 
lincosamides, and streptogramin B (74).  Prior work has demonstrated that all five of 
these ARGs are present at substantial concentrations in wastewater and/or wastewater 
solids (10,27,121).  Class 1 integrons were quantified because of their association with 
multiple antibiotic resistance.  These integrons enable bacteria to collect multiple, 
exogenous ARGs and modulate their expression (82).  qPCR was also used to determine 
the concentrations of 16S rRNA genes (a measure of total bacterial biomass), all 
Bacteroides spp. (a measure of total fecal bacteria), and human-specific Bacteroides spp. 
(a measure of human fecal bacteria) (194–196).  Additional information regarding the use 
of qPCR to quantify these genes can be found in Table A.1. 
Real-time PCR was carried out on an Eppendorf Mastercycler EP Realplex 
thermal cycler (Eppendorf, Westbury, NY).  PCR assays were optimized to reduce or 
eliminate the formation of primer-dimers and non-specific products.  Typical PCR assays 
began with a 1 minute initial denaturation at 95°C.  This step was followed by 40 cycles 
of denaturation at 95°C for 15 seconds and combined annealing and extension at the 
primer-specific annealing temperature for 1 minute.  Typical reaction volumes were 25 
μL and consisted of 12.5 µL of BioRad iTaq SYBR Green Supermix with ROX (Life 
Science Research, Hercules, CA), 25 µg of bovine serum albumin, optimized quantities 
of forward and reverse primers, and approximately 1 ng of template genomic DNA.  Each 
analysis consisted of three replicates.  Standards were made from positive controls 
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selected from municipal wastewater solids using our qPCR primers.  These positive 
controls were then ligated into a pGEM-T Easy cloning vector, transformed into JM109 
competent cells, and extracted from cell cultures using an alkaline lysis procedure (197).  
The DNA concentration of cell extracts was quantified using a TD-700 fluorometer and 
Hoechst 33258 dye.  Each standard curve consisted of a 10-fold dilution series containing 
at least 5 standards (r
2
 ≥ 0.99).  Amplification efficiencies were typically 100% ± 10%. 
Data Analysis.  All data obtained from groups of triplicate samples were treated 
as if they had been obtained from a normal distribution (i.e. means and standard 
deviations were used to describe the data).  This assumption of normal distributions was 
based on results from Shapiro-Wilk normality tests performed in SigmaPlot 12.0 that 
indicated the complete semi-continuous flow data series for most gene targets could not 
be distinguished from a normal distribution (P > 0.05).  Analysis of variance (ANOVA; 
Microsoft Excel 2010) was used with data from the semi-continuous flow experiment to 
determine the statistical significance of differences in gene target concentrations between 
untreated and treated residual solids samples.   
Simple linear regression (Arc 1.06) was used with log-transformed data from the 
batch experiment to determine the goodness of fit of the data to a first-order kinetic 
model.  The first-order kinetic model was chosen based on previous empirical 
observations that it tends to fit this type of data well.  Values of P used to compare the 
relative statistical significance of different kinetic coefficients (Table A.2) were 
determined using Welch’s t-test for unequal n and unequal sample variance.  The sample 
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variance for each estimated first-order kinetic coefficient was obtained from the 
estimated standard error for that coefficient as provided by Arc 1.06. 
3.3 Results 
Semi-Continuous-Flow Operating Mode.  With respect to typically monitored 
operating variables, the lab-scale aerobic digester performed as an appropriate 
experimental model simulation during the semi-continuous flow experimental period 
(Table 3.1).  The pH was circumneutral, digester temperature was the same as the 
ambient air temperature, and dissolved oxygen concentrations were well above the target 
dissolved oxygen concentration of 2 mg/L.  The total and volatile solids concentrations 
for the untreated and treated solids were well within ranges typically encountered in 
practice (2%-5% TS, 0.6%-3% VS) (184).  The fractions of total and volatile solids 
destroyed were 26% and 41%, respectively, which is also typical for a full-scale aerobic 
digestion process (184). 
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Table 3.1.  Operating variables during operation in semi-continuous-flow mode. 
Variable Mean ± Standard Deviation 
pH   7.5 ± 0.2   n = 12 
Temperature (°C)   17.0 ± 0.3   n = 12 
Dissolved Oxygen (mg/L)   5.8 ± 1.5   n = 12 
Hydraulic Residence Time (days)   13.5 ± 0.7   n = 12 
Untreated Total Solids   4.6% ± 0.04%   n = 4 
Treated Total Solids   3.4% ± 0.3%   n = 4 
Total Solids Destruction   26.3% ± 6.0%   n = 4 
Total Solids Residence Time (days)   33.1 ± 0.4   n = 12 
Untreated Volatile Solids   3.2% ± 0.05%   n = 4 
Treated Volatile Solids   1.9% ± 0.1%   n = 4 
Volatile Solids Destruction   41.1% ± 4.8%   n = 4 
Volatile Solids Residence Time (days)   27.7 ± 0.6   n = 12 
Untreated Inert Solids   1.5% ± 0.02%   n = 4 
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Treated Inert Solids   1.5% ± 0.1%   n = 4 
Inert Solids Destruction   -5.7% ± 8.4%   n = 4 
Inert Solids Residence Time (days)   41.7 ± 0.1   n = 12 
 
The aerobic digester eliminated a substantial fraction of bacterial biomass and 
fecal indicator bacteria (FIB) as measured by qPCR targeting the 16S rRNA gene and 
16S rRNA genes specific for all Bacteroides spp. and for human-specific Bacteroides 
spp. (Figure 3.1).  The concentrations of 16S rRNA genes were 77% lower in treated 
samples compared to the untreated samples.  This indicates net destruction of total 
bacterial biomass in the digester, consistent with the total and volatile solids removal.  
Significant removal was observed for both types of FIB.  The concentrations of all 
Bacteroides spp. were 99.9% lower in treated samples compared to untreated samples.  
Similarly, the concentrations of human-specific Bacteroides spp. were approximately 
5108 gene copies mL-1 in untreated samples, but were below the detection limit (1108 
gene copies mL
-1
) in treated samples.   
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Figure 3.1.  The quantities of: (A) 16S rRNA genes and (B) fecal indicator bacteria 
as measured by 16S rRNA genes of all Bacteroides spp. in untreated (closed circles) 
and treated (open circles) residual solids.  Values are the arithmetic mean of 
triplicate samples; error bars represent one standard deviation.  The concentrations 
of human-specific Bacteroides spp. were approximately 5108 gene copies mL-1 in 
untreated samples, but were below the detection limit (1108 gene copies mL-1) in 
treated samples. 
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The untreated wastewater solids contained substantial quantities of each of the 
ARGs investigated in this study.  The quantities of intI1, sul1, and tet(W) were similar, 
present at a concentration of approximately 10
10
 gene copies mL
-1
.  In contrast, the 
concentration of erm(B) was approximately 10
11
 gene copies mL
-1
, and the 
concentrations of tet(A) and tet(X) were approximately 10
9
 gene copies mL
-1
.  Given that 
the concentrations of 16S rRNA genes were approximately 10
12
 gene copies mL
-1
 in the 
untreated solids, the ratio of the various antibiotic resistance determinants examined in 
this study to bacterial cells ranged from approximately 0.1%  for tet(A) and tet(X) to 1% 
for intI1, sul1, and tet(W), and to 10% for erm(B).   
The bench-scale aerobic digester removed between 85% and 98% of erm(B), sul1, 
tet(A), and tet(W) during the semi-continuous flow experimental period (Figure 3.2), 
which was substantially greater than that for bacterial biomass (i.e. 16S rRNA genes).  In 
contrast, the quantity of intI1 was not statistically different (P = 0.17) in the untreated and 
treated solids, suggesting that aerobic digestion operated in semi-continuous flow mode 
does not eliminate intI1 (Figure 3.3).  Furthermore, the ratio of intI1 to 16S rRNA genes 
increased in the treatment process from 0.8% to 3%, indicating that aerobic digestion 
likely selects for bacterial cells possessing a class 1 integron.  Interestingly, the aerobic 
digestion process also appeared to select for bacterial cells containing tet(X), as the 
quantity of this gene was 5-fold greater in the treated solids than in the untreated solids. 
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Figure 3.2.  The quantities of: (A) erm(B), (B) sul1, (C) tet(A), and (D) tet(W) in 
untreated (closed circles) and treated (open circles) residual solids.  Values are the 
arithmetic mean of triplicate samples; error bars represent one standard deviation. 
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Figure 3.3.  The quantities of: (A) intI1 and (B) tet(X) in untreated (closed circles) 
and treated (open circles) residual solids.  Values are the arithmetic mean of 
triplicate samples; error bars represent one standard deviation. 
  
49 
 
Batch Operating Mode.  Following the semi-continuous flow experimental 
phase, the aerobic digester was shifted to batch mode to determine decay rates for each 
target gene.  As with the previous experimental phase, typically monitored operating 
variables indicated that the digester operated as an appropriate simulation of a full-scale 
aerobic digester.  The pH rose from a semi-continuous phase value between 7 and 7.5 to 
just above 8 following the addition of untreated residual solids, but then gradually 
decreased to between 7 and 7.5.  A substantial decrease in dissolved oxygen 
concentration to less than 1 mg/L was initially observed, but increased to > 4 mg/L 
within 24 hours and remained so for the duration of the batch experiment.     
A significant decay rate was observed for 16S rRNA genes and FIB during 
operation in batch mode (Figure 3.4).  The quantities of 16S rRNA genes decayed by 
90% during the 20-day batch experiment (t1/2 = 5.5 d; Table 3.2).  In contrast, all 
Bacteroides spp. decayed by nearly four orders of magnitude over 20 days (t1/2 = 1.4 d; 
Table 3.2), whereas human-specific Bacteroides spp. decayed to below the detection limit 
within one week of beginning the batch experimental phase (t1/2 = 4.6 d; Table 3.2).  
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Figure 3.4.  The quantities of: (A) 16S rRNA genes, (B) fecal indicator bacteria as 
measured by 16S rRNA genes of all Bacteroides spp., and (C) fecal indicator 
bacteria as measured by 16S rRNA genes of human-specific Bacteroides spp. in 
residual solids undergoing batch treatment.  Values are the arithmetic mean of 
triplicate samples; error bars represent one standard deviation. 
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In contrast to operation in semi-continuous flow mode, the quantities of all of the 
antibiotic resistance determinants, including intI1 and tet(X), declined in the batch 
experimental phase (Figure 3.5).  The quantities of erm(B) and tet(W) declined by 
approximately two orders of magnitude during the 20-day experiment, whereas the 
quantities of intI1, sul1, tet(A), and tet(X) each declined by one order of magnitude 
during the same time period.  Correspondingly, the first-order decay rates varied 
considerably among individual gene targets.  The intI1 and tet(X) genes decayed the most 
slowly, each with a half-life of approximately 6 days (Table 3.2).  These rates of decay 
were statistically similar to each other as well as to the rate of decay for the 16S rRNA 
gene (Table A.2).  In contrast, the first-order decay rates were significantly (P < 0.05) 
more rapid for the remaining gene targets, with half-lives ranging from 2.8 days to 4.6 
days (Table 3.2).  These rates of decay were significantly faster than the decay rate for 
16S rRNA genes (Table A.2). 
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Figure 3.5.  The quantities of: (A) erm(B), (B) intI1, (C) sul1, (D) tet(A), (E) tet(W), 
and (F) tet(X) in residual solids undergoing batch treatment.  Values are the 
arithmetic mean of triplicate samples; error bars represent one standard deviation. 
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Table 3.2.  Summary of first-order degradation kinetic model parameter estimates 
for the 16S rRNA gene, fecal indicator bacteria as measured by 16S rRNA genes of 
all Bacteroides spp., fecal indicator bacteria as measured by 16S rRNA genes of 
human-specific Bacteroides spp., erm(B), intI1, sul1, tet(A), tet(W), and tet(X) during 
batch mode operation.  All rates were regressed from 10 data points (except human-
specific Bacteroides spp., n = 6) and are statistically significant (P < 0.05).   
Gene Target k (day
-1
) ± 
Standard  
Error (day
-1
) 
t1/2 (days)  
16S rRNA gene 0.13 ± 0.008  5.5   
All Bacteroides spp. 0.49 ± 0.048  1.4   
Human-specific Bacteroides spp. 0.15 ± 0.047  4.6   
erm(B) 0.19 ± 0.025  3.6   
intI1 0.11 ± 0.011  6.3   
sul1 0.15 ± 0.009  4.6   
tet(A) 0.16 ± 0.011  4.4   
tet(W) 0.25 ± 0.025  2.8   
tet(X) 0.12 ± 0.006  5.7   
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3.4 Discussion 
The long-term goal of our research is to determine how the numerous 
technologies used to treat municipal wastewater can simultaneously be used to eliminate 
the substantial quantities of ARB and ARGs that are known to exist in untreated sewage.  
The present study makes an important advance in our knowledge by elucidating the 
extent and rate by which aerobic digestion can be used to eliminate ARGs.  This research 
is practically important because the overwhelming majority of ARB and ARGs in raw 
sewage ultimately end up in the residual wastewater solids, and a recent study suggested 
that more than 2,200 municipal wastewater treatment facilities use this technology to 
produce more than 85,000 dry tons of treated wastewater solids in the United States each 
year (186). 
In most cases, the rate of disappearance of different ARGs exceeded that of the 
total number of bacteria (as measured by 16S rRNA gene copies), suggesting that these 
ARGs were actively eliminated during the aerobic digestion process.  Although there is 
only very limited data presently available in the published literature, these disappearance 
rates are generally similar to the rates that were previously observed during anaerobic 
digestion at 37°C (121).  In contrast, the quantities of tet(X) and intI1 decayed at a rate 
similar to that of all bacteria, suggesting that these genes were passively eliminated, 
paralleling the decline in the total number of bacteria.   This observation is substantially 
different than our previous study, in which both tet(X) and intI1 rapidly declined in 
bench-scale anaerobic digestion processes operated at temperatures of 37°C or higher 
(121).  Therefore, the rates by which different ARGs decay in a conventional aerobic 
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digestion process are either similar to or slower than the decay rates observed in 
anaerobic digestion processes.  This apparent inferiority of aerobic digestion is pertinent 
because anaerobic digestion is also a commonly used technology to treat residual 
wastewater solids (184). 
This research also demonstrated that reactor design has a major effect on the fate 
of ARGs during the treatment of residual municipal wastewater solids.  The most obvious 
difference occurred with tet(X), which declined under batch experimental conditions but 
increased substantially in semi-continuous flow conditions.  Similarly, the quantity of 
intI1 declined under batch conditions but remained static during semi-continuous-flow 
operation.  In contrast, model results suggest that the quantities of erm(B) and tet(W) 
declined more rapidly in semi-continuous flow operation than would be suggested by the 
first-order decay coefficient elucidated under batch conditions (analyses not shown).  
Previous researchers have suggested that reactor design affects the removal of ARGs 
during wastewater solids digestion (131); our results support this hypothesis.  Additional 
research is needed to clarify the importance of reactor design and the disappearance of 
ARGs during the digestion of wastewater solids.   
A growing body of evidence suggests that class 1 integrons, which are linked to 
multiple antibiotic resistance, are particularly prominent in wastewater 
(24,32,131,137,198).  Our research has shown significant variation in removal 
efficiencies of intI1 depending on the specific technology (i.e., anaerobic digestion 
achieves better and more efficient removal than aerobic digestion) and the specific 
operating conditions (temperature, flow regime, etc.).  Additional research is needed to 
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better understand the fate and gene cassette content of class 1 integrons in residual solids 
treatment systems. 
Prior research has suggested that sul1 flanks all class 1 integrons (82).  When the 
aerobic digester was operated in semi-continuous flow mode, however, the quantities of 
sul1 genes declined by almost an order of magnitude, whereas the quantities of intI1 were 
similar in the treated and in the untreated residual solids.  Similarly, the rate by which 
sul1 declined in batch operating mode was significantly faster than the rate by which 
intI1 declined (P = 0.01; Table A.2).  This suggests that the coupling of the sul1 gene to 
class 1 integrons is not universal; additional research is needed to better understand the 
relationship between class 1 integrons and sul1 genes in the unit operations used to treat 
wastewater solids.     
The most significant limitation of our research is the use of real-time quantitative 
PCR targeting various ARGs as a surrogate for ARB.  The genes quantified here could be 
present in dead but intact bacteria or in bacteria in which the gene is non-functional.  
Similarly, the identity of the ARB harboring the ARGs detected in this study, and their 
clinical significance, remain unknown.  Finally, only a select group of ARGs were 
targeted; even though these genes represent several important classes of antibiotics and 
all three known molecular mechanisms of resistance to tetracycline, they cover a 
relatively small cross-section of possible resistance gene targets.   
In conclusion, aerobic digestion can be used to eliminate antibiotic resistance 
genes in untreated wastewater solids, but rates can vary substantially depending on the 
reactor design and the specific ARG examined.  This information represents a critical 
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step towards our long-term goal of applying wastewater treatment technologies to 
mitigate the spread of antibiotic resistance.  This knowledge is particularly useful to 
wastewater treatment engineers as they compare the relative merits of alternative residual 
solids treatment technologies and for designing specific unit operations to eliminate 
ARGs.  Specifically, aerobic digestion technology, which is used by numerous full-scale 
municipal wastewater treatment facilities, appears less effective at eliminating ARGs 
than both conventional and high temperature anaerobic digestion. 
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This study investigated whether air-drying beds reduce antibiotic resistance gene 
(ARG) concentrations in residual municipal wastewater solids.  Three laboratory-scale 
drying beds were operated for a period of nearly 100 days.  Real-time PCR was used to 
quantify 16S rRNA genes, 16S rRNA genes specific to fecal bacteria (AllBac) and 
human fecal bacteria (HF183), the integrase gene of class 1 integrons (intI1), and five 
ARGs representing a cross-section of antibiotic classes and resistance mechanisms 
(erm(B), sul1, tet(A), tet(W), and tet(X)).  Air-drying beds were capable of reducing all 
gene target concentrations by 1 to 5 orders of magnitude, and the nature of this reduction 
was consistent with both a net decrease in the number of bacterial cells and lack of 
selection within the microbial community.  Half-lives varied between 1.5 d (HF183) and 
5.4 d (tet(X)) during the first 20 d of treatment.  After the first 20 d of treatment, 
however, half-lives varied between 8.6 d (tet(X)) and 19.3 d (AllBac), and 16S rRNA 
gene, intI1, and sul1 concentrations did not change (P > 0.05).  These results demonstrate 
that air-drying beds can reduce ARG and intI1 concentrations in residual municipal 
wastewater solids within timeframes typical of operating practices. 
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4.1 Introduction 
 Antibiotics are important to the success of modern medicine.  Bacterial resistance 
to antibiotics, however, is believed to be an inevitable consequence of their use and 
eventually negates their benefits (199).  Two solutions to the resistance problem are 
typically employed by medical practitioners.  The first is to prescribe newer antibiotics 
for which there has not been sufficient time for resistance to develop (3).  The second is 
to prescribe a combination of antibiotics to be taken simultaneously; this combination is 
typically lethal to the infectious microorganisms because multiple resistance is not as 
frequent as resistance to a single antibiotic (3).  Unfortunately, both approaches are 
becoming less effective, which has led to a search for new solutions for managing 
antibiotic resistance.   
As part of these efforts, antibiotic resistance genes (ARGs) have been identified 
as an emerging pollutant of concern (5).  As with all pollutants, a critical component of 
elucidating and managing the fate of ARGs is identifying the environmental reservoirs 
from which they are currently discharged.  One of the most important environmental 
reservoirs of ARGs appears to be municipal wastewater.  ARGs have been found in 
relatively high concentrations at almost every point in the municipal wastewater 
treatment process, including the raw influent, primary effluent, aeration tanks, secondary 
effluent, and residual solids (5,10,21–32).  The residual solids are of particular interest 
because they contain the vast majority of prokaryotic biomass in the treatment process, 
and, as a result, the vast majority of ARGs discharged from the treatment process (27).  
Thus, residual municipal wastewater solids treatment could be targeted as a key point in 
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the treatment process to implement strategies to reduce the quantity of ARGs discharged 
from municipal wastewater treatment plants. 
Previous work has demonstrated the potential for some existing treatment 
technologies to reduce concentrations of ARGs in residual municipal wastewater solids.  
For instance, full-scale thermophilic anaerobic digestion has been demonstrated to 
remove substantial fractions (≥ 75%) of intI1, tet(A), tet(O), and tet(X) relative to 16S 
rRNA genes (24).  Furthermore, removal of 80% to 90% of intI1, sul1, sul2, tet(G), and 
tet(X) genes has been demonstrated in laboratory-scale mesophilic anaerobic digestors, 
while similar removal efficiencies have been demonstrated for intI1, sul1, sul2, erm(B), 
erm(F), and tet(W) in laboratory-scale thermophilic anaerobic digestors (131).  Half-lives 
for intI1, tet(A), tet(L), tet(O), tet(W), and tet(X) in anaerobic digestors appear to be on 
the order of days and may decrease with increasing temperature (121).  However, the 
effect that other existing residual solids treatment technologies may have on ARG 
removal is poorly understood.  These alternative technologies (e.g. aerobic digestion, air-
drying, composting, lime stabilization, etc.) might also offer opportunities for reducing 
ARG concentrations in residual solids.  Furthermore, approximately 80% of all treatment 
plants in the country employ technologies other than anaerobic digestion for treatment of 
residual solids (186).  Many of these treatment plants serve small municipalities with 
limited financial and technical resources and, as a result, use less sophisticated types of 
residual solids treatment technology.  Because of this, there is a need to assess the 
treatment potential of these technologies for their ability to remove ARGs.     
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Our overall hypothesis is that existing technologies for treating residual municipal 
wastewater solids can be used to reduce ARG concentrations during solids treatment.  
The goal of the work presented here was to assess the potential of air-drying beds to 
remove ARGs from municipal wastewater solids.  Air drying is designated in the U.S. as 
a “Process to Significantly Reduce Pathogens” (PSRP).  It is used to produce Class B 
treated residual solids at more than 400 U.S. wastewater treatment plants and is also used 
to dewater treated solids at approximately 30% of treatment plants in the United States 
(185,186).  Air drying is accomplished by loading wastewater solids to a relatively 
shallow depth onto an outdoor drying bed, typically constructed of gravel, sand, and 
concrete or wood (184).  The solids are left to dry for a minimum of three months, with 
an average ambient daily temperature above 0°C for at least two of those three months 
(185).  Air-drying beds cause strong odors and tend to require a large physical footprint 
relative to alternative technologies.  However, they are also simple to operate and are 
characterized by relatively low capital costs.  As a result, they may represent a tractable 
strategy for removing ARGs from municipal wastewater solids in smaller treatment 
plants and sparsely populated municipalities if they are found to reduce ARG 
concentrations effectively. 
4.2 Materials and Methods 
Experimental Design.  Three drying beds were constructed outdoors at the 
University of Minnesota.  Each drying bed was approximately 0.6 m wide, 0.6 m long, 
and 0.6 m deep with two 8 cm (diameter) holes drilled in the bottom to allow for water 
drainage.  A 15 cm layer of gravel, covered by a 15 cm layer of sand, was placed into 
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each drying bed to support the residual solids and allow for drainage.  Residual solids, 
which consisted of a mixture of primary and secondary solids, were collected from a full-
scale treatment plant in southern Minnesota.   
Precipitation and temperature data were obtained from the Minnesota 
Climatology Working Group website for National Weather Service Station 214884 (44° 
55’ N, 93° 11’ W) located near St. Anthony Falls, which is approximately 2 km west of 
where the drying beds were located.  Moisture content was quantified periodically by 
collecting and weighing approximately 15 g triplicate samples from each drying bed.  
Solids were dried overnight at 103°C, allowed to cool in a desiccator, and weighed again.  
Moisture content was calculated as the fraction of the total mass lost during the drying 
process. 
Sample Collection and Genomic DNA Extraction.  Three 200 µL replicates 
(for “liquid” samples) or 500 mg replicates (for “dry” samples) were collected directly 
from the surface of each drying bed following thorough horizontal and vertical mixing of 
the drying bed contents.  Each liquid sample was diluted with 500 µL of lysis buffer (120 
mM sodium phosphate buffer, 5% dodecyl sulfate, pH 8.0 ± 0.1) and subjected to three 
consecutive freeze-thaw cycles followed by incubation at 70°C for 90 minutes.  Genomic 
DNA was then extracted using a FastDNA Spin Kit (MP Biomedicals LLC, Solon, OH).  
Each dry sample was stored at -20°C until being mixed with 500 µL of lysis buffer (CLS-
TC, MP Biomedicals LLC, Solon, OH) in bead-beating tubes (Lysis Matrix E, MP 
Biomedicals LLC, Solon, OH).  Each tube was then subjected to bead-beating for 30 s in 
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a Bio101 Savant FastPrep instrument followed by genomic DNA extraction using a 
FastDNA Spin Kit for Soil (MP Biomedicals LLC, Solon, OH).   
Quantitative PCR.  Real-time quantitative PCR (qPCR) was used to quantify the 
concentrations of three tetracycline resistance genes (tet(A), tet(W), and tet(X)), an 
erythromycin resistance gene (erm(B)), a sulfonamide resistance gene (sul1), and the 
integrase gene of class 1 integrons (intI1) (24,95,151,200–202).  The tetracycline 
resistance genes represent each of the three known tetracycline resistance mechanisms: 
efflux pumps, ribosomal protection proteins, and enzymatic modification systems, 
respectively (73).  The erythromycin resistance gene encodes an rRNA methyltransferase 
that confers resistance to macrolides, lincosamides, and streptogramin B (74).  These 
drugs are among the most frequently prescribed antibiotics in human medicine.  Class 1 
integrons were quantified due to their association with multiple antibiotic resistance; they 
enable bacteria to collect multiple, exogenous ARGs and modulate their expression (82).  
Real-time PCR was also used to determine the concentrations of 16S rRNA genes (a 
measure of total bacterial biomass), all Bacteroides spp. 16S rRNA genes (AllBac, a 
measure of total fecal material), and human-specific Bacteroides spp. 16S rRNA genes 
(HF183, a measure of human fecal material) (194–196,203).  The primer sequences, 
expected amplicon size, and annealing temperature of each gene target can be found in 
Table B.1. 
Real-time PCR was carried out using an Eppendorf Mastercycler EP Realplex 
thermal cycler (Eppendorf, Westbury, NY).  PCR assays were optimized to reduce or 
eliminate the formation of primer-dimers and other non-specific products.  Typical qPCR 
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assays began with a 1 min initial denaturation at 95°C, followed by 40 cycles of 
denaturation at 95°C for 15 s and combined annealing and extension at the primer-
specific annealing temperature for 1 min.  Reaction volumes of 25 μL consisted of 12.5 
µL of BioRad iTaq SYBR Green Supermix with ROX (Life Science Research, Hercules, 
CA), 25 µg of bovine serum albumin, optimized quantities of forward and reverse 
primers, and approximately 1 ng of template genomic DNA.  Standards were made from 
PCR products selected from municipal wastewater solids or well-described bacterial 
isolates.  PCR products were ligated into a pGEM-T Easy cloning vector, transformed 
into JM109 competent cells, and extracted from cell cultures using an alkaline lysis 
procedure (197).  The DNA concentrations of qPCR standards were quantified using a 
TD-700 fluorometer and Hoechst 33258 dye.  The standard curve for each real-time PCR 
assay consisted of a 10-fold dilution series of the qPCR standard containing at least 7 
points (r
2
 ≥ 0.99).  Amplification efficiencies were 100% ± 12% (maximum deviation 
from 100%). 
Data Analysis.  Simple linear regression (obtained using Arc 1.06) was used to 
determine the goodness of fit of the data to both a monophasic first-order kinetic model 
and a biphasic first-order kinetic model.  The monophasic first-order kinetic model was 
initially hypothesized based on previous empirical observations that it tends to fit this 
type of data well for a variety of gene targets in several different environmental 
conditions (115,121,170,204).  It also provides a useful interpretive tool and basis of 
comparison to other studies that may consider different gene targets and environmental 
conditions.  However, a formal lack-of-fit test provided evidence that several time series 
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of gene target concentrations varied significantly (P ≤ 0.05)  from the fitted monophasic 
first-order kinetic models (205).  A biphasic first-order model was subsequently 
hypothesized based on the observation that the time series trends of drying bed moisture 
content and several gene targets appeared to be biphasic, with the major switch in rates 
occurring at approximately 20 d.  A biphasic pattern is also consistent with empirical 
observations of the behavior of gene targets representing ARGs in surface waters and 
fecal indicators in manure-amended soils (115,206,207).  The biphasic first-order model 
was constructed by splitting each time series of gene target concentrations into two 
phases and determining independent first-order kinetic fits for each phase using simple 
linear regression (obtained using Arc 1.06).  The first phase of each biphasic model 
contains gene target concentrations for times less than 20 d, while the second phase 
contains gene target concentrations for times greater than 20 d. 
4.3 Results 
Residual municipal wastewater solids in each bed dried substantially over the 
course of the experiment despite several relatively large precipitation events (> 2 cm) 
during the first 50 d (Figure 4.1).  Drying took place over the course of more than 3 
months, during which the ambient air temperature remained above 0°C.  The moisture 
content of the drying solids was approximately 70% after 10 d, which is consistent with 
expectations for full-scale drying beds operated under favorable conditions (184). 
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Figure 4.1.  The (A) moisture content in three replicate drying beds (closed circles, 
open circles, and closed triangles represent unique experimental replicates), (B) 
daily precipitation, and (C) daily maximum (closed circles) and minimum (open 
circles) temperatures.  Values for moisture content are the arithmetic mean of 
triplicate samples; error bars represent one standard deviation. 
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Total bacterial biomass and the concentrations of fecal bacteria decreased over 
time, although they followed separate patterns (Figure 4.2). The concentration of 16S 
rRNA genes decreased by an order of magnitude during the first 10 d and then remained 
constant for the duration of the experiment.  In contrast, the concentration of all 
Bacteroides spp. 16S rRNA genes decreased rapidly by 4 orders of magnitude during the 
first 30 d and continued to decrease for the remainder of the experiment.  Similarly, the 
concentration of human-specific Bacteroides spp. 16S rRNA genes decreased rapidly 
during the first 10 d of the experiment, after which they were below the detection limit 
(5.7107 copies g-1 dry weight).  
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Figure 4.2.  The quantities of (A) 16S rRNA genes, (B) fecal indicator bacteria as 
measured by 16S rRNA genes of all Bacteroides spp. (AllBac), and (C) fecal 
indicator bacteria as measured by 16S rRNA genes of human-specific Bacteroides 
spp. (HF183) in residual solids applied to three replicate drying beds (closed circles, 
open circles, and closed triangles represent unique experimental replicates).  Values 
are the arithmetic mean of triplicate samples; error bars represent one standard 
deviation. 
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Concentrations of all ARGs and intI1 decreased, although the rate and extent 
depended on the specific gene target (Figure 4.3).  Two targets, intI1 and sul1, exhibited 
patterns similar to that of the 16S rRNA gene; they decreased by an order of magnitude 
within the first 10 d and then remained constant for the remainder of the experiment.  In 
contrast, concentrations of erm(B), tet(A), and tet(W) all decreased by 4 to 5 orders of 
magnitude during the course of the experiment.  The concentration of tet(X), however, 
exhibited a unique pattern among the gene targets examined in this study.  The tex(X) 
concentration initially decreased by an order of magnitude within the first 10 d, but then 
increased by nearly 2 orders of magnitude by 27 d, after which it again decreased for the 
remainder of the experiment. 
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Figure 4.3.  The quantities of intI1, sul1, erm(B), tet(A), tet(W), and tet(X) in residual 
solids applied to three replicate drying beds (closed circles, open circles, and closed 
triangles represent unique experimental replicates).  Values are the arithmetic mean 
of triplicate samples; error bars represent one standard deviation. 
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The ratios of ARGs and intI1 to the 16S rRNA gene concentration exhibited 
distinct patterns compared to absolute concentrations (Figure 4.4).  The ratios of intI1 and 
sul1 to the 16S rRNA gene remained constant throughout the experiment, while the ratios 
of tet(A) and tet(W) to the 16S rRNA gene remained constant for time less than 20 d, 
after which they decreased.  Only the ratio of erm(B) decreased throughout the course of 
the experiment relative to 16S rRNA genes, and the ratio of tet(X) to 16S rRNA genes 
initially increased for the first 20 d, after which it decreased. 
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Figure 4.4.  The ratios of intI1, sul1, erm(B), tet(A), tet(W), and tet(X) to the 16S 
rRNA gene in residual solids applied to three replicate drying beds (closed circles, 
open circles, and closed triangles represent unique experimental replicates).  Values 
are the arithmetic mean of triplicate samples; error bars represent one standard 
deviation. 
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  A biphasic first-order kinetic model fit the data better than a monophasic first-
order kinetic model for concentrations of ARGs and intI1 (Table 4.1 and Table 4.2).  
When the concentrations of each gene target were modeled as monophasic first-order 
kinetic processes, half-lives varied between 1.5 d (16S rRNA gene of human-specific 
Bacteroides spp.) and 36.7 d (16S rRNA gene).  However, according to lack-of-fit P 
values, only the concentrations of tet(A) and the 16S rRNA gene from human-specific 
Bacteroides spp. fit a monophasic first-order model well (P > 0.05).  In contrast, 15 of 17 
time series for the biphasic models are characterized by favorable (P > 0.05) lack-of-fit P 
values.  Half-lives for concentrations of gene targets in the first 20 d of the experiment 
varied between 1.5 d for the human-specific Bacteroides spp. 16S rRNA gene and 5.4 d 
for tet(X).  Half-lives for concentrations of gene targets after the first 20 d varied between 
8.6 d for tet(X) and 19.3 d for all Bacteroides spp. 16S rRNA genes, while concentrations 
of the 16S rRNA gene, intI1, and sul1 did not change (P > 0.05).   
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Table 4.1.  First-order kinetic coefficients (k)
a
, half-lives (t1/2), r
2
, and lack-of-fit P from monophasic first-order kinetic models 
of gene target concentrations in 3 replicate drying beds. 
Gene Target k (d
-1
) ± 
Std. Error 
(d
-1
) 
t1/2 (d) r
2
 Lack-of-fit P 
16S rRNA gene -1.910-2 ± 6.810-3 36.7 0.29 < 110-4 
all Bacteroides spp. -1.310-1 ± 1.510-2 5.4 0.79 < 110-4 
human-specific Bacteroides spp. -4.710-1 ± 3.910-2 1.5 0.95 0.99 
erm(B) -1.110-1 ± 1.210-2 6.4 0.81 < 110-4 
intI1 -2.210-2 ± 7.210-3 31.7 0.32 210-5 
sul1 -2.010-2 ± 6.210-3 35.3 0.34 0.05 
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tet(A) -7.910-2 ± 8.710-3 8.8 0.81 0.34 
tet(W) -9.510-2 ± 8.210-3 7.3 0.88 < 110-4 
tet(X) -4.010-2 ± 7.910-3 17.2 0.58 110-4 
a
All kinetic coefficients were regressed from 21 data points (7 time points  3 replicate drying beds), except for the human-
specific Bacteroides spp. coefficient, which was regressed from 9 data points (3 time points  3 replicate drying beds).  All 
kinetic coefficients are statistically significant (P < 0.05). 
  
77 
 
Table 4.2.  First-order kinetic coefficients (k)
a
, half-lives (t1/2), r
2
, P, and lack-of-fit P from biphasic first-order kinetic models of 
gene target concentrations in 3 replicate drying beds. 
Gene Target Phase k (d
-1
) ± 
Std. Error 
(d
-1
) 
t1/2 (d) r
2
 P Lack-of-fit P 
16S rRNA gene < 20 days -2.210-1 ± 2.210-2 3.2 0.91 < 110-4 0.12 
16S rRNA gene > 20 days -3.510-3 ± 5.310-3 200.8 0.06 0.54 0.28 
all Bacteroides spp. < 20 days -3.610-1 ± 1.610
-2
 1.9 0.98 < 110-4 0.05 
all Bacteroides spp. > 20 days -3.610-2 ± 4.510
-3
 19.3 0.90 110-4 0.22 
human-specific Bacteroides spp. < 20 days -4.710-1 ± 3.910
-2
 1.5 0.95 < 110-4 0.99 
human-specific Bacteroides spp. > 20 days ND
b
 ND ND ND ND 
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erm(B) < 20 days -4.210-1 ± 3.010
-2
 1.6 0.95 < 110-4 0.09 
erm(B) > 20 days -6.710-2 ± 1.210
-2
 10.4 0.81 910-4 0.66 
intI1 < 20 days -1.710-1 ± 3.310
-2
 4.1 0.72 510-4 0.08 
intI1 > 20 days -5.110-3 ± 1.310
-2
 136.0 0.02 0.71 0.35 
sul1 < 20 days -1.410-1 ± 1.710
-2
 5.1 0.86 < 110-4 0.32 
sul1 > 20 days 210-4 ± 1.310
-2
 -3,191.3 0.00 0.99 0.83 
tet(A) < 20 days -2.110-1 ± 3.510
-2
 3.4 0.78 110-4 0.14 
tet(A) > 20 days -6.310-2 ± 2.010
-2
 11.0 0.58 210-2 0.84 
tet(W) < 20 days -1.810-1 ± 1.610
-2
 3.9 0.92 < 110-4 0.29 
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tet(W) > 20 days -4.710-2 ± 9.510
-3
 14.7 0.78 210-3 0.13 
tet(X) < 20 days -1.310-1 ± 2.010
-2
 5.4 0.80 110-4 0.03 
tet(X) > 20 days -8.110-2 ± 1.110
-2
 8.6 0.89 110-4 0.24 
a
All kinetic coefficients for time less than 20 d were regressed from 12 data points (4 time points  3 replicate drying beds), 
except for the human-specific Bacteroides spp. coefficient, which was regressed from 9 data points (3 time points  3 replicate 
drying beds).  All kinetic coefficients for time greater than 20 d were regressed from 9 data points (3 time points  3 replicate 
drying beds).   
b
Human-specific Bacteroides spp. were below the detection limit (5.7107 copies g-1 dry weight) for time greater than 20 d, so k 
was not determined (ND). 
 
80 
 
A biphasic first-order kinetic model also fit well for the ratios of ARGs and intI1 
to the 16S rRNA gene (Table 4.3).  During the first 20 d of the experiment, the half-life 
for the ratio of erm(B) to 16S rRNA genes was 3.3 d, and the ratio of tet(A) to 16S rRNA 
genes did not change (P > 0.05).  Ratios of the remaining ARGs and intI1 to 16S rRNA 
genes actually increased (P ≤ 0.05) during the first 20 d, with doubling times varying 
between 7.9 d for tet(X) and 16.9 d for tet(W).  After the first 20 d, the ratios of intI1 and 
sul1 to 16S rRNA genes did not change (P > 0.05), while half-lives for ratios of the 
remaining ARGs to 16S rRNA genes varied between 9.0 d for tet(X) and 15.9 d for 
tet(W).
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Table 4.3.  First-order kinetic coefficients (k)
a
, half-lives (t1/2), r
2
, P, and lack-of-fit P from biphasic first-order kinetic models of 
gene target to 16S rRNA gene ratios in 3 replicate drying beds. 
Gene Target Phase k (d
-1
) ± 
Std. Error 
(d
-1
) 
t1/2 (d) r
2
 P Lack-of-fit P 
erm(B) < 20 days -2.110-1 ± 1.210-2 3.4 0.97 < 110-4 0.01 
erm(B) > 20 days -6.310-2 ± 1.110-2 11.1 0.82 810-4 0.29 
intI1 < 20 days 5.010-2 ± 1.210
-2
 -13.8 0.63 210-3 0.04 
intI1 > 20 days -1.610-3 ± 1.210
-2
 421.3 0.00 0.89 0.09 
sul1 < 20 days 8.210-2 ± 8.110
-3
 -8.5 0.91 < 110-4 0.02 
sul1 > 20 days -2.710-3 ± 8.110
-3
 259.5 0.02 0.75 0.69 
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tet(A) < 20 days 1.110-2 ± 1.410
-2
 -63.5 0.06 0.45 0.24 
tet(A) > 20 days -6.010-2 ± 1.910
-2
 11.7 0.59 210-2 0.94 
tet(W) < 20 days 4.110-2 ± 8.210
-3
 -16.9 0.71 610-4 0.02 
tet(W) > 20 days -4.410-2 ± 1.210
-2
 15.9 0.64 110-2 0.09 
tet(X) < 20 days 8.810-2 ± 1.410
-2
 -7.9 0.79 110-4 910-3 
tet(X) > 20 days -7.710-2 ± 1.010
-2
 9.0 0.89 110-4 0.05 
a
All kinetic coefficients for time less than 20 d were regressed from 12 data points (4 time points  3 replicate drying beds).  All 
kinetic coefficients for time greater than 20 d were regressed from 9 data points (3 time points  3 replicate drying beds). 
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4.4 Discussion 
Air-drying beds can be used to reduce ARG concentrations in residual municipal 
wastewater solids.  In this study, the concentrations of gene targets for erm(B), tet(A), 
tet(W), and tet(X) were reduced by 2 to 5 orders of magnitude over the course of 100 d, 
while concentrations of the most persistent gene targets in the group, intI1 and sul1, were 
reduced by approximately an order of magnitude.  The extents of gene loss found here are 
comparable to those found for the same genes in other treatment technologies, including 
mesophilic anaerobic digestion, thermophilic anaerobic digestion, and aerobic digestion 
(24,121,131,204).  Thus, small municipalities with limited resources, which are likely to 
find drying beds appealing for residual solids treatment due to their low capital and 
operating costs, may be able to achieve significant reduction of ARG concentrations with 
air-drying beds.  Furthermore, municipalities that use drying beds for dewatering treated 
residual solids (approximately 30% in the U.S.) may be able to use air-drying beds to 
provide further ARG removal in addition to that achieved by upstream treatment units 
(186).    
Drying beds, however, do not reduce ARG concentrations in residual municipal 
wastewater solids as quickly as other treatment technologies.  The half-lives determined 
here for erm(B), intI1, sul1, tet(A), tet(W), and tet(X) within the first 20 d of treatment in 
drying beds are similar to those in aerobic digestion at approximately 20°C, where they 
vary between approximately 3 and 6 d (204).  However, half-lives for intI1, tet(A), 
tet(W), and tet(X) vary between 0.7 and 5 d in mesophilic anaerobic digestion and 
between 0.2 and 2 d in thermophilic anaerobic digestion (121).  As a result, air-drying 
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beds may not be as practical an option for removing ARGs at wastewater treatment plants 
with large flow volumes, because the relatively slow kinetics will require treatment units 
with extremely large physical footprints.  
The persistence of intI1, which represents class 1 integrons, may be of particular 
concern.  Integrons enable bacteria to collect and manage multiple exogenous genes with 
little or no genetic cost (82).  When integrons contain multiple ARGs, they may result in 
microorganisms resistant to multiple antibiotics, which are the most difficult to treat in 
patients with antibiotic resistant infections.  Thus, the most persistent gene target 
considered in this work may also represent the genetic element with the most serious 
consequences for human health.  However, the relationship between class 1 integrons and 
the ARGs considered in this work is not clear, because ARG concentrations decrease 
substantially while concentrations of intI1 are relatively persistent.  Future work should 
be directed at determining the genetic content of integrons that persist during residual 
solids treatment (198).  If these integrons are found to harbor multiple ARGs, then intI1 
may qualify for consideration as a “design gene”.  Under the “ARGs are pollutants” 
paradigm, the design gene would be the gene that limits the design (e.g. tank size) of 
individual treatment units because its concentration is reduced most slowly among all the 
potential genes that might be of interest due to their consequences for human health.     
We hypothesize that reduction of ARG and intI1 concentrations in residual 
municipal wastewater solids during this study was due to both a net decrease in the 
number of bacterial cells (i.e. 16S rRNA genes) and lack of selection for ARGs within 
the bacterial community.  The biphasic first-order kinetic model shows that 
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concentrations of all ARGs and intI1 are reduced relatively quickly within the first 20 d, 
after which degradation appears to slow down significantly or stop (Table 4.2).  The rates 
at which intI1 and sul1 concentrations are reduced relative to 16S rRNA genes, however, 
are not statistically significant throughout the course of the experiment (Table 4.3).  
Furthermore, the first-order rate coefficients for tet(A) and tet(W) normalized to 16S 
rRNA genes are also not statistically significant for time less than 20 d, while 
concentrations of tet(X) normalized to 16S rRNA genes increase for time < 20 d.  Thus, 
all reduction of these gene concentrations during the first 20 d appears to be due to a net 
decrease in the number of bacterial cells (i.e. reduction of 16S rRNA gene 
concentrations), while any reduction that takes place after 20 d for tet(A), tet(W), and 
tet(X) appears to be due to lack of selection for ARGs within the microbial community.  
As a result, the overall first-order rate coefficients for concentrations of all ARGs and 
intI1 (Table 4.2) in each phase are equal to the sum of the 16S rRNA gene first-order rate 
coefficient for that phase and the first-order rate coefficient for the ARG (or intI1) 
relative to 16S rRNA genes for that same phase (Table 4.3).  This suggests that ARGs 
can be removed from residual municipal wastewater solids both by enhancing net cell 
death and by optimizing conditions in treatment units to avoid selection for known 
ecological characteristics (e.g. redox regime) of particular ARGs.     
Although the approach used here provides the advantages of being quantitative 
and culture-independent, it has several significant limitations.  First, our real-time qPCR 
protocol does not provide the capability to distinguish between genes that are in live or 
dead bacterial cells.  Similarly, our qPCR protocol does not indicate whether genes can 
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be expressed in their current bacterial hosts.  Finally, this study investigates only a small 
fraction of the known ARGs.  For example, at least 30 ARGs are known to encode 
tetracycline resistance, yet we have considered only 3 (73).  We have attempted to 
include a cross-section of resistance mechanisms, antibiotic classes, and genes of clinical 
relevance, but the fate of the ARGs considered here does not necessarily reflect that of all 
ARGs. 
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Chapter 5: The Kinetics of Declining Antibiotic Resistance Gene and 
Class 1 Integron Quantities During Hyperthermophilic Anaerobic 
Digestion of Residual Municipal Wastewater Solids 
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A number of treatment technologies have been investigated for their potential to 
remove antibiotic resistance genes (ARGs), which are increasingly regarded as 
environmental pollutants, from residual municipal wastewater solids.  The work 
presented here investigates hyperthermophilic (≥ 60°C) anaerobic digestion for this 
purpose.  Four laboratory-scale anaerobic digesters were operated in eight-day batch 
cycles at temperatures of 40°C, 56°C, 60°C, and 63°C.  Two tetracycline resistance genes 
(tet(W) and tet(X)), a fluoroquinolone resistance gene (qnrA), the integrase gene of class 
1 integrons (intI1), the origin of replication of incompatibility group A/C plasmids 
(repA), 16S rRNA genes, 16S rRNA genes of all Bacteroides spp. (AllBac), and 16S 
rRNA genes of methanogens were quantified using real-time PCR.  ARG and intI1 
quantities decreased at all temperatures, and the form of most of these decreases was 
found to best fit a modified form of the Collins-Selleck disinfection kinetic model.  The 
magnitude of Collins-Selleck kinetic parameters tended to increase with temperature, 
although these increases were often not statistically significant (P ≥ 0.05).  This work 
demonstrates the potential for hyperthermophilic anaerobic digestion to be an effective 
technology for removing ARGs and intI1 from residual municipal wastewater solids.  It 
also demonstrates the benefits of a modified form of the Collins-Selleck kinetic model for 
describing trends of ARG and intI1 quantities with time during semi-batch anaerobic 
digestion of residual municipal wastewater solids. 
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5.1 Introduction 
 Pathogenic resistance to antibiotic chemotherapy is a significant public health 
dilemma.  Antibiotic resistant infections account for at least two million illnesses and 
23,000 deaths per year in the United States (65).  Meanwhile, the rate of antibiotic 
development has slowed considerably in recent years, from more than 15 new approved 
drugs between 1980 and 1984 to just one between 2010 and 2012 (65).  Potential 
solutions to antibiotic resistance include redoubling efforts to develop new antibiotics, 
developing alternatives to antibiotics, and making major policy decisions to use 
antibiotics more frugally (e.g. in agriculture) (2,87–89,188).  This multi-component 
approach is likely to continue well into the future, and researchers from the 
environmental science and engineering community have recently proposed an additional 
component to complement existing strategies.  This new approach relies on identifying 
antibiotic resistance genes (ARGs) as environmental contaminants (5), identifying their 
environmental reservoirs, and developing technology and management strategies to 
minimize their discharge from these reservoirs.    
 One of the largest identified reservoirs appears to be residual municipal 
wastewater solids (27).  Prior research has demonstrated that existing treatment 
technologies can reduce the quantities of ARGs and intI1 discharged from the municipal 
wastewater treatment process in treated residual wastewater solids.  These technologies 
include air-drying beds, mesophilic and thermophilic aerobic digestion, and mesophilic 
and thermophilic anaerobic digestion (121,131,204,208).  Among these, variants of 
anaerobic digestion seem critically important because mesophilic anaerobic digestion is 
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currently used to treat approximately 50% of all residual municipal wastewater solids 
produced in the United States (186), and thermophilic anaerobic digestion represents an 
infrastructural and operational upgrade to mesophilic anaerobic digestion that could be 
pursued as an alternative treatment strategy if found to be more effective at removing 
ARGs from residual wastewater solids.  
Thermophilic anaerobic digestion has been demonstrated to substantially 
outperform mesophilic anaerobic digestion at times, although the benefits of increasingly 
higher temperatures are not clear, and the relative performance of the two technologies 
appears to vary a great deal based on flow regime in addition to temperature.  For 
instance, semi-continuous-flow thermophilic (47°C, 52°C, and 59°C) digestion has been 
demonstrated to achieve up to one to three orders of magnitude greater removal of 
erm(B), erm(F), tet(O), and tet(W) compared to mesophilic (37°C) anaerobic digestion, 
although differences in extent of ARG removal among the three thermophilic digestion 
temperatures were frequently not obvious (131).  In the same work, semi-continuous-
flow thermophilic digestion at all three temperatures also performed the same or worse 
for removing intI1, sul1, sul2, tet(C), tet(G), and tet(X) relative to mesophilic anaerobic 
digestion (131).  In contrast, semi-batch thermophilic (55°) anaerobic digesters operated 
in five-day batch cycles were shown to reduce  quantities of intI1, tet(A), tet(O), tet(W), 
and tet(X) by an additional order of magnitude relative to mesophilic (37°C) anaerobic 
digesters operated under otherwise similar conditions (121).  A similar dependence of the 
extents of removal for ARGs and intI1 on flow regime has also been demonstrated for 
aerobic digestion at 15°C (204). 
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 The objective of this work was to assess the potential for semi-batch 
hyperthermophilic (≥ 60°C) anaerobic digestion to remove ARGs and intI1 from residual 
municipal wastewater solids.  It was hypothesized that, just as thermophilic anaerobic 
digestion increased rates of removal relative to mesophilic anaerobic digestion during 
semi-batch treatment, increasing digestion temperatures into the hyperthermophilic range 
would provide even faster rates of removal.  The experiment described here was designed 
to produce relatively long batch periods of anaerobic digestion to facilitate kinetic 
modeling and to maximize differences in the degree of ARG and intI1 removal among 
different temperatures.  Two hyperthermophilic digesters were operated at 60°C and 
63°C.  Two additional digesters were operated at 40°C and 56°C in order to act as 
experimental controls.  All four digesters were operated for ten eight-day batches at 
relatively steady end-of-batch residence times.  The influent (untreated residual 
municipal wastewater solids) and effluent of each digester were sampled for all ten 
batches, and within-batch time series of samples were collected for each of the final three 
batches.  Real-time PCR was used to quantify bacterial 16S rRNA genes, 16S rRNA 
genes of all Bacteroides spp. (AllBac), 16S rRNA genes of methanogens, intI1, qnrA, 
repA, tet(W), and tet(X) in all samples.  Data from the first seven batches for each 
digester were used to assess the degree to which digesters achieved consistent removal of 
each gene target, and data from the final three batches for each digester were fit against 
first-order, second-order, and a modified form of the Collins-Selleck kinetic expressions 
in order to determine their goodness of fit to those models. 
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5.2 Materials and Methods 
Experimental Design.  Four six-L anaerobic digesters were inoculated with a 
mixture of untreated residual municipal wastewater solids and mesophilic anaerobic 
digester solids from a full-scale municipal wastewater treatment plant in southern 
Minnesota.  The digesters were operated at temperatures of 40°C, 56°C, 60°C, and 63°C 
with residence times between 32 and 36 days.  Mixing was provided by magnetic stir 
plates and heating was provided by heat tape controlled by Johnson Controls A419ABG-
3C Electronic Temperature Controls equipped with Johnson Controls A99B Series 
Temperature Sensors (Johnson Controls, Milwaukee, WI).  After each digester achieved 
consistent methane production, the four digesters were operated for 80 days while being 
fed untreated residual municipal wastewater solids every eight days.  Samples were 
collected for genomic DNA extraction from each digester at the end of each of the first 
seven eight-day batches and at six time points within each of the final three eight-day 
batches.  Samples were collected for genomic DNA extraction from the untreated 
residual municipal wastewater solids at the beginning of each eight-day batch.   
Typical operating variables, including temperature, pH, total solids (TS), volatile 
solids (VS), inert solids (IS), gas production, and gas methane content were monitored 
throughout the entire time period the digesters were in operation.  Temperature was read 
directly from the A419ABG-3C Electronic Temperature Control units, while pH was 
measured using a Corning 430 (Corning, Tewksbury, MA) pH meter and a Pinnacle 
Model 476466 3-in-1 Electrode (Nova Analytics Corporation, Woburn, MA).  TS was 
measured by collecting approximately 50-mL triplicate samples from each digester and 
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recording the fraction of mass remaining for each sample following overnight oven-
drying at 103°C to 105°C.  VS was measured by combusting the remaining oven-dried 
fraction of each sample at 550°C for at least two hours and recording the fraction of mass 
lost during combustion.  Gas production was measured by collecting the gas produced 
during each feeding cycle in a 16-L Tedlar bag and then forcing the contents of the bag 
through a gas meter and recording the total volume of gas that had been contained in the 
bag.  Finally, methane content was measured using a Hewlett Packard HP 6890 Series 
gas chromatographer (GC) with a thermal conductivity detector (TCD).     
 Sample Collection and Genomic DNA Extraction.  Triplicate samples (100 µL) 
were collected from larger aliquots (50 to 300 mL) of digester contents to ensure accurate 
sample collection volumes.  Samples were then diluted with 500 µL of lysis buffer (120 
mM sodium phosphate buffer, 5% dodecyl sulfate, pH 8.0 ± 0.1) and subjected to three 
consecutive freeze-thaw cycles followed by incubation at 70°C for 90 minutes.  Genomic 
DNA was extracted using a FastDNA SPIN Kit (MP Biomedicals LLC, Solon, OH) 
according to the manufacturer’s instructions.   
 Quantitative PCR.  Real-time PCR was conducted to quantify 16S rRNA genes, 
AllBac, 16S rRNA genes of methanogens, the integrase gene of class 1 integrons (intI1), 
a fluoroquinolone resistance gene (qnrA), and two tetracycline resistance genes (tet(X) 
and tet(W)) as described previously (8,24,95,195,196,201,209).  The 16S rRNA gene was 
quantified as a measure of total bacterial biomass, AllBac was used as a representative 
fecal indicator, and 16S rRNA genes of methanogens were quantified as an additional 
line of evidence for methanogenesis in the anaerobic digesters.  The integrase of class 1 
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integrons was quantified due to its association with multiple antibiotic resistance and 
horizontal gene transfer (82).  The fluoroquinolone resistance gene was quantified 
because it confers resistance to one of the most recently developed and widely used 
human antibiotics.  Finally, the tetracycline resistance genes represent two of the three 
known tetracycline resistance mechanisms: enzymatic modification systems (tet(X)) and 
ribosomal protection proteins (tet(W)) (73).  Furthermore, tet(X) requires the presence of 
oxygen to be expressed (210,211), while tet(W) tends to be found in anaerobic 
microorganisms (212).  As a result, these genes may be expected to exhibit divergent 
fates during anaerobic digestion of residual municipal wastewater solids as has been 
demonstrated for aerobic digestion of residual municipal wastewater solids (204).  Real-
time PCR was also used to quantify the origin of replication (replication initiation protein 
A) for incompatibility group A/C plasmids (repA).  The repA method was developed in 
collaboration with Timothy Johnson and Kevin Lang of the University of Minnesota 
Department of Veterinary and Biomedical Sciences (St. Paul, Minnesota, United States).  
Table C.1 contains the forward and reverse primer sequences, expected amplicon sizes, 
and primer annealing temperatures for all gene targets considered in this work 
(8,24,95,195,196,201,213). 
 Real-time PCR assays were carried out on an Eppendorf Mastercycler EP 
Realplex thermal cycler (Eppendorf, Westbury, NY).  Thermal cycles began with 1 min 
of initial denaturation at 95°C, followed by 40 cycles of denaturation at 95°C for 15 s and 
combined annealing and extension for 1 min at the primer-specific annealing 
temperature.  PCR assays were optimized to reduce or eliminate the formation of primer 
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dimers, and melting curves were conducted for all assays following amplification to 
screen for non-specific products.  Melting curves began with 15 s at the primer-specific 
annealing temperature followed by a 20 min ramp up to 95°C and a final hold at 95°C for 
15 s.  Reaction volumes were 25 µL and consisted of 12.5 µL of BioRad iTaq SYBR 
Green Supermix with ROX (Life Science Research, Hercules, CA) or iTaq Universal 
SYBR Green Supermix (Life Science Research, Hercules, CA), 25 µg of bovine serum 
albumin, 12.5 pmol of forward primer, 6.25 pmol of reverse primer, and approximately 1 
ng of template genomic DNA.  Standards were prepared by initially amplifying gene 
targets from well-described bacterial isolates or municipal wastewater solids using PCR.  
PCR products were then ligated into the pGEM-T Easy cloning vector and transformed 
into either JM109 or DH5α competent cells.  Cloned plasmids were extracted from cell 
cultures using either an alkaline lysis procedure (197) or a QIAprep Spin Miniprep Kit 
(Qiagen, Valencia, CA).  Plasmid DNA concentrations in these extracts were determined 
using a TD-700 fluorometer and Hoechst 33258 dye.  Separate standard curves were 
constructed for each individual assay (i.e. each 96-well plate contained a standard curve), 
and each standard curve consisted of a 10-fold serial dilution of an aliquot of plasmid 
DNA extract.   The number of standards, slope, intercept, amplification efficiency, r
2
, and 
quantification limit for each standard curve are provided in Appendix C (Table C.2).  Of 
the 32 assays performed, 19 (59%) had amplification efficiencies of 100% ± 10% 
(maximum deviation from 100%) with r
2
 ≥ 0.99 for a minimum of six points on each 
standard curve.  The absolute values by which amplification efficiencies for the 
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remaining 13 assays deviated from 100% were between 11% and 19% with r
2
 ≥ 0.99 for 
a minimum of seven points on each standard curve. 
Each triplicate sample was analyzed once to produce triplicate analytical 
measurements for each soil microcosm on each sample date.  Thus, these triplicate 
measurements reflect the combined variability of DNA extraction and real-time PCR.  
Values represented in figures and tables are typically the arithmetic mean of triplicate 
measurements.  If, however, only one sample in a triplicate set amplified for any given 
gene target, then that value was discarded and the set of triplicates that it belonged to 
were collectively reported as less than the quantification limit.  If two samples in a 
triplicate set amplified, then the arithmetic mean of those two values was reported as 
representing the set of triplicates that they belonged to.  These cases are referred to as 
being duplicate samples in figure captions.  
 Data Analysis.  Linear regression (R 2.15.0) was used to estimate the goodness of 
fit of the data from the final three eight-day batches for each digester to several kinetic 
models including a first-order kinetic model (Equation 5.1), a second-order kinetic model 
(Equation 5.2), and a modified form of the Collins-Selleck disinfection model (Equation 
5.3) (214,215).  A first-order kinetic model was initially hypothesized because previous 
work has shown the decline of ARG and intI1 quantities in several different types of 
natural and engineered systems to follow first-order trends (115,121,170,204,206,208).  
First-order kinetic models also provide a valuable descriptive and interpretive tool that is 
useful for comparing results across different gene targets and environments.  However, a 
formal lack-of-fit test (205) provided strong evidence against the null hypothesis that the 
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natural logarithm of gene target quantities (or ARG and intI1 ratios to 16S rRNA gene 
quantities) varied linearly with respect to time for a large fraction of the time series in this 
data set.  As a result, the other two kinetic models were investigated to determine if either 
provided a more suitable fit to the data.  A formal non-constant variance test (205) was 
also used to test the null hypothesis that any given transformation of the data, 
corresponding to a particular kinetic model, produced a distribution of errors with 
constant variance as a function of the fitted model values. 
Equation 5.1:  
  
  
    
Equation 5.2:  
  
  
     
Equation 5.3:  
    (
 
 
)
 
 
The first-order and second-order models were fit to the data by integrating the 
differential kinetic expressions and solving for a linear relationship between gene target 
concentration (C) and time (t) to fit to the general form of the linear regression 
expression.  The modified Collins-Selleck expression replaces the unitless Collins-
Selleck coefficient of specific lethality (−ΛCS) from the traditional Collins-Selleck model 
(214) with a unitless generic kinetic parameter (k) and models analyte concentration (C) 
as a function of time (t) rather than chlorine dose (Ct).  In this context, time can be 
thought of as representing a “dose” of anaerobic digestion at a given temperature.  The 
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modified Collins-Selleck model was fit to the data by taking its logarithm and solving for 
a linear relationship between the logarithm of C and the logarithm of t. 
5.3 Results 
Operating Conditions.  The digesters operated as adequate experimental 
simulations of full-scale anaerobic digesters while achieving the intended experimental 
temperature and flow-regime characteristics (Figure 5.1, Figure 5.2, Figure 5.3, Figure 
5.4, Figure C.1, Figure C.2, and Figure C.3).  Although the temperature of each digester 
varied substantially on a day-to-day basis, the differences in mean temperature among all 
the digesters over the entire 80-day experiment were statistically significant (P ≤ 110-6, 
Welch’s t-tests).  The mean hydraulic residence times at the end of batches varied 
between averages of approximately 33 (56°C) and 37 (40°C) days and pH was 
circumneutral in each digester over the entire course of the experiment.  Total solids in 
the untreated residual municipal wastewater solids declined from approximately 5% to 
just over 4%, while total solids in the anaerobic digesters remained relatively constant 
between 3.5% and 4%.  Similarly, volatile solids in the untreated residual municipal 
wastewater solids declined steadily from approximately 3.5% to 3%, while volatile solids 
in the anaerobic digesters remained relatively constant between approximately 2% and 
2.5%.  Total solids removal efficiencies in the digesters varied between 12% (at 60°C) 
and 24% (at 40°C), while volatile solids removal efficiencies in the digesters varied 
between 25% (at 60°C) and 37% (at 40°C).  The gas production and gas methane content 
for the mesophilic (40°C) digester differed from that of the thermophilic and 
hyperthermophilic digesters.  Both gas production and methane content varied 
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considerably over time at 40°C, with a major peak in both quantities at 40 d.  In contrast, 
gas production and methane content varied less for the thermophilic and 
hyperthermophilic digesters and was substantially lower than peak methane content at 
40°C (approximately 20% versus more than 60%).  The methane production normalized 
to volatile solids destruction at 40°C, 56°C, 60°C, and 63°C was 169 ± 137, 73 ± 62, 39 ± 
32, and 90 ± 49 (mean ± standard deviation) L CH4 kg
-1
 VS destroyed, respectively.            
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Figure 5.1.  The temperatures of anaerobic digesters operated at nominal 
temperatures of 40°C, 56°C, 60°C, and 63°C.  Dashed lines represent the mean 
temperature for each digester.  These values were 39.9°C ± 3.4°C, 55.7°C ± 2.2°C, 
60.3°C ± 2.3°C, and 63.4°C ± 2.9°C (mean ± standard deviation). 
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Figure 5.2.  The mean hydraulic residence time (HRT) for each of four anaerobic 
digesters operated at nominal temperatures of 40°C, 56°C, 60°C, and 63°C.  Dashed 
lines represent the mean value of HRT at the end of batches.  These values were 35.7 
± 1.2, 32.5 ± 0.8, 35.0 ± 0.8, and 33.0 ± 0.7 days (mean ± standard deviation), 
respectively.   
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Figure 5.3.  The volatile solids content of untreated residual municipal wastewater 
solids and four anaerobic digesters operated at nominal temperatures of 40°C, 56°C, 
60°C, and 63°C.  Values are the arithmetic mean of triplicate samples; error bars 
represent one standard deviation.    
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Figure 5.4.  The methane content of gas produced by anaerobic digesters operated 
at nominal temperatures of 40°C, 56°C, 60°C, and 63°C.  Values are the arithmetic 
mean of three or more samples; error bars represent one standard deviation.  
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Gene Target Quantities in Untreated Residual Solids.  Quantities of all gene 
targets were relatively consistent with time in untreated residual municipal wastewater 
solids, although they varied considerably across gene targets (Figure 5.5, Figure 5.6, 
Figure C.4, and Figure C.5).  Quantities of 16S rRNA genes were approximately 11012 
copies mL
-1
 and were considerably less variable than quantities of AllBac or methanogen 
16S rRNA genes.  Methanogen 16S rRNA genes made up approximately 0.2% of the 
community’s 16S rRNA genes, while AllBac quantities were approximately twice as high 
as 16S rRNA genes.  This discrepancy appears to be the result of an inaccurately 
quantified AllBac standard, and as a result, AllBac quantities in this work are less 
accurate than those of other gene targets.  Relative changes of AllBac quantities remain 
valid, however, because the same AllBac standard was used for all AllBac assays.  
Quantities of ARGs, intI1, and repA were all lower than those of 16S rRNA genes and 
varied considerably from gene to gene.  Quantities of intI1 and tet(W) were the highest 
among this group, on the order of 10
10
 copies mL
-1
, and were more numerous than 
methanogen 16S rRNA genes.  Quantities of qnrA and repA were considerably lower, on 
the order of 10
7
 copies mL
-1
.  The ratios of ARGs, intI1, and repA to 16S rRNA genes 
exhibited the same relative relationships as the volume-normalized quantities.   
105 
 
 
Figure 5.5.  Quantities of 16S rRNA genes, AllBac, and methanogen 16S rRNA 
genes in untreated residual municipal wastewater solids.  Values are the arithmetic 
mean of triplicate samples; error bars represent one standard deviation. 
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Figure 5.6.  Quantities of ARGs, intI1, and repA in untreated residual municipal 
wastewater solids.  Values are the arithmetic mean of duplicate or triplicate 
samples; error bars represent one standard deviation.  
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Total Bacterial Biomass.  The extent to which 16S rRNA genes were removed 
from untreated residual municipal wastewater solids by anaerobic digestion varied by 
temperature (Figure 5.7 and Figure C.6).  An approximately 7-fold reduction in 16S 
rRNA gene quantities was achieved in the first seven eight-day batches at 40°C, while the 
thermophilic and hyperthermophilic digesters achieved between 11-fold (at 56°C) and 
25-fold (at 60°C) reductions in 16S rRNA gene quantities over the same time period.  A 
significant portion of the overall 16S rRNA gene removal for the thermophilic digesters 
occurred during the first two days of each eight-day batch, after which 16S rRNA gene 
quantities leveled off at relatively constant values that were consistent with those from 
the end points of the first seven eight-day batches. 
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Figure 5.7.  Quantities of 16S rRNA genes during the final three batches (green, 
orange, and red symbols represent unique batches) in anaerobic digesters operated 
at nominal temperatures of 40°C, 56°C, 60°C, and 63°C.  Values are the arithmetic 
mean of triplicate samples; error bars represent one standard deviation. 
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Fecal Bacterial Biomass.  Quantities of AllBac were significantly more reduced 
by anaerobic digestion than 16S rRNA gene quantities, although the relationship between 
the extent of removal and temperature was less clear (Figure 5.8, Figure C.7, Figure C.8, 
and Figure C.9).  A 160-fold reduction in AllBac quantities was achieved in the first 
seven eight-day batches at 40°C.  At thermophilic and hyperthermophilic temperatures, 
however, reductions of AllBac quantities varied between 66-fold (at 60°C) and 140-fold 
(at 63°C) over the same time period.  Ratios of AllBac to 16S rRNA genes were reduced 
24-fold at 40°C during the first seven eight-day batches and between approximately 3-
fold (at 60°C) and 9-fold (at 56°C) at thermophilic and hyperthermophilic temperatures.  
Like 16S rRNA gene quantities, AllBac quantities during the final three eight-day 
batches decline most rapidly in the first two days of each batch at thermophilic and 
hyperthermophilic temperatures, after which they approach quantities that are consistent 
with those from the end points of the first seven eight-day batches.  The difference 
between initial rates of decline and rates of decline at the end of batches, however, is less 
pronounced compared to 16S rRNA genes.  Furthermore, the ratios of AllBac to 16S 
rRNA genes during the final three eight-day batches appear to decline at steady rates 
regardless of temperature.   
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Figure 5.8. Quantities of AllBac during the final three batches (green, orange, and 
red symbols represent unique batches) in anaerobic digesters operated at nominal 
temperatures of 40°C, 56°C, 60°C, and 63°C.  Values are the arithmetic mean of 
triplicate samples; error bars represent one standard deviation.  
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Methanogens.  The extent to which methanogen 16S rRNA gene quantities 
decreased during anaerobic digestion was much less than that of AllBac or 16S rRNA 
genes in general and varied with temperature (Figure 5.9, Figure C.10, Figure C.11, and 
Figure C.12).  Methanogen 16S rRNA gene quantities were enriched at 40°C during the 
first seven eight-day batches, with a major peak in methanogen quantities coinciding with 
major peaks in gas production and methane content at approximately 40 d.  Methanogen 
16S rRNA genes accounted for between approximately 1% and 10% of the total 16S 
rRNA genes in the 40°C digester during this time period.  In contrast, methanogen 16S 
rRNA gene quantities were reduced between 5-fold (at 56°C) and 13-fold (at 60°C) at 
thermophilic and hyperthermophilic temperatures during the first seven eight-day batches 
and remained relatively constant.  The ratios of methanogen 16S rRNA genes to 16S 
rRNA genes, however, increased approximately 2-fold in all thermophilic and 
hyperthermophilic digesters over this same time period.  Thus, methanogen 16S rRNA 
genes were enriched to account for between approximately 0.2% and 0.8% of the total 
16S rRNA genes in thermophilic and hyperthermophilic digesters despite undergoing a 
net decrease in their absolute numbers.  The majority of this enrichment occurred during 
the first two days of each eight-day batch, with ratios of methanogen 16S rRNA genes to 
16S rRNA genes remaining constant thereafter at 40°C and decreasing steadily at 
thermophilic temperatures. 
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Figure 5.9.  Quantities of methanogen 16S rRNA genes during the final three 
batches (green, orange, and red symbols represent unique batches) in anaerobic 
digesters operated at nominal temperatures of 40°C, 56°C, 60°C, and 63°C.  Values 
are the arithmetic mean of triplicate samples; error bars represent one standard 
deviation. 
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ARGs, repA, and intI1.  The extents of removal for ARGs, intI1, and repA 
during anaerobic digestion were higher at thermophilic and hyperthermophilic 
temperatures than at 40°C (Figure 5.10, Figure 5.11, Figure 5.12, Figure 5.13, Figure 
5.14, Figure C.13, Figure C.14, Figure C.15, Figure C.16, Figure C.17, Figure C.18, 
Figure C.19, Figure C.20, Figure C.21, Figure C.22, Figure C.23, Figure C.24, and Figure 
C.25).  Quantities of intI1, tet(W), and tet(X) were reduced on average by approximately 
11-fold (tet(W)) to 23-fold (tet(X)) at 40°C during the first seven eight-day batches.  
Quantities of the same gene targets were reduced by between approximately 53-fold 
(tet(W), 63°C) and 1,300-fold (tet(X), 63°C) at thermophilic and hyperthermophilic 
temperatures, with a median reduction in gene target quantity of 110-fold (intI1, 60°C).  
Quantities of qnrA at 40°C and quantities of repA at all temperatures were below 
quantification limits at the end of each of the first seven eight-day batches.  It is apparent 
that some reduction in these gene targets’ quantities occurred, with at least 2-fold (repA) 
to 17-fold (qnrA) removal at 40°C and at least 2-fold (repA, 63°C) to 130-fold (qnrA, 
60°C) removal at thermophilic and hyperthermophilic temperatures.  These trends with 
temperature were approximately the same for ratios of intI1, tet(W), and tet(X) to 16S 
rRNA genes.  These ratios were reduced approximately 2-fold (tet(W)) to 3-fold (tet(X)) 
at 40°C and approximately 3-fold (tet(X), 60°C) to 71-fold (tet(X), 63°C) at thermophilic 
and hyperthermophilic temperatures.  The natures of the decline in ARG, intI1, and repA 
quantities during each batch were similar to those observed for 16S rRNA genes and 
AllBac, particularly at higher temperatures.  A significant portion of the reduction in gene 
quantities occurred within the first two days of each batch, after which the rate of decline 
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either slowed considerably (for intI1, tet(W), and tet(X)) or gene target quantities were 
below quantification limits (for qnrA and repA).   
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Figure 5.10.  Quantities of intI1 during the final three batches (green, orange, and 
red symbols represent unique batches) in anaerobic digesters operated at nominal 
temperatures of 40°C, 56°C, 60°C, and 63°C.  Values are the arithmetic mean of 
triplicate samples; error bars represent one standard deviation. 
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Figure 5.11.  Quantities of qnrA during the final three batches (green, orange, and 
red symbols represent unique batches) in anaerobic digesters operated at nominal 
temperatures of 40°C, 56°C, 60°C, and 63°C.  Values are the arithmetic mean of 
duplicate or triplicate samples; error bars represent one standard deviation.  
Dashed lines represent the limit of quantification for data sets that contain one or 
more experimental observations below that limit. 
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Figure 5.12.  Quantities of repA during the final three batches (green, orange, and 
red symbols represent unique batches) in anaerobic digesters operated at nominal 
temperatures of 40°C, 56°C, 60°C, and 63°C.  Values are the arithmetic mean of 
duplicate or triplicate samples; error bars represent one standard deviation.  
Dashed lines represent the limit of quantification for data sets that contain one or 
more experimental observations below that limit. 
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Figure 5.13.  Quantities of tet(W) during the final three batches (green, orange, and 
red symbols represent unique batches) in anaerobic digesters operated at nominal 
temperatures of 40°C, 56°C, 60°C, and 63°C.  Values are the arithmetic mean of 
triplicate samples; error bars represent one standard deviation. 
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Figure 5.14.  Quantities of tet(X) during the final three batches (green, orange, and 
red symbols represent unique batches) in anaerobic digesters operated at nominal 
temperatures of 40°C, 56°C, 60°C, and 63°C.  Values are the arithmetic mean of 
duplicate or triplicate samples; error bars represent one standard deviation.  
Dashed lines represent the limit of quantification for data sets that contain one or 
more experimental observations below that limit. 
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Kinetic Modeling.  Out of the three models considered here, the Collins-Selleck 
kinetic model tended to produce the best fit to the majority of the time series (Table C.3, 
Table C.4, and Table C.5).  The Collins-Selleck model produced 37 out of 50 non-trivial 
(degrees of freedom ≥ 3) linear regression fits with ANOVA P values < 0.05, 46 out of 
50 fits with LOF P values ≥ 0.05, and 44 out of 50 fits with NCV P values ≥ 0.05.  
Furthermore, visual inspection of residuals plots and the fit of the kinetic models to both 
transformed and untransformed data (figures not shown) confirmed that the Collins-
Selleck model tended to fit time series exhibiting retarded kinetics particularly well.  In 
contrast, the first-order kinetic model produced only 19 of 50 fits with LOF P values ≥ 
0.05, although it produced a slightly higher number (40 out of 50) of fits with ANOVA P 
values < 0.05 and 50 out of 50 fits with NCV P values ≥ 0.05.  The first-order kinetic 
model was also clearly the best fit model for a handful of time series that, based on visual 
inspection, clearly displayed linear relationships between the logarithm of gene target 
quantities (or ratios to 16S rRNA genes) and time.  The second-order kinetic model 
produced only 30 out of 50 fits with NCV P values ≥ 0.05 and 18 valid (corresponding to 
NCV P values ≥ 0.05) LOF P values ≥ 0.05.   
The magnitudes of fitted kinetic coefficients of all models tended to vary with 
temperature, although differences between mesophilic and thermophilic temperatures 
were more obvious than differences between thermophilic and hyperthermophilic 
temperatures (Table 5.1, Table 5.2, and Table C.6).  The absolute values of the Collins-
Selleck k parameters for intI1, tet(W), and tet(X) quantities normalized to sample volume 
increased by factors of 1.7 (intI1) to 2.9 (tet(W)) from 40°C to 56°C, while the absolute 
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values of the Collins-Selleck k parameters for the same gene target quantities normalized 
to 16S rRNA genes increased by factors of 2.0 (tet(X)) to 4.0 (tet(W)).  Between 56°C 
and 60°C, only the increase of the Collins-Selleck k parameter for intI1 mL
-1
, which 
increased by a factor of 1.4, was statistically significant (P = 3×10
-3, Welch’s t-test).  The 
Collins-Selleck k parameters for all remaining gene quantities, whether normalized to 
sample volume or 16S rRNA gene quantities, either did not change (P ≥ 0.05, Welch’s t-
test) or decreased.  Similarly, none of the differences in Collins-Selleck k values between 
56°C and 63°C were statistically significant (P ≥ 0.05, Welch’s t-test), and only the 
increases in the Collins-Selleck k values for tet(X) (normalized to both sample volume 
and 16S rRNA genes) were statistically significant (P < 0.01, Welch’s t-test) between 
60°C and 63°C.  The values of Collins-Selleck b parameters showed no clear relationship 
with temperature.  The general trends in values of k, however, were the same for first-
order and second-order models, with all coefficients tending to increase with temperature. 
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Table 5.1.  Fitted values of k and calculated half-lives (t1/2) from an ordinary least squares fit of the first-order kinetic model to 
each time series of gene target quantities or ratios of gene target quantities to 16S rRNA genes.  Error terms represent the 
standard error of the mean. 
Target Units (copies) Temperature k
a
 (day
-1
) t1/2 (days) 
16S rRNA gene mL
-1
 40°C -3.9×10
-2
 ± 1.2×10
-2
 17.6 
16S rRNA gene mL
-1
 56°C -6.0×10
-2
 ± 1.9×10
-2
 11.5 
16S rRNA gene mL
-1
 60°C -7.8×10
-2
 ± 2.5×10
-2
 8.8 
16S rRNA gene mL
-1
 63°C -1.0×10
-1
 ± 3.1×10
-2
 6.8 
AllBac mL
-1
 40°C -3.9×10
-1
 ± 2.6×10
-2
 1.8 
AllBac mL
-1
 56°C -2.5×10
-1
 ± 2.7×10
-2
 2.8 
AllBac mL
-1
 60°C -3.2×10
-1
 ± 3.6×10
-2
 2.2 
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AllBac mL
-1
 63°C -4.0×10
-1
 ± 4.6×10
-2
 1.7 
AllBac (16S rRNA gene)
-1
 40°C -3.5×10
-1
 ± 2.5×10
-2
 2.0 
AllBac (16S rRNA gene)
-1
 56°C -1.9×10
-1
 ± 1.9×10
-2
 3.7 
AllBac (16S rRNA gene)
-1
 60°C -2.4×10
-1
 ± 2.2×10
-2
 2.9 
AllBac (16S rRNA gene)
-1
 63°C -3.0×10
-1
 ± 3.1×10
-2
 2.3 
Methanogen 16S rRNA genes mL
-1
 40°C -7.3×10
-3
 ± 2.5×10
-2
 94.8 
Methanogen 16S rRNA genes mL
-1
 56°C -8.5×10
-2
 ± 1.4×10
-2
 8.2 
Methanogen 16S rRNA genes mL
-1
 60°C -8.7×10
-2
 ± 1.9×10
-2
 8.0 
Methanogen 16S rRNA genes mL
-1
 63°C -1.9×10
-1
 ± 3.2×10
-2
 3.7 
Methanogen 16S rRNA genes (16S rRNA gene)
-1
 40°C 3.4×10
-2
 ± 2.7×10
-2
 -20.5 
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Methanogen 16S rRNA genes (16S rRNA gene)
-1
 56°C -2.4×10
-2
 ± 2.1×10
-2
 29.0 
Methanogen 16S rRNA genes (16S rRNA gene)
-1
 60°C -8.8×10
-3
 ± 2.0×10
-2
 78.8 
Methanogen 16S rRNA genes (16S rRNA gene)
-1
 63°C -8.7×10
-2
 ± 3.0×10
-2
 8.0 
intI1 mL
-1
 40°C -1.1×10
-1
 ± 1.6×10
-2
 6.4 
intI1 mL
-1
 56°C -1.9×10
-1
 ± 2.8×10
-2
 3.7 
intI1 mL
-1
 60°C -2.3×10
-1
 ± 3.2×10
-2
 3.0 
intI1 mL
-1
 63°C -2.5×10
-1
 ± 5.3×10
-2
 2.7 
intI1 (16S rRNA gene)
-1
 40°C -6.7×10
-2
 ± 1.3×10
-2
 10.3 
intI1 (16S rRNA gene)
-1
 56°C -1.3×10
-1
 ± 1.6×10
-2
 5.5 
intI1 (16S rRNA gene)
-1
 60°C -1.5×10
-1
 ± 1.9×10
-2
 4.5 
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intI1 (16S rRNA gene)
-1
 63°C -1.5×10
-1
 ± 3.0×10
-2
 4.6 
qnrA mL
-1
 40°C -1.6×10
0
 ± 8.8×10
-1
 0.4 
qnrA mL
-1
 56°C -8.5×10
-2
 ± 4.2×10
-2
 8.2 
qnrA mL
-1
 60°C -1.9×10
-1
 ± 1.3×10
-1
 3.7 
qnrA mL
-1
 63°C -3.3×10
-1
 ± 1.7×10
-1
 2.1 
qnrA (16S rRNA gene)
-1
 40°C -1.7×10
0
 ± 1.0×10
0
 0.4 
qnrA (16S rRNA gene)
-1
 56°C -2.5×10
-2
 ± 3.2×10
-2
 28.2 
qnrA (16S rRNA gene)
-1
 60°C -5.3×10
-2
 ± 1.2×10
-1
 13.1 
qnrA (16S rRNA gene)
-1
 63°C -1.2×10
-1
 ± 9.5×10
-2
 5.9 
repA mL
-1
 40°C ND
b
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repA mL
-1
 56°C -2.1×10
0
 ± 9.8×10
-1
 0.3 
repA mL
-1
 60°C ND
b
 
repA mL
-1
 63°C ND
b
 
repA (16S rRNA gene)
-1
 40°C ND
b
 
repA (16S rRNA gene)
-1
 56°C -1.2×10
0
 ± 1.2×10
0
 0.6 
repA (16S rRNA gene)
-1
 60°C ND
b
 
repA (16S rRNA gene)
-1
 63°C ND
b
 
tet(W) mL
-1
 40°C -1.1×10
-1
 ± 3.4×10
-2
 6.6 
tet(W) mL
-1
 56°C -3.0×10
-1
 ± 2.8×10
-2
 2.3 
tet(W) mL
-1
 60°C -3.4×10
-1
 ± 4.3×10
-2
 2.1 
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tet(W) mL
-1
 63°C -3.8×10
-1
 ± 5.8×10
-2
 1.8 
tet(W) (16S rRNA gene)
-1
 40°C -6.5×10
-2
 ± 2.9×10
-2
 10.6 
tet(W) (16S rRNA gene)
-1
 56°C -2.4×10
-1
 ± 1.7×10
-2
 2.9 
tet(W) (16S rRNA gene)
-1
 60°C -2.6×10
-1
 ± 2.6×10
-2
 2.7 
tet(W) (16S rRNA gene)
-1
 63°C -2.8×10
-1
 ± 3.7×10
-2
 2.5 
tet(X) mL
-1
 40°C -1.8×10
-1
 ± 1.8×10
-2
 3.9 
tet(X) mL
-1
 56°C -3.5×10
-1
 ± 3.4×10
-2
 2.0 
tet(X) mL
-1
 60°C -1.9×10
-1
 ± 5.7×10
-2
 3.6 
tet(X) mL
-1
 63°C -1.0×10
0
 ± 2.0×10
-1
 0.7 
tet(X) (16S rRNA gene)
-1
 40°C -1.4×10
-1
 ± 1.4×10
-2
 5.0 
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tet(X) (16S rRNA gene)
-1
 56°C -2.8×10
-1
 ± 2.9×10
-2
 2.4 
tet(X) (16S rRNA gene)
-1
 60°C -1.2×10
-1
 ± 4.4×10
-2
 5.9 
tet(X) (16S rRNA gene)
-1
 63°C -8.0×10
-1
 ± 8.6×10
-2
 0.9 
a
See Table C.3 for ANOVA P values, which are equal to values of P for k, as well as other summary metrics that describe the 
quality of fit of the model to the data. 
b
Quantities of some gene targets were above quantification limits for only n ≤ 2 time points, so k was not determined (ND). 
 
 
 
 
  
129 
 
Table 5.2.  Fitted values of k and b from an ordinary least squares fit of the modified Collins-Selleck kinetic model to each time 
series of gene target quantities or ratios of gene target quantities to 16S rRNA genes.  Error terms represent the standard 
error of the mean. 
Target Units (copies) Temperature k
a
 (unitless) b (days) 
16S rRNA gene mL
-1
 40°C -8.9×10
-2
 ± 3.5×10
-2
 9.3×10
-2
 
16S rRNA gene mL
-1
 56°C -1.0×10
-1
 ± 3.9×10
-2
 1.0×10
-2
 
16S rRNA gene mL
-1
 60°C -1.6×10
-1
 ± 4.9×10
-2
 2.7×10
-2
 
16S rRNA gene mL
-1
 63°C -1.4×10
-1
 ± 7.0×10
-2
 1.8×10
-3
 
AllBac mL
-1
 40°C -9.9×10
-1
 ± 9.0×10
-2
 5.4×10
-1
 
AllBac mL
-1
 56°C -5.9×10
-1
 ± 6.9×10
-2
 2.9×10
-1
 
AllBac mL
-1
 60°C -7.9×10
-1
 ± 3.1×10
-2
 2.4×10
-1
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AllBac mL
-1
 63°C -9.0×10
-1
 ± 6.3×10
-2
 1.7×10
-1
 
AllBac (16S rRNA gene)
-1
 40°C -9.0×10
-1
 ± 1.0×10
-1
 6.4×10
-1
 
AllBac (16S rRNA gene)
-1
 56°C -4.9×10
-1
 ± 6.0×10
-2
 5.8×10
-1
 
AllBac (16S rRNA gene)
-1
 60°C -6.2×10
-1
 ± 3.5×10
-2
 4.3×10
-1
 
AllBac (16S rRNA gene)
-1
 63°C -7.6×10
-1
 ± 8.9×10
-2
 4.0×10
-1
 
Methanogen 16S rRNA genes mL
-1
 40°C -7.0×10
-3
 ± 8.5×10
-2
 6.7×10
5
 
Methanogen 16S rRNA genes mL
-1
 56°C -2.0×10
-1
 ± 6.5×10
-2
 5.7×10
-1
 
Methanogen 16S rRNA genes mL
-1
 60°C -1.8×10
-1
 ± 7.1×10
-2
 1.3×10
-1
 
Methanogen 16S rRNA genes mL
-1
 63°C -4.4×10
-1
 ± 1.1×10
-1
 4.8×10
-1
 
Methanogen 16S rRNA genes (16S rRNA gene)
-1
 40°C 8.8×10
-2
 ± 9.1×10
-2
 3.2×10
-2
 
131 
 
Methanogen 16S rRNA genes (16S rRNA gene)
-1
 56°C -8.9×10
-2
 ± 5.8×10
-2
 6.0×10
1
 
Methanogen 16S rRNA genes (16S rRNA gene)
-1
 60°C -2.2×10
-2
 ± 4.7×10
-2
 9.1×10
3
 
Methanogen 16S rRNA genes (16S rRNA gene)
-1
 63°C -3.0×10
-1
 ± 7.9×10
-2
 6.1×10
0
 
intI1 mL
-1
 40°C -2.3×10
-1
 ± 2.2×10
-2
 1.1×10
-1
 
intI1 mL
-1
 56°C -3.9×10
-1
 ± 3.6×10
-2
 8.3×10
-2
 
intI1 mL
-1
 60°C -5.5×10
-1
 ± 3.2×10
-2
 1.6×10
-1
 
intI1 mL
-1
 63°C -4.9×10
-1
 ± 8.0×10
-2
 3.6×10
-2
 
intI1 (16S rRNA gene)
-1
 40°C -1.4×10
-1
 ± 3.3×10
-2
 1.1×10
-1
 
intI1 (16S rRNA gene)
-1
 56°C -2.9×10
-1
 ± 3.9×10
-2
 1.8×10
-1
 
intI1 (16S rRNA gene)
-1
 60°C -3.9×10
-1
 ± 4.9×10
-2
 3.4×10
-1
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intI1 (16S rRNA gene)
-1
 63°C -3.5×10
-1
 ± 5.0×10
-2
 1.2×10
-1
 
qnrA mL
-1
 40°C ND
b
 
qnrA mL
-1
 56°C -9.0×10
-2
 ± 9.1×10
-2
 5.6×10
-6
 
qnrA mL
-1
 60°C -1.6×10
-2
 ± 1.2×10
-1
 1.6×10
-33
 
qnrA mL
-1
 63°C -1.6×10
-1
 ± 1.3×10
-1
 6.1×10
-5
 
qnrA (16S rRNA gene)
-1
 40°C ND
b
 
qnrA (16S rRNA gene)
-1
 56°C 1.4×10
-2
 ± 7.3×10
-2
 1.8×10
18
 
qnrA (16S rRNA gene)
-1
 60°C 1.0×10
-1
 ± 2.3×10
-1
 4.0×10
2
 
qnrA (16S rRNA gene)
-1
 63°C -7.8×10
-2
 ± 1.3×10
-1
 1.2×10
-4
 
repA mL
-1
 40°C ND
b
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repA mL
-1
 56°C ND
b
 
repA mL
-1
 60°C ND
b
 
repA mL
-1
 63°C ND
b
 
repA (16S rRNA gene)
-1
 40°C ND
b
 
repA (16S rRNA gene)
-1
 56°C ND
b
 
repA (16S rRNA gene)
-1
 60°C ND
b
 
repA (16S rRNA gene)
-1
 63°C ND
b
 
tet(W) mL
-1
 40°C -2.4×10
-1
 ± 7.3×10
-2
 5.7×10
-2
 
tet(W) mL
-1
 56°C -7.0×10
-1
 ± 5.6×10
-2
 2.3×10
-1
 
tet(W) mL
-1
 60°C -7.8×10
-1
 ± 3.0×10
-2
 1.6×10
-1
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tet(W) mL
-1
 63°C -8.1×10
-1
 ± 6.3×10
-2
 1.1×10
-1
 
tet(W) (16S rRNA gene)
-1
 40°C -1.5×10
-1
 ± 7.8×10
-2
 4.5×10
-2
 
tet(W) (16S rRNA gene)
-1
 56°C -6.0×10
-1
 ± 5.1×10
-2
 4.0×10
-1
 
tet(W) (16S rRNA gene)
-1
 60°C -6.3×10
-1
 ± 5.7×10
-2
 2.6×10
-1
 
tet(W) (16S rRNA gene)
-1
 63°C -6.7×10
-1
 ± 4.1×10
-2
 2.4×10
-1
 
tet(X) mL
-1
 40°C -4.2×10
-1
 ± 3.5×10
-2
 2.5×10
-1
 
tet(X) mL
-1
 56°C -8.0×10
-1
 ± 6.7×10
-2
 2.1×10
-1
 
tet(X) mL
-1
 60°C -4.3×10
-1
 ± 1.5×10
-1
 5.1×10
-2
 
tet(X) mL
-1
 63°C -1.1×10
0
 ± 1.3×10
-1
 9.2×10
-2
 
tet(X) (16S rRNA gene)
-1
 40°C -3.4×10
-1
 ± 4.2×10
-2
 3.4×10
-1
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tet(X) (16S rRNA gene)
-1
 56°C -6.9×10
-1
 ± 7.7×10
-2
 3.3×10
-1
 
tet(X) (16S rRNA gene)
-1
 60°C -2.7×10
-1
 ± 1.3×10
-1
 7.4×10
-2
 
tet(X) (16S rRNA gene)
-1
 63°C -9.7×10
-1
 ± 1.3×10
-1
 1.8×10
-1
 
a
See Table C.5 for ANOVA P values, which are equal to values of P for k, as well as other summary metrics that describe the 
quality of fit of the model to the data. 
b
Quantities of some gene targets were above quantification limits for only n ≤ 2 time points, so k was not determined (ND).
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5.4 Discussion 
Hyperthermophilic anaerobic digestion holds promise as a treatment technology 
that can remove ARGs and intI1 from residual municipal wastewater solids.  
Hyperthermophilic digestion outperformed both mesophilic anaerobic digestion and 
thermophilic anaerobic digestion by tending to increase the magnitude of kinetic 
parameters with temperature.  The difference in performance between hyperthermophilic 
and thermophilic anaerobic digestion was not as clear as the difference between 
thermophilic and mesophilic digestion, however.  As a result, future work should focus 
on varying other operational conditions within the hyperthermophilic temperature range, 
like hydraulic residence time and flow regime, to determine if hyperthermophilic 
anaerobic digestion can be optimized to further enhance the removal of ARGs and intI1 
from residual municipal wastewater solids relative to thermophilic anaerobic digestion.  
These future efforts would be aided by continued consideration of the kinetics of ARG 
and intI1 removal, because they provide an excellent means for comparing performance 
among various treatment conditions.  An important caveat to this approach is that the 
kinetic model must be appropriate for the data.  For the results presented here, a modified 
form of the Collins-Selleck kinetic model was found to be the most appropriate of the 
models considered, because it could describe retarded rate kinetics well.  Visual 
inspection of some previous results (121) indicates that the same model could be 
appropriate for those previous data as well.   
The fact that the modified form of the Collins-Selleck model tended to be the best 
fit model for most of the time series in this work is likely a reflection of cell death being 
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the primary driver, particularly in the early stages of each batch, of ARG removal in these 
treatment units.  The Collins-Selleck model was originally developed to describe the 
kinetics of bacterial inactivation with chlorine (215).  This process is often characterized 
by values of the logarithm of concentration that decline at a retarded rate with time 
(184,214), which was the same trend observed for many gene targets in this work.  The 
typical explanation for retarded rate kinetics during chlorine disinfection is that the 
distribution of bacterial community members’ resistance to chlorine is initially relatively 
wide, and that as the less resistant microorganisms in the community are eliminated, the 
observed rate of decline in bacterial concentrations slows because the distribution of 
resistance to chlorine narrows to include only those microorganisms that are most 
resistant to the disinfectant (184,214).  It seems likely that a similar process occurs during 
anaerobic digestion.  The initial distribution of bacterial community members’ ability to 
survive in an anaerobic environment at a particular temperature is probably quite wide, 
but as members of the original community die off, this distribution narrows to include 
only those microorganisms most able to cope with the conditions presented by the 
anaerobic digestion environment.  As a result, observed quantities of 16S rRNA genes, 
16S rRNA genes of microorganisms unable to survive under the given conditions (e.g. 
AllBac), and other gene targets associated with microorganisms unable to survive under 
the given conditions (i.e. ARGs, intI1, and repA) all decrease with time in a trend 
consistent with disinfection (i.e. mixed-community cell death) kinetics.  This may also 
offer a potential explanation for why semi-batch thermophilic and hyperthermophilic 
anaerobic digestion appear to be superior to semi-batch mesophilic anaerobic digestion 
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for removing ARGs and intI1 from residual solids.  Due to the unique environments they 
impose, thermophilic and hyperthermophilic anaerobic digesters significantly narrow the 
subset of the initial distribution of microorganisms (and the ARGs and integrons that they 
carry) that will survive to the end of treatment.   
This work suggests that batch or semi-batch treatment of residual municipal 
wastewater solids at relatively long target solids residence times may hold promise as an 
effective means of reducing the quantities of ARGs and intI1 discharged from the 
municipal wastewater treatment process.  Quantities of all gene targets in this work 
decreased during eight-day semi-batches at target residence times of 30 to 35 d.  A 
similar result has been demonstrated during batch aerobic digestion at a target residence 
time of approximately 40 d, even when semi-continuous-flow aerobic digestion at the 
same target residence time failed to remove intI1 and enriched tet(X) (204).  At shorter 
target residence times (15 d) and with five-day batches, however, some gene targets 
tended to decrease in quantity during mesophilic and thermophilic anaerobic digestion 
while tet(L) tended to remain unchanged and tet(W) decreased only at thermophilic 
temperatures (121).  Similarly, semi-continuous-flow mesophilic anaerobic digestion at 
relatively short residence times (10 d and 20 d) causes some ARGs to decrease in 
quantity during treatment and others to increase (131).  This may be due to continuous-
flow or semi-continuous-flow environments inducing feast-famine cycles of cell growth, 
while batch or semi-batch treatment environments ultimately induce only famine (i.e. cell 
death).     
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The distribution of gene cassettes on class 1 integrons in residual municipal 
wastewater solids needs to be examined more thoroughly in order to critically assess the 
factors governing the fate of class 1 integrons during treatment of residual municipal 
wastewater solids.  Class 1 integrons are a potentially important gene target on which to 
focus treatment and management strategies intended to reduce the number of ARGs 
discharged from the municipal wastewater treatment process because they enable both 
horizontal gene transfer of ARGs and the accumulation of multiple resistance genotypes 
(82).  However, their fate during treatment of residual municipal wastewater solids has 
been demonstrated to vary widely depending on operating conditions.  Semi-batch 
thermophilic anaerobic digestion was demonstrated to remove intI1 to a greater extent 
than semi-batch mesophilic anaerobic digestion in both this work and a previous study 
(121).  However, other studies have demonstrated semi-continuous-flow mesophilic 
anaerobic digestion at solids residence times of both 10 d and 20 d to outperform semi-
continuous-flow thermophilic anaerobic digestion (131).  Quantities of intI1 have also 
been demonstrated to remain unchanged during semi-continuous-flow aerobic digestion 
at 15°C (204) and to increase by approximately two orders of magnitude during semi-
continuous-flow aerobic digestion following semi-continuous-flow anaerobic digestion 
(131).  These disparate results could be plausibly explained by the hypothesis that the 
relationship between the distribution of gene cassettes on class 1 integrons and the 
treatment environment determines a selective advantage (or lack thereof) for the 
integron’s host.  However, the majority of the current body of knowledge regarding the 
distribution of gene cassettes on integrons in the municipal wastewater treatment process 
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is focused on treatment stages other than residual solids treatment (198).  Understanding 
the distribution of gene cassettes, ARGs or otherwise, on integrons in residual solids 
undergoing treatment in various technologies will be critical to determining how their 
fate can be controlled during residual solids treatment.  
 This work adds support to previous results suggesting that the relationship 
between the ecological conditions of the treatment unit and the presumed ecological 
niche of specific ARGs (or intI1) can have a significant impact on the effectiveness of the 
treatment technology (204,208).  This can be illustrated by comparing the differing fates 
of tet(W), which is associated with anaerobic microorganisms (212), and tet(X), which 
requires oxygen to be functional (210,211), during anaerobic and aerobic digestion.  
During aerobic digestion of residual municipal wastewater solids under semi-continuous-
flow conditions, tet(W) quantities are reduced by more than an order of magnitude, while 
tet(X) quantities are enriched approximately 5-fold (204).  Similarly, although quantities 
of both gene targets are reduced during aerobic digestion under batch conditions, tet(W) 
quantities are reduced at a significantly faster rate (P = 6×10
-4
) than tet(X) (204).  In 
contrast, quantities of tet(W) were reduced 11-fold at 40°C in the current study, while 
quantities of tet(X) were reduced 23-fold at 40°C.  This suggests that the ecological 
conditions of individual treatment units might be optimized relative to the ecological 
niches of particular ARGs to provide additional controls over the fate of ARGs in those 
systems.  Furthermore, depending on the ARG or ARGs that limit the design of a 
particular residual solids treatment system, ideal treatment processes may consist of 
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multiple treatment units that alternate between extremes in terms of ecological conditions 
(e.g. redox conditions).  
     The major limitations of this work are related to the semi-batch design of the 
anaerobic digesters and to the well-known limitations of culture-independent analytical 
approaches.  While the potential benefits of semi-batch treatment of residual municipal 
wastewater solids have been discussed above, the semi-batch design of the digesters 
examined here does not reflect the design of existing full-scale (i.e. continuous-flow or 
semi-continuous-flow) anaerobic digesters.  Thus, these results, and in particular the 
specific kinetic parameters presented here, may not be readily transferable to the existing 
infrastructure.  Furthermore, the real-time PCR protocol used in this work cannot 
distinguish gene targets in pathogens from those in non-pathogens or gene targets in 
living bacteria from those in dead bacteria or present as extracellular DNA in the sample 
matrix.  This work also investigates a very small handful (three) of ARGs along with 
intI1 and repA.  There are numerous known ARGs, plasmids, and other genetic elements 
related to antibiotic resistance, and the fate of those considered here does not necessarily 
represent that of all the others.    
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Chapter 6: The Fate of Antibiotic Resistance Genes and Class 1 
Integrons in Soil Microcosms Following the Application of Treated 
Residual Municipal Wastewater Solids from Full-Scale Treatment 
Facilities 
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Substantial quantities of antibiotic resistance genes (ARGs) are discharged in 
treated residual municipal wastewater solids.  While the fate of ARGs in residual solids 
treatment units is under scrutiny, their fate following treatment has received minimal 
attention.  The objective of this work was to determine kinetic coefficients for ARG and 
class 1 integron quantities in soil following simulated land-application of treated residual 
solids.  Treated residual solids from two full-scale treatment plants were applied to sets of 
triplicate soil microcosms in two experiments.  Experiment 1 investigated loading rates of 
20, 40, and 100 g residual solids kg
-1
 soil in a sand mixture, while Experiment 2 
investigated a loading rate of 40 g kg
-1
 in a silt loam.  Six ARGs (erm(B), qnrA, sul1, 
tet(A), tet(W), and tet(X)), the integrase of class 1 integrons (intI1), the origin of 
replication of incompatibility group A/C plasmids (repA), 16S rRNA genes, 16S rRNA 
genes of all Bacteroides spp. (AllBac), and 16S rRNA genes of human-specific 
Bacteroides spp. (HF183) were quantified using real-time PCR.  ARG and intI1 
quantities declined in most microcosms, with statistically significant (P < 0.05) half-lives 
varying between 13 d (erm(B), Experiment 1, 100 g kg
-1
) and 81 d (intI1, Experiment 1, 
40 g kg
-1
).  First-order kinetic coefficients for ARGs and intI1 varied more substantially 
with gene target than with loading rate in Experiment 1, and ARGs and intI1 were as 
persistent (P ≥ 0.05, Welch’s t-test) or more persistent (P < 0.05, Welch’s t-test) in 
Experiment 2 compared to Experiment 1.  These kinetic coefficients can be used to 
optimize the residual solids disposal process to reduce the quantities of ARGs and intI1 
discharged from municipal wastewater treatment plants. 
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6.1 Introduction 
 Resistance of pathogenic bacteria to antibiotic chemotherapy is a major global 
public health predicament (3,199).  As a result, the bacterial antibiotic resistance genes 
(ARGs) that confer resistance are increasingly regarded as environmental pollutants (5).  
ARGs have been found in a number of environmental reservoirs, including surface 
waters, aquaculture facilities, and agricultural waste (5–20).  The municipal wastewater 
treatment process, however, is one of the most significant reservoirs of ARGs.  Numerous 
studies have reported the detection of ARGs at all stages of the treatment process 
(5,10,21–32).  The vast majority of these ARGs, along with the vast majority of 
prokaryotic biomass, are discharged from the municipal wastewater treatment process in 
the treated residual solids (27).  As a result, the residual solids treatment step could be an 
excellent target for the application of strategies intended to eliminate ARGs from the 
municipal wastewater treatment process. 
 Existing technologies can remove ARGs from residual municipal wastewater 
solids.  Aerobic digestion, air-drying beds, mesophilic anaerobic digestion, and 
thermophilic anaerobic digestion have all been demonstrated to reduce ARG quantities in 
residual municipal wastewater solids in laboratory-scale treatment units 
(121,131,132,204,208).  Mesophilic and thermophilic anaerobic digestion have also been 
demonstrated to reduce ARG quantities at a full-scale treatment facility (24).  Efforts 
have been undertaken to optimize these treatment technologies for reducing ARG 
quantities, as some work has investigated varying temperatures, residence times, and 
pretreatment options (121,131).   
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In contrast, the fate of the ARGs in treated residual solids following their 
application to agricultural soils remains poorly understood.  Understanding the fate of 
ARGs in such soils is important because approximately 50% of all treated residual 
municipal wastewater solids in the United States are ultimately disposed of via land-
application (186).  Furthermore, this scenario potentially leads to several plausible 
transport pathways that could result in human exposure to ARGs.  These pathways 
include transport in microorganisms in stormwater runoff to surface waters used for 
recreation and drinking water sources (216) as well as aerosolization of microorganisms 
over local and even global scales (217–221).  
The objective of this research was to determine the rate at which ARG quantities 
decline in soils following the application of treated residual municipal wastewater solids.  
An initial experiment (Experiment 1) was performed to test the hypothesis that ARG 
quantities would decline more slowly at higher mass loading rates of residual solids to 
soil.  Soil microcosms were constructed using a sand mixture, and dewatered treated 
residual solids from a full-scale treatment facility were mixed with the soil at loading 
rates of 20, 40, and 100 g residual solids kg
-1
 soil.  These loading rates are within the 
range of those commonly used in practice (184).  This procedure was then repeated in a 
second experiment (Experiment 2) using a similar source of residual municipal 
wastewater solids and a different soil type (silt loam).  Experiment 2 used a loading rate 
of 40 g residual solids kg
-1
 soil.  A set of representative ARGs and the integrase of class 1 
integrons (intI1) were quantified over time in all soil microcosms using real-time PCR.  
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The quantities of ARGs and intI1 declined over time under most experimental conditions, 
with half-lives on the order of months. 
6.2 Materials and Methods 
Experimental Design.  Two experiments were conducted using two different 
soils and residual wastewater solids from two different treatment facilities.  Triplicate 
microcosms were constructed for each experimental condition by adding 200 g of soil to 
a 710-mL sealable plastic container (Rubbermaid Consumer Products, Fairlawn, OH).  
Soil 1 was a 1:1 mixture of sand with homogenized and sieved (2 mm) soil cuttings from 
the vadose and saturated zones of an aquifer in southwestern Minnesota.  The 
composition of Soil 1 was 90% sand, 1.8% silt, and 8.3% clay, with an average organic 
matter fraction of 0.006 by mass.  Soil 2 was a Waukegan silt loam (fine-silty, mixed, 
mesic Typic Hapludoll) with an initial moisture content of 12.1% ± 0.3% (mean ± 
standard deviation).  Residual Solids 1 and 2 were dewatered treated residual municipal 
wastewater solids collected from similar full-scale treatment plants.  Residual Solids 1 
were collected from a 24 MGD plant in eastern Minnesota that uses mesophilic anaerobic 
digestion for residual solids treatment.  Residual Solids 2 were collected from an 11 
MGD plant in southern Minnesota that uses mesophilic anaerobic digestion for solids 
treatment and a belt filter press for dewatering.  Residual Solids 2 had an initial moisture 
content of 82.8% ± 0.5% (mean ± standard deviation).  All microcosms were stored at 
room temperature (approximately 20°C).  Evaporative water losses for all microcosms 
were estimated by weighing the microcosms at approximately monthly intervals and 
assuming that all mass loss was due to evaporation of water.     
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Sample Collection and Genomic DNA Extraction.  Triplicate samples of 
approximately 0.5 g were collected from each soil microcosm at each time point. 
Samples were then stored at -20 °C until genomic DNA was extracted and purified using 
the FastDNA Spin Kit for Soil (MP Biomedicals, Solon, OH) and a BIO 101 Thermo 
Savant FastPrep FP120 Cell Disruptor (Qbiogene, Inc., Carlsbad, CA). 
Real-time PCR.  Real-time PCR was used to quantify 11 different gene targets.  
Three of these gene targets represent different fractions of prokaryotic biomass.  The 16S 
rRNA gene was quantified as a measure of total bacterial biomass, while AllBac was 
used as a representative fecal indicator (195), and HF183 was used has an indicator of 
human feces (194,203).  Six gene targets correspond to ARGs that collectively represent 
a cross-section of antibiotic classes (macrolides, tetracyclines, sulfonamides, and 
fluoroquinolones) and resistance mechanisms. The final two gene targets were the 
integrase gene of class 1 integrons (intI1) and the origin of replication (replication 
initiation protein A) for incompatibility group A/C plasmids (repA), each of which 
represents the potential for both horizontal gene transfer and the accumulation of multiple 
ARGs (82,222).  The repA method was developed in collaboration with Timothy Johnson 
and Kevin Lang of the University of Minnesota Department of Veterinary and 
Biomedical Sciences (St. Paul, Minnesota, United States).  The forward and reverse 
primer sequences, expected amplicon sizes, and primer annealing temperatures for all 
gene targets are listed in Appendix D (Table D.1) (8,24,95,151,195,196,200–202).   
Real-time PCR assays were carried out on an Eppendorf Mastercycler EP 
Realplex thermal cycler (Eppendorf, Westbury, NY).  Thermal cycles typically began 
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with 1 min of initial denaturation at 95°C, followed by 40 cycles of denaturation at 95°C 
for 15 s and combined annealing and extension for 1 min at the primer-specific annealing 
temperature.  PCR assays were optimized to reduce or eliminate the formation of primer 
dimers, and melting curves were typically conducted for all assays following 
amplification to screen for non-specific products.  Melting curves began with 15 s at the 
primer-specific annealing temperature followed by a 20 min ramp up to 95°C and a final 
hold at 95°C for 15 s.  Reaction volumes were 25 µL and consisted of 12.5 µL of BioRad 
iTaq SYBR Green Supermix with ROX (Life Science Research, Hercules, CA), 25 µg of 
bovine serum albumin, 12.5 pmol of forward primer, 6.25 pmol of reverse primer, and 
approximately 1 ng of template genomic DNA.  Standards were prepared by initially 
amplifying gene targets from well-described bacterial isolates or municipal wastewater 
solids using PCR.  PCR products were then ligated into the pGEM-T Easy cloning vector 
and transformed into either JM109 or DH5α competent cells.  Cloned plasmids were 
extracted from cell cultures using either an alkaline lysis procedure (197) or a QIAprep 
Spin Miniprep Kit (Qiagen, Valencia, CA).  Plasmid DNA concentrations in these 
extracts were determined using a TD-700 fluorometer and Hoechst 33258 dye.  Separate 
standard curves were constructed for each individual assay (i.e. each 96-well plate 
contained a standard curve), and each standard curve consisted of a 10-fold serial dilution 
of an aliquot of plasmid DNA extract.   The number of standards, slope, intercept, 
amplification efficiency, r
2
, and quantification limit for each standard curve are provided 
in Appendix D (Table D.2).  Of the 51 assays performed, 38 (74%) had amplification 
efficiencies of 100% ± 10% (maximum deviation from 100%) with r
2
 ≥ 0.98 for a 
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minimum of five points on each standard curve.  The absolute values by which 
amplification efficiencies for the remaining 13 assays deviated from 100% were between 
11% and 21% with r
2
 ≥ 0.99 for a minimum of seven points on each standard curve.   
Each triplicate sample was analyzed once to produce triplicate analytical 
measurements for each soil microcosm on each sample date.  Thus, these triplicate 
measurements reflect the combined variability of DNA extraction and real-time PCR.  
Values represented in figures and tables are typically the arithmetic mean of triplicate 
measurements.  If, however, only one sample in a triplicate set amplified for any given 
gene target, then that value was discarded and the set of triplicates that it belonged to 
were collectively reported as less than the quantification limit.  If two samples in a 
triplicate set amplified, then the arithmetic mean of those two values was reported as 
representing the set of triplicates that they belonged to.  These cases are referred to as 
being duplicate samples in figure captions.   
Data Analysis.  Simple linear regression (Arc 1.06) was used to determine first-
order kinetic coefficients for all time series of gene target quantities and all time series of 
ARG and intI1 ratios to the 16S rRNA gene.  A first-order kinetic model was 
hypothesized because previous work has shown the decline of ARG and intI1 quantities 
in several different types of natural and engineered systems to follow first-order trends 
(115,121,170,204,206,208).  First-order kinetic models also provide a valuable 
descriptive and interpretive tool that is useful for comparing results across different gene 
targets and environments.  A formal lack-of-fit test was applied to test the null hypothesis 
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that the natural logarithm of gene target quantities (or ARG and intI1 ratios to 16S rRNA 
gene quantities) varied linearly with respect to time (205). 
6.3 Results 
Initial and Operating Conditions.  Two experiments were performed using 
different soil types (a sand mixture in Experiment 1 and silt loam soil in Experiment 2) 
and residual solids from two different wastewater treatment facilities.  Experiments 1 and 
2 were similar with respect to evaporation and initial ARG and intI1 quantities in the 
residual solids (Table 6.1 and Table 6.2).  The rates and extents of water loss during the 
experiments were low and similar across groups of microcosms despite differences in soil 
type, residual solids loading rates, and residual solids source.  Similarly, the quantities of 
16S rRNA genes, AllBac, and tet(A) in Residual Solids 1 and 2 were not significantly 
different (P ≥ 0.05).  Quantities of erm(B), intI1, and sul1 differed significantly (P < 
0.05), but minimally, by factors of two to four.  Only quantities of HF183, tet(W), and 
tet(X) differed (P < 0.05) substantially between the two residual solids sources.  
Quantities of tet(W) and tet(X) differed by factors of 12 and nearly 60, respectively, 
while HF183 was on the order of 10
3
 copies mg
-1
 wet mass in Residual Solids 1 but was 
below the quantification limit (2.3103 copies mg-1 wet mass) for Residual Solids 2.  
Finally, quantities of qnrA were extremely low, and quantities of repA were below the 
quantification limit (2.0103 copies mg-1 wet mass) in Residual Solids 2, so they were not 
quantified in Residual Solids 1. 
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Table 6.1.  Net evaporation rates and the total mass of water lost to evaporation 
(expressed as the fraction of the initial mass of soil and residual solids present in 
each microcosm) for sets of three replicate microcosms at all loading rates for each 
experiment.  Error terms represent the standard error of the mean. 
Loading Rate 
(g kg
-1
) 
Experiment 
Net Evaporation Rate
a
 
(mm H2O day
-1
) 
Fraction of Initial 
Microcosm Mass Lost 
to Evaporation 
0 1 210-3 ± 310-4 3.5% ± 1.1% 
20 1 210-3 ± 410-4 3.6% ± 1.2% 
40 1 110-3 ± 110-4 2.0% ± 0.4% 
100 1 210-3 ± 210-4 2.0% ± 0.6% 
0 2 210-3 ± 910-5 3.3% ± 0.6% 
40 2 210-3 ± 610-5 3.4% ± 0.3% 
a
Net evaporation rates were determined using linear regression (Arc 1.06).  The 
predictor was time, and the cumulative mass of water lost from each group of 
replicate soil microcosms (i.e. three values at each time point) was used as the 
response variable.  All evaporation rates are statistically significant (P < 0.05). 
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Table 6.2.  The quantities of all gene targets in both residual solids sources.  Values 
are the arithmetic mean of triplicate samples; error terms represent one standard 
deviation. 
Gene Target 
Gene Copies (mg
-1
 wet mass) 
Residual Solids 1 Residual Solids 2 
16S rRNA genes 4.5108 ± 2107 9.2108 ± 4108 
AllBac 1.6107 ± 1106 1.2107 ± 5106 
HF183
a
 4.2103 ± 8102 < 2.3103 
erm(B) 3.1106 ± 4105 1.9106 ± 4105 
intI1 2.1105 ± 2104 6.7105 ± 2105 
qnrA ND
b
 2.7101 ± 2101 
repA ND
b
 < 2.0103 
sul1 6.0105 ± 1105 2.1106 ± 5105 
tet(A) 3.7104 ± 4103 4.4104 ± 1104 
tet(W) 6.4105 ± 3104 7.8106 ± 3106 
tet(X) 3.4105 ± 5104 5.8103 ± 3103 
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a
HF183 quantities were below the quantification limit in Residual Solids 2. 
b
Quantities of qnrA and repA were extremely low or below the quantification limit, 
respectively, in Residual Solids 2, so they were not determined (ND) in Residual 
Solids 1. 
 
Negative Control Microcosms.  Experiments 1 and 2 differed with respect to 
ARG and intI1 quantities in experimental negative control microcosms (Table 6.3).  All 
ARGs and intI1 were below quantification limits in Soil 1 throughout the experiment, 
except for sul1, which appeared in low quantities at three time points.  In contrast, sul1 
and intI1 were detected at 15 of 24 and 24 of 24 time points, respectively, in Soil 2 during 
the experiment, although these background quantities were low relative to those found in 
both residual solids.  The erm(B) and tet(X) gene targets also appeared in relatively low 
quantities at a handful of time points, while quantities of tet(A) and tet(W) were below 
quantification limits throughout Experiment 2.  
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Table 6.3.  The number of data points with quantifiable values (n) and quantities for 
AllBac, HF183, ARGs, and intI1 in triplicate experimental negative control 
microcosms for both experiments.  Values are the arithmetic mean of n data points; 
error terms represent one standard deviation. 
Gene 
Target 
Experiment 1 Experiment 2 
n
a
 
Gene Copies                        
(mg
-1
 wet mass) 
n
b
 
Gene Copies                        
(mg
-1
 wet mass) 
AllBac 0 NA 4 420 ± 300 
HF183 0 NA ND
c
 
erm(B) 0 NA 5 1,100 ± 200 
intI1 0 NA 15 970 ± 400 
sul1 3 92 ± 40 24 520 ± 200 
tet(A) 0 NA 0 NA 
tet(W) 0 NA 0 NA 
tet(X) 0 NA 1 140 
a
Out of 18 total data points for Experiment 1 (3 microcosms  6 time points per 
microcosm). 
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b
Out of 24 total data points for Experiment 2 (3 microcosms  8 time points per 
microcosm). 
c
Quantities of HF183 were below the quantification limit (2.4103 copies mg-1 wet 
mass) in soil microcosms that received residual solids in Experiment 2, so they were 
not determined (ND) for the negative control microcosms. 
 
Total Bacterial Biomass.  Experiments 1 and 2 also differed with respect to total 
bacterial biomass (Figure 6.1).  Soil 2 contained a larger (one to two orders of magnitude) 
quantity of 16S rRNA genes than Soil 1.  However, 16S rRNA gene quantities in both 
soils were within the range of previously reported values for direct cell counts in soil 
(223).  Quantities of 16S rRNA genes in both sets of experimental negative controls were 
low relative to those found in both residual solids and either increased (Soil 1, P < 0.05) 
by less than an order of magnitude or remained constant (Soil 2, P ≥ 0.05).  The initial 
quantities of 16S rRNA genes in microcosms that received residual solids were higher 
than in experimental negative controls for both experiments, and remained constant (P ≥ 
0.05) or decreased (P < 0.05) by less than an order of magnitude. 
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Figure 6.1.  The quantities of 16S rRNA genes in three replicate soil microcosms 
(closed circles, open circles, and closed triangles represent unique experimental 
units) at all loading rates for both experiments.  Values are the arithmetic mean of 
duplicate or triplicate samples; error bars represent one standard deviation. 
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Fecal Bacterial Biomass.  Experiments 1 and 2 were similar with respect to 
indicators for fecal bacterial biomass, and fecal biomass followed a different trend with 
time compared to total bacterial biomass (Figure 6.2).  Quantities of AllBac were 
generally below quantification limits in negative control microcosms for both 
experiments, except for several sporadic appearances at low quantities in Experiment 2 
(Table 6.3).  Quantities of AllBac were relatively high in microcosms that received 
residual solids for both experiments, and initial quantities in microcosms that received 40 
g residual solids kg
-1
 soil were similar for the two experiments.  These initially high 
quantities decreased by approximately three orders of magnitude or more for both 
experiments, which was consistent with the behavior of genetic markers for other fecal 
indicators in soil (207).  Quantities of HF183 were below quantification limits (5.9102 
to 1.5103 copies mg-1 wet mass) in all microcosms throughout Experiment 1, except for 
the initial time points in the microcosms containing the most residual solids, where it 
occurred at 1.2103 ± 3102 copies mg-1 wet mass.  Quantities of HF183 were also below 
the quantification limit (2.4103 copies mg-1 wet mass) throughout Experiment 2 in the 
microcosms that received residual solids. 
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Figure 6.2.  The quantities of 16S rRNA genes of all Bacteroides spp. in three 
replicate soil microcosms (closed circles, open circles, and closed triangles represent 
unique experimental units) at loading rates of 20, 40, and 100 g residual solids kg
-1
 
soil for Experiment 1 and 40 g residual solids kg
-1
 soil for Experiment 2.  Values are 
the arithmetic mean of duplicate or triplicate samples; error bars represent one 
standard deviation. 
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ARGs and intI1.  ARG and intI1 quantities in microcosms that received residual 
solids decreased with time for nearly all cases in Experiment 1 (Figure 6.3, Figure D.1, 
Figure D.2, Figure D.3, Figure D.4, and Figure D.5).  The extents of these decreases 
varied between approximately one order of magnitude (e.g. sul1 for 40 g kg
-1
) and four 
orders of magnitude (e.g. erm(B) for 100 g kg
-1
).  The only quantities that remained 
constant (P ≥ 0.05) were those of sul1 in microcosms receiving 100 g kg-1 of treated 
residual solids.  Similar trends were also observed for the ratios of ARGs and intI1 to the 
16S rRNA gene.  All ratios decreased (P < 0.05) by one to four orders of magnitude over 
the course of approximately six months.  The only ratios that remained constant (P ≥ 
0.05) were those of intI1 and sul1 in microcosms receiving 40 g kg
-1
 of residual solids 
and intI1 in microcosms receiving 100 g kg
-1
 of residual solids. 
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Figure 6.3.  The quantities of ARGs and intI1 in three replicate soil microcosms 
(closed circles, open circles, and closed triangles represent unique experimental 
units) at a loading rate of 40 g residual solids kg
-1
 soil for Experiment 1.  Values are 
the arithmetic mean of duplicate or triplicate samples; error bars represent one 
standard deviation. 
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In contrast, the quantities of ARGs and intI1 in microcosms that received residual 
solids only decreased for half of the gene targets considered in Experiment 2 (Figure 6.4 
and Figure D.6).  Initial quantities were within one order of magnitude of those for the 40 
g kg
-1
 microcosms from Experiment 1, except for quantities of tet(X), which were 18-fold 
higher in the Experiment 1 microcosms.  The initially large quantities of erm(B), sul1, 
and tet(W) all decreased (P < 0.05) to similar extents as they did in Experiment 1.  
Quantities of intI1, tet(A), and tet(X), however, all remained constant (P ≥ 0.05) 
throughout Experiment 2.  Quantities of qnrA and repA were below quantification limits 
throughout Experiment 2 (4.9102 and 2.1102 copies mg-1 wet mass, respectively) in 
microcosms that received residual solids, so they were not quantified in any other 
microcosms from Experiment 1 or 2.  The trends for ratios of ARGs and intI1 to 16S 
rRNA genes were similar.  Ratios of erm(B), sul1, and tet(W) all decreased (P < 0.05), 
while ratios of intI1 and tet(X) did not change (P ≥ 0.05), and the ratio of tet(A) to 16S 
rRNA genes actually increased (P < 0.05) during Experiment 2.  
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Figure 6.4.  The quantities of ARGs and intI1 in three replicate soil microcosms 
(closed circles, open circles, and closed triangles represent unique experimental 
units) at a loading rate of 40 g residual solids kg
-1
 soil for Experiment 2.  Values are 
the arithmetic mean of duplicate or triplicate samples; error bars represent one 
standard deviation.   
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 Kinetic Modeling.  A first-order kinetic model described the trends in gene target 
quantities as a function of time reasonably well for soil microcosms in both Experiment 1 
and 2 (Table 6.4 and Table 6.5).  The lack-of-fit test provided significant (P < 0.05) 
evidence against the null hypothesis for only 14 of the 65 (i.e. 22%) time series to which 
it could be applied (n ≥ 3, values for experimental replicates at a minimum of one time 
point).  The 16S rRNA gene was relatively persistent in both experiments.  It varied from 
having a half-life of 110 d (Experiment 1, 40 g kg
-1
) to a doubling time of 150 d 
(Experiment 1, negative control microcosms), and most (four of six) of its first-order 
kinetic coefficients were not statistically significant (P < 0.05).  In contrast, most (20 of 
24) first-order kinetic coefficients for ARGs and intI1 in microcosms that received 
residual solids were statistically significant (P < 0.05).  Statistically significant half-lives 
for ARGs and intI1 varied between 13 d (erm(B), Experiment 1, 100 g kg
-1
) and 81 d 
(intI1, Experiment 1, 40 g kg
-1
), and the half-lives of AllBac bracketed the low end of this 
range at values between 10 d (Experiment 1, 40 g kg
-1
) and 26 d (Experiment 2, 40 g kg
-
1
).  Similar trends were observed for the ratios of ARGs and intI1 to 16S rRNA genes in 
microcosms that received residual solids.  Most (19 of 24) first-order kinetic coefficients 
for these ratios were statistically significant (P < 0.05), and their associated half-lives 
varied between 15 d (erm(B), Experiment 1, 40 and 100 g kg
-1
) and 200 d (tet(X), 
Experiment 1, 100 g kg
-1
), except for sul1 at 100 g kg
-1
 in Experiment 1, which had a 
doubling time of 150 d.
164 
 
Table 6.4.  First-order kinetic coefficients (k), P, number of data points (n), lack-of-fit P (LOF P), r
2
, and half-lives (t1/2) from 
first-order kinetic models of gene target quantities in three replicate soil microcosms at all loading rates (LR, g treated 
residual municipal wastewater solids kg
-1
 soil) for both experiments. 
Gene Target Experiment LR 
k ± Standard Error  
(day
-1
) 
P n LOF P r
2
 t1/2 (days) 
16S rRNA gene 1 0 4.810-3 ± 110-3 310-3 18 0.05 0.44 -150 
16S rRNA gene 1 20 -4.510-3 ± 310-3 0.17 18 0.98 0.11 150 
16S rRNA gene 1 40 -6.110-3 ± 310-3 0.04 18 0.96 0.24 110 
16S rRNA gene 1 100 -7.510-3 ± 410-3 0.11 17 0.66 0.16 93 
16S rRNA gene 2 0 9.410-4 ± 610-4 0.13 24 0.63 0.10 -740 
16S rRNA gene 2 40 -2.710-3 ± 210-3 0.14 18 0.63 0.13 260 
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AllBac 1 0 ND
a
 
AllBac 1 20 -5.010-2 ± 610-3 < 110-4 12 0.10 0.86 14 
AllBac 1 40 -7.210-2 ± 710-3 < 110-4 10 0.61 0.94 10 
AllBac 1 100 -4.210-2 ± 710-3 < 110-4 15 0.04 0.74 17 
AllBac 2 0 3.510-3 ± 510-3 0.54 4 0.64 0.21 -200 
AllBac 2 40 -2.610-2 ± 410-3 < 110-4 18 0.20 0.73 26 
erm(B) 1 0 ND
a
 
erm(B) 1 20 -3.910-2 ± 410-3 < 110-4 18 0.64 0.87 18 
erm(B) 1 40 -5.310-2 ± 510-3 < 110-4 13 0.84 0.92 13 
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erm(B) 1 100 -5.310-2 ± 810-3 < 110-4 15 0.01 0.77 13 
erm(B) 2 0 -3.810-4 ± 110-3 0.78 5 0.19 0.03 1,800 
erm(B) 2 40 -2.210-2 ± 310-3 < 110-4 18 710-4 0.72 32 
intI1 1 0 ND
a
 
intI1 1 20 -2.310-2 ± 710-3 0.01 10 0.96 0.56 30 
intI1 1 40 -8.610-3 ± 310-3 0.03 13 0.99 0.37 81 
intI1 1 100 -9.310-3 ± 410-3 0.03 17 0.75 0.29 75 
intI1 2 0 -6.210-5 ± 210-3 0.97 15 0.99 0.00 11,000 
intI1 2 40 -1.610-3 ± 310-3 0.55 18 0.13 0.02 440 
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sul1 1 0 -4.710-3 ± 110-2 0.76 3 NDb 0.13 150 
sul1 1 20 -1.310-2 ± 310-3 210-4 18 0.71 0.59 53 
sul1 1 40 -1.210-2 ± 210-3 110-4 18 0.95 0.65 57 
sul1 1 100 -2.710-3 ± 310-3 0.41 18 0.75 0.04 250 
sul1 2 0 -4.710-4 ± 110-3 0.73 24 0.58 0.01 1,500 
sul1 2 40 -1.110-2 ± 310-3 610-4 18 0.26 0.53 63 
tet(A) 1 0 ND
a
 
tet(A) 1 20 -2.510-2 ± 510-3 110-3 11 0.44 0.72 28 
tet(A) 1 40 -2.810-2 ± 210-3 < 110-4 18 0.65 0.90 25 
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tet(A) 1 100 -1.910-2 ± 410-3 110-4 18 0.29 0.63 37 
tet(A) 2 0 ND
a
 
tet(A) 2 40 2.810-3 ± 210-3 0.21 18 410-3 0.10 -240 
tet(W) 1 0 ND
a
 
tet(W) 1 20 -3.310-2 ± 310-3 < 110-4 17 110-3 0.91 21 
tet(W) 1 40 -3.310-2 ± 310-3 < 110-4 14 410-3 0.91 21 
tet(W) 1 100 -4.310-2 ± 210-2 0.03 9 0.19 0.52 16 
tet(W) 2 0 ND
a
 
tet(W) 2 40 -2.210-2 ± 310-3 < 110-4 18 0.16 0.74 31 
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tet(X) 1 0 ND
a
 
tet(X) 1 20 -2.310-2 ± 610-3 210-3 17 0.89 0.48 30 
tet(X) 1 40 -1.810-2 ± 310-3 < 110-4 18 0.02 0.73 38 
tet(X) 1 100 -1.210-2 ± 410-3 0.01 17 0.67 0.34 59 
tet(X) 2 0 ND
a
 
tet(X) 2 40 3.510-3 ± 410-3 0.45 14 0.04 0.05 -200 
a
Quantities of some gene targets were above quantification limits for only n ≤ 2 time points, so k was not determined (ND). 
b
Quantities of sul1 were above quantification limits in only one soil microcosm at a loading rate of 0 g residual solids kg
-1
 soil 
for Experiment 1, so the lack-of-fit test could not be conducted, and LOF P was not determined (ND). 
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Table 6.5.  First-order kinetic coefficients (k), P, number of data points (n), lack-of-fit P (LOF P), r
2
, and half-lives (t1/2) from 
first-order kinetic models of ratios of ARGs and intI1 to 16S rRNA genes in three replicate soil microcosms at all loading rates 
(LR, g treated residual municipal wastewater solids kg
-1
 soil) for both experiments. 
Gene Target Experiment LR 
k ± Standard Error 
(day
-1
) 
P n LOF P r
2
 t1/2 (days) 
erm(B) 1 0 ND
a
 
erm(B) 1 20 -3.410-2 ± 310-3 < 110-4 18 0.41 0.89 20 
erm(B) 1 40 -4.610-2 ± 710-3 < 110-4 13 0.98 0.81 15 
erm(B) 1 100 -4.710-2 ± 710-3 < 110-4 15 < 110-4 0.79 15 
erm(B) 2 0 -1.010-3 ± 810-4 0.28 5 0.04 0.36 680 
erm(B) 2 40 -1.910-2 ± 310-3 < 110-4 18 110-4 0.66 36 
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intI1 1 0 ND
a
 
intI1 1 20 -1.310-2 ± 310-3 310-3 9 0.70 0.75 52 
intI1 1 40 3.110-3 ± 610-3 0.61 13 0.99 0.02 -220 
intI1 1 100 -8.810-4 ± 110-3 0.51 17 0.13 0.03 780 
intI1 2 0 -1.610-3 ± 210-3 0.39 15 1.00 0.06 440 
intI1 2 40 1.210-3 ± 210-3 0.59 18 0.28 0.02 -560 
sul1 1 0 -1.710-2 ± 110-2 0.36 3 NDb 0.71 40 
sul1 1 20 -7.610-3 ± 210-3 110-3 18 0.74 0.48 91 
sul1 1 40 -6.110-3 ± 410-3 0.11 18 0.90 0.15 110 
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sul1 1 100 4.710-3 ± 210-3 0.02 17 0.67 0.30 -150 
sul1 2 0 -1.610-3 ± 110-3 0.27 24 0.82 0.06 450 
sul1 2 40 -8.110-3 ± 310-3 610-3 18 0.16 0.39 86 
tet(A) 1 0 ND
a
 
tet(A) 1 20 -2.610-2 ± 410-3 110-4 11 0.54 0.84 27 
tet(A) 1 40 -2.210-2 ± 410-3 < 110-4 18 0.94 0.69 32 
tet(A) 1 100 -1.210-2 ± 210-3 < 110-4 17 0.32 0.79 58 
tet(A) 2 0 ND
a
 
tet(A) 2 40 6.010-3 ± 210-3 0.02 18 0.08 0.28 -120 
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tet(W) 1 0 ND
a
 
tet(W) 1 20 -2.810-2 ± 410-3 < 110-4 17 0.26 0.75 24 
tet(W) 1 40 -2.910-2 ± 310-3 < 110-4 14 0.01 0.90 24 
tet(W) 1 100 -3.510-2 ± 810-3 310-3 9 510-3 0.74 20 
tet(W) 2 0 ND
a
 
tet(W) 2 40 -1.910-2 ± 310-3 < 110-4 18 0.07 0.72 36 
tet(X) 1 0 ND
a
 
tet(X) 1 20 -1.910-2 ± 410-3 210-4 17 0.32 0.62 37 
tet(X) 1 40 -1.210-2 ± 410-3 710-3 18 0.59 0.37 57 
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tet(X) 1 100 -3.410-3 ± 110-3 0.02 17 0.47 0.33 200 
tet(X) 2 0 ND
a
 
tet(X) 2 40 5.910-3 ± 510-3 0.22 14 0.03 0.12 -120 
a
Quantities of some gene targets were above quantification limits for only n ≤ 2 time points, so k was not determined (ND). 
b
Quantities of sul1 were above quantification limits in only one soil microcosm at a loading rate of 0 g residual solids kg
-1
 soil 
for Experiment 1, so the lack-of-fit test could not be conducted, and LOF P was not determined (ND). 
 
175 
 
 The first-order kinetic coefficients determined for Experiment 1 tended to vary 
more by gene target than by loading rate (Figure 6.5).  The largest kinetic coefficients 
(i.e. slowest decline in gene quantities) tended to be those of intI1 and sul1, while erm(B) 
tended to have the smallest (i.e. fastest decline in gene quantities).  There was no clear 
relationship between the collective values of kinetic coefficients and the solids-to-soil 
mass loading rate, as kinetic coefficients for quantities of some gene targets appeared to 
increase with loading rate while others appeared to decrease.  Furthermore, few of the 
apparent increases or decreases with loading rate were significant.  Only 4 of 18 possible 
comparisons (i.e. comparing kinetic coefficients for 40 g kg
-1
 to 20 g kg
-1
, 100 g kg
-1
 to 
40 g kg
-1
, and 100 g kg
-1
 to 20 g kg
-1
) for kinetic coefficients describing the changes in 
quantities of ARGs and intI1 were significant (P < 0.05, Welch’s t-test), and 8 of 18 
possible comparisons for kinetic coefficients describing changes in ratios of ARGs and 
intI1 to the 16S rRNA gene were significant (P < 0.05, Welch’s t-test).  Also, the largest 
changes in kinetic coefficients with loading rate for individual gene targets were smaller 
than the largest differences in kinetic coefficients between different gene targets at the 
same loading rates.  
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Figure 6.5.  The kinetic coefficients for (A) quantities of ARGs and intI1 and (B) 
ratios of ARGs and intI1 to the 16S rRNA gene from Experiment 1 as a function of 
loading rate.  Values are from Table 6.4 and Table 6.5; error bars represent the 
standard error of the mean.  Values of “0” have been substituted for kinetic 
coefficients with P > 0.05.  Connecting lines are intended as visual aids only. 
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Quantities of several gene targets declined at a slower rate in Experiment 2 than in 
the equivalent (i.e. 40 g kg
-1
) microcosms from Experiment 1.  The differences in kinetic 
coefficients for the 16S rRNA gene, intI1, and sul1 between Experiments 1 and 2 were 
not statistically significant (P ≥ 0.05, Welch’s t-test).  The same differences for AllBac, 
erm(B), tet(A),  tet(W), and tet(X), however, were statistically significant (P < 0.05, 
Welch’s t-test).  The quantities of these gene targets declined between 30% and 100% 
more slowly in Experiment 2 compared to Experiment 1.  Similar results were found for 
the ratios of ARGs and intI1 to 16S rRNA genes.  The difference in rates at which ratios 
of intI1 and sul1 declined were not significant (P ≥ 0.05, Welch’s t-test) between the two 
experiments.  The ratios of erm(B), tet(W), and tet(X), however, all declined more slowly 
(P < 0.05, Welch’s t-test) in Experiment 2 than in Experiment 1, and the ratios of tet(A) 
actually increased in Experiment 2 while they decreased in Experiment 1. 
6.4 Discussion 
Quantities of ARGs and intI1 start high and decline at relatively slow rates in soil 
to which treated residual municipal wastewater solids have been applied.  While previous 
work has indicated that the vast majority of ARGs in the municipal wastewater treatment 
process are ultimately discharged to the environment in the residual solids (27), the 
relative persistence of ARGs in soil following land-application of treated residual solids 
has not been investigated.  This is important because approximately 50% of all residual 
solids produced in the United States are land-applied (186), and, as shown here, treated 
residual solids contain large quantities of ARGs that are relatively persistent in the soil 
environment.  Initial ARG and intI1 quantities were often several orders of magnitude 
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higher than the quantification limit for HF183, a human-specific fecal indicator, in 
microcosms that received residual solids, and half-lives for intI1, sul1, tet(A), and tet(X) 
were longer than those of AllBac, a fecal indicator.  Furthermore, half-lives of erm(B), 
intI1, sul1, tet(A), tet(W), and tet(X) in this work varied from weeks to months, whereas 
the half-lives of the same genes in a laboratory-scale aerobic digestor and in laboratory-
scale mesophilic and laboratory-scale thermophilic anaerobic digestors have been 
demonstrated to vary from hours to days (121,204).  Thus, ARGs and intI1 can persist for 
longer periods of time and at comparable or substantially larger quantities than at least 
some fecal indicators.  Also, the removal of ARGs and intI1 from residual municipal 
wastewater solids can probably be carried out most effectively within the treatment plant 
(i.e. during solids treatment) prior to land-application.    
The relative persistence of ARGs and intI1 from treated residual municipal 
wastewater solids in soil provides adequate time for off-site transport, and ultimately, 
human exposure to ARGs.  For example, the most significant risk of exposure to residual 
wastewater solids, other than direct ingestion, is inhalation of residual solids aerosols 
during land-application by populations living near land-application sites (224).  The 
estimated inhalable dose of treated residual solids at 165 m from an emission source 
during disc-incorporation (i.e. land-application) of 40 to 110 g of Class B residual solids 
kg
-1
 soil has been estimated to be between 2 and 8 µg (218).  Based on the quantities of 
ARGs and intI1 reported here, this would correspond to an inhalable ARG (or intI1) dose 
of 10 (tet(X), Residual Solids 2) to 60,000 (tet(W), Residual Solids 2) copies.  This likely 
represents a worst-case scenario that would occur immediately upon land-application of 
179 
 
treated residual solids.  However, the persistence of ARGs and intI1 in soil at relatively 
high concentrations for time periods on the order of months provides the opportunity for 
other transport and exposure events during mechanical disturbances of the soil (e.g. 
tilling, planting, or high-wind events) or in runoff during storm events.  The human 
health risks posed by these potential events are not currently well understood and need to 
be critically evaluated.   
Contrary to expectations, the mass loading rate of treated residual solids to soil 
did not affect the persistence of ARGs and intI1 in soil significantly.  This indicates that 
the mass loading rate of residual solids to soil is unlikely to be a useful variable for 
controlling the fate of ARGs and intI1 in land-applied treated residual solids.  The 
potential exists, however, for ARGs and intI1 to accumulate in soil to which treated 
residual solids are applied repeatedly.  For example, sul1 and sul2 have been 
demonstrated to accumulate in agricultural soil to which animal manure containing 
sulfadiazine has been applied repeatedly at a loading rate of 40 g manure kg
-1
 soil (150).  
This loading rate is within the range of those typically used for treated municipal 
wastewater solids on agricultural fields, which vary between 12 and 2,250 Mg ha
-1
 (184) 
(1.5 to 290 g residual solids kg
-1
 dry soil for solids that are mechanically incorporated 
into the soil to a depth of 0.6 m).  Furthermore, dewatered residual solids are generally 
applied at loading rates on the higher end of this range (184).  The first-order kinetic 
coefficients determined in this work, which investigated loading rates of 20 to 100 g 
residual solids kg
-1
 soil, should therefore be useful for managing the frequency with 
which treated residual solids are land-applied to individual fields.  
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One of the most persistent gene targets in all soil microcosms that received treated 
residual solids was intI1, which is similar to our previous results in aerobic digestion and 
air-drying beds (204,208).  Integrons enable both horizontal gene transfer and the 
collection of multiple ARGs (82).  This characteristic makes them particularly significant 
from a public health standpoint, and when considered in context of how frequently they 
are found in the environment, suggests that more research ought to be directed at 
understanding their distribution and genetic contents in the environment (198).  It may be 
that these integrons are found to be empty or contain genes that are more-or-less 
innocuous from a public health perspective.  If, however, integrons are found to 
frequently contain multiple ARGs, then they may be appropriate specific targets for 
treatment systems and management strategies intended to remove ARGs from residual 
municipal wastewater solids. 
 The advantages of the approach used in this work are that it is quantitative, 
culture-independent, and isolates the mixture of soil and residual solids in a closed and 
reasonably homogenous system.  However, there are a number of limitations related to 
the use of both real-time PCR and soil microcosms that may influence our results.  Most 
importantly, the real-time PCR protocol used in this work cannot distinguish gene targets 
in pathogens from those in non-pathogens.  Similarly, it cannot distinguish gene targets in 
living bacteria from those in dead bacteria or present as extracellular DNA in the soil 
matrix.  The real-time PCR protocol also provides no information regarding the 
expression of gene targets in living hosts and cannot distinguish full-length genes from 
partial gene fragments that coincidentally contain the primer annealing sites.  Also, 
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because the soil microcosms were closed and stored indoors, they did not simulate the 
effects of direct sunlight, natural fluctuations in moisture content and temperature, or the 
presence of a full soil ecosystem on the rates at which ARG and intI1 quantities decline 
in soil.  Finally, the work presented in this manuscript investigates only a small fraction 
of known ARGs. 
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Chapter 7: Effects of Several Processes to Significantly Reduce 
Pathogens and Processes to Further Reduce Pathogens on the Fate of 
Antibiotic Resistance Genes and Class 1 Integrons in Soil 
Microcosms Following the Application of Treated Residual 
Municipal Wastewater Solids 
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Antibiotic resistance genes (ARGs) can persist for months at high concentrations 
in soil microcosms following application of treated residual municipal wastewater solids 
from full-scale treatment facilities.  The objective of this research was to assess the 
effects of alternative treatment technologies on this persistence.  Treated residual solids 
from laboratory-scale treatment units were applied to sets of triplicate soil microcosms.  
The treatment technologies included aerobic digestion, air drying, alkali stabilization, 
anaerobic digestion at 38°C, anaerobic digestion at 55°C, anaerobic digestion at 62°C, 
anaerobic digestion at 69°C, and pasteurization.  Soil microcosms containing untreated 
residual solids from a full-scale treatment facility were also included.  Six ARGs 
(erm(B), qnrA, sul1, tet(A), tet(W), and tet(X)), the integrase gene of class 1 integrons 
(intI1), 16S rRNA genes, 16S rRNA genes of all Bacteroides spp. (AllBac), and 16S 
rRNA genes of human-specific Bacteroides spp. (HF183) were quantified using real-time 
PCR.  ARG and intI1 quantities decreased in most microcosms, but the nature of the 
decrease varied depending on treatment technology.  ARG and intI1 quantities decreased 
slowly, with half-lives of 19 (erm(B), untreated) to 76 (tet(A), aerobically digested) d, in 
microcosms that received aerobically digested or untreated residual solids.  However, 
ARG and intI1 quantities in microcosms that received alkali stabilized, pasteurized, or 
anaerobically digested (at 55°C, 62°C, or 69°C) residual solids decreased by a median of 
95.0% (tet(W), anaerobically digested at 55°C) within one month and then persisted at 
relatively low concentrations thereafter.  These results demonstrate that the selection of 
residual solids treatment technology can be used to decrease the persistence of ARGs and 
intI1 in soil following land-application of treated residual municipal wastewater solids. 
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7.1 Introduction 
The development of resistance to antibiotics among pathogens is a major public 
health dilemma with serious health and financial consequences (65,67).  A number of 
strategies are being pursued to mitigate the effects of antibiotic resistance, including the 
development of new antibiotics, the development of alternatives to antibiotics, and the 
reduction of antibiotic use for purposes other than treating disease in humans (2,86–90).  
An alternative, and complementary, strategy consists of identifying and managing 
antibiotic resistance genes (ARGs) as environmental contaminants (5).  This has led to 
the identification of numerous environmental reservoirs of ARGs, including surface 
waters, aquaculture facilities, and agricultural waste (5–20).  One of the largest 
reservoirs, however, appears to be the municipal wastewater treatment process (5,10,21–
32) and, in particular, the residual municipal wastewater solids, which contain the vast 
majority of ARGs that exit the municipal wastewater treatment process (27).  As a result, 
residual solids treatment may present an excellent opportunity to control the quantity of 
ARGs circulating in the environment. 
 Previous results have demonstrated the potential for existing treatment 
technologies to remove ARGs from residual solids.  These technologies, referred to as 
Processes to Significantly Reduce Pathogens (PSRPs) and Processes to Further Reduce 
Pathogens (PFRPs) (185), are currently designed to reduce the water, organic carbon, and 
pathogen content of untreated residual municipal wastewater solids (184).  However, 
PSRPs and PFRPs have also been demonstrated to remove ARGs from untreated residual 
municipal wastewater solids (121,131,204,208), both by reducing the overall number of 
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microorganisms in the residual solids and by creating environmental conditions that fail 
to select for particular ARGs based on their ecological niches (208) (Chapter 5).  Aerobic 
digestion, air-drying beds, and anaerobic digestion have all been demonstrated to remove 
ARGs from residual municipal wastewater solids to varying degrees, and it also appears 
that their capacities in this regard can be optimized by adding pretreatment steps, 
increasing treatment temperatures, and inducing feast-famine (i.e. batch) cycles 
(121,131,204,208) (Chapter 5).   
 The degree to which all of these technologies affect the fate of ARGs in soil 
following land-application of treated residual solids, however, is unknown.  This is a 
significant gap in the body of knowledge, because approximately 50% of all treated 
residual municipal wastewater solids in the United States are land-applied (186).  
Furthermore, previous work has indicated that ARGs originating in treated residual solids 
can persist for months at relatively high concentrations in soil following land-application 
(Chapter 6), thereby creating the opportunity for off-site transport of, and ultimately 
human exposure to, ARGs with stormwater or airborne particulate matter (100,167).  
Many PSRPs and PFRPs are already widespread in the U.S. (186) or could be added to 
existing infrastructure with relative ease.  Thus, their implementation for controlling the 
quantities of ARGs circulating in the environment could represent a tractable 
management strategy for preventing antibiotic resistant infections.   
 The objective of this work was to determine how a variety of PSRPs and PFRPs 
affected the persistence of ARGs and class 1 integrons in soil following land-application 
of treated residual solids.  A group of five PSRPs and one PFRP was considered.  The 
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PSRPs included aerobic digestion at 15°C, air drying, alkali (i.e. lime) stabilization, 
anaerobic digestion at 38°C, and anaerobic digestion at 55°C.  The PFRP was 
pasteurization.  In addition to these six technologies, anaerobic digestion at 62°C and 
69°C, technologies not classified under the PSRP/PFRP scheme, were also considered, 
along with untreated residual municipal wastewater solids.  The untreated residual solids 
represent a “worst-case scenario” positive control for the application of ARGs to soil.  
Residual solids from each of the nine sources were added to soil microcosms, and the 
quantities of several ARGs and the integrase gene of class 1 integrons were determined in 
each microcosm using real-time PCR over an approximately six-month time series.    
7.2 Materials and Methods 
Experimental Design.  Soil microcosms were constructed as described in Section 
6.2 using the Waukegan silt loam soil (fine-silty, mixed, mesic Typic Hapludoll) from 
that experiment.  Soil microcosms from the current experiment were constructed and 
sampled concurrently with soil microcosms containing Soil 2 from the previously 
described experiment, and the negative control (i.e. soil only) microcosms from the 
previously described experiment also served as negative controls for the current 
experiment.  Triplicate microcosms were constructed for each of nine residual solids 
sources.  Residual solids from eight different treatment technologies were considered, 
including aerobic digestion, air drying, alkali stabilization, anaerobic digestion at 38°C, 
anaerobic digestion at 55°C, anaerobic digestion at 62°C, anaerobic digestion at 69°C, 
and pasteurization.  Aerobically and anaerobically digested residual solids were collected 
from the laboratory-scale treatment units described in Table E.1.  Air-dried residual 
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solids were collected from composite samples of the laboratory-scale air-drying beds 
described in (208).  Alkali stabilized and pasteurized residual solids were produced in the 
lab on December 1, 2011, from untreated residual solids collected on November 30, 
2011, from a full-scale (11 MGD) municipal wastewater treatment plant in southern 
Minnesota.  To produce alkali stabilized residual solids, the pH (Fisher Scientific 
Accumet Model 15 pH meter with automatic temperature correction and an Accumet 13-
620-221 probe) of untreated residual solids was increased to above 12 for a period of two 
hours using sodium hydroxide (Figure E.1).  The pH was then neutralized using 
hydrochloric acid.  To produce pasteurized residual solids, the temperature of untreated 
residual solids was increased to above 70°C (temperature measured with Fisher Scientific 
Accumet Model 15 pH meter) for a period of 30 minutes (Figure E.1).  A ninth residual 
solids source was untreated residual municipal wastewater solids from the same 11 MGD 
plant in southern Minnesota, but collected at an earlier date (October 26, 2011).  Soil 
microcosms that received no residual solids (i.e. negative controls), aerobically digested 
residual solids, air-dried residual solids, or untreated residual solids were initiated on 
October 27, 2011.  Soil microcosms that received anaerobically digested residual solids 
were initiated on October 28, 2011, and soil microcosms that received alkali stabilized or 
pasteurized residual solids were initiated on December 1, 2011.  Residual solids treated in 
air-drying beds were added directly to their respective soil microcosms, but all other 
residual solids were centrifuged (30 min at 5,000 rpm and 10°C in a Beckman J2-HS 
centrifuge) to dewater them prior to addition to the soil microcosms.  Residual solids 
were added to the soil microcosms at a mass loading rate of approximately 40 g 
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dewatered residual solids kg
-1
 soil (wet mass), which is typical of mass loading rates used 
in practice (184).  All microcosms were stored at room temperature (approximately 
20°C).  Evaporative water losses for all microcosms were estimated by weighing the 
microcosms at approximately monthly intervals and assuming that all mass loss was due 
to evaporation of water. 
Sample Collection, Genomic DNA Extraction, and Real-time PCR.  Sample 
collection, genomic DNA extraction, and real-time PCR were conducted as described in 
Section 6.2, except that repA could not be quantified reliably in samples from the current 
work and was discarded from the data set as a result.  The forward and reverse primer 
sequences, expected amplicon sizes, and primer annealing temperatures for all gene 
targets are listed in Appendix D (Table D.1) (8,24,95,151,195,196,200–202).  The 
number of standards, slope, intercept, amplification efficiency, r
2
, and quantification limit 
for each standard curve are provided in Appendix E (Table E.2).  Of the 58 assays 
performed, 26 (45%) had amplification efficiencies of 100% ± 10% (maximum deviation 
from 100%) with r
2
 ≥ 0.99 for a minimum of five points on each standard curve.  The 
absolute values by which amplification efficiencies for the remaining 32 assays deviated 
from 100% were between 11% and 27% (median of 15%) with r
2
 ≥ 0.98 for a minimum 
of five points on each standard curve. 
Data Analysis.  Simple linear regression (Arc 1.06) was used to determine first-
order kinetic coefficients for time series of gene target quantities.  A first-order kinetic 
model was hypothesized because previous work has shown the decline of ARG and intI1 
quantities in several different types of natural and engineered systems to follow first-
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order trends (115,121,170,204,206,208).  First-order kinetic models also provide a 
valuable descriptive and interpretive tool that is useful for comparing results across 
different gene targets and environments.  A formal lack-of-fit test was applied to test the 
null hypothesis that the natural logarithm of gene target quantities varied linearly with 
respect to time (205).   
7.3 Results 
Initial and Operating Conditions.  Gene target quantities in soil were similar 
among all sets of microcosms, although initial gene target quantities in source residual 
solids varied based on the experimental treatment (Table 6.3, Table E.3, Table E.4, Table 
E.5, Figure 7.1, Figure 7.2, and Figure E.2).  Initial gene target quantities in soil used to 
initiate sets of microcosms on separate dates were reasonably similar, with measurable 
quantities varying by a factor of five or less.  As described in Chapter 6, quantities of all 
Bacteroides spp. 16S rRNA genes (AllBac), human-specific Bacteroides spp. 16S rRNA 
genes (HF183), ARGs, and intI1 were generally very low or below quantification limits 
and changed little from their initial values in negative control microcosms.  Quantities of 
16S rRNA genes, ARGs, and intI1 tended to be highest in alkali stabilized and 
pasteurized residual solids, followed by aerobically digested and untreated residual 
solids.  Quantities of 16S rRNA genes, intI1, and tet(X) all decreased (P < 0.05) or 
remained constant (P ≥ 0.05) during alkali stabilization and pasteurization.  The higher 
gene target quantities in alkali stabilized and pasteurized residual solids compared to 
untreated residual solids may be due to differences in how initial gene target quantities 
were measured in these different residual solids sources (see Figure 7.1, Figure 7.2, and 
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following paragraph).  They may also reflect true differences in gene target quantities 
between residual solids sampled on October 26, 2011 and residual solids sampled on 
November 30, 2011.  Evaporation rates were similar among all sets of soil microcosms, 
and microcosms lost between approximately 29% (aerobically digested) and 61% (air-
dried and anaerobically digested at 38°C) of their initial moisture content during the 
experiment.     
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Figure 7.1.  The quantities of 16S rRNA genes, AllBac, and HF183 in source 
residual solids.  Values are the arithmetic mean of duplicate or triplicate samples; 
error bars represent one standard deviation.  Quantities of all gene targets were 
measured prior to centrifugation in alkali stabilized and pasteurized residual solids; 
they were measured following centrifugation (or centrifugation was not required) in 
all other residual solids sources.  Quantities of HF183 are not shown for residual 
solids sources where they were below quantification limits (see Table E.2). 
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Figure 7.2.  The quantities of ARGs and intI1 in source residual solids.  Values are 
the arithmetic mean of duplicate or triplicate samples; error bars represent one 
standard deviation.  Quantities of all gene targets were measured prior to 
centrifugation in alkali stabilized and pasteurized residual solids; they were 
measured following centrifugation (or centrifugation was not required) in all other 
residual solids sources.  Quantities of qnrA are not shown for residual solids sources 
where they were below quantification limits (see Table E.2). 
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Mass balances based on gene target quantities in soil and source residual solids 
were able to account for initial gene target quantities within a factor of six for 48 of 68 
(71%) cases.  A notable exception to this was for all gene targets in soil microcosms that 
received alkali stabilized residual solids.  Measurements of initial gene target quantities 
in these microcosms were all well below values predicted by mass balances by factors of 
one (erm(B)) to 52 (intI1).  Furthermore, the initial quantities of five of eight gene targets 
(AllBac, intI1, sul1, tet(A), and tet(X)) were below values predicted by mass balances by 
factors of more than 20.  All gene targets were quantified prior to centrifugation in alkali 
stabilized and pasteurized residual solids, while all gene targets were quantified following 
centrifugation in other residual solids sources (or centrifugation was not required).  Thus, 
the most likely explanation for this discrepancy in gene target recovery is that a large 
fraction of DNA was extracellular in alkali stabilized residual solids, and that the 
extracellular DNA was inadvertently separated from the residual solids during 
centrifugation.  In support of this hypothesis, measured initial gene target quantities in 
soil microcosms that received pasteurized residual solids were also relatively low 
compared to expectations, varying by factors of four (tet(A)) to 12 (AllBac) from 
estimates based on mass balances. 
First-order Kinetic Modeling.  Two first-order kinetic models were developed 
to describe the data (Table E.6 and Table E.7).  The first consisted of a single first-order 
kinetic model applied to the entire time series of data for each gene target in each set of 
soil microcosms.  Only 17 of a possible 64 (27%) fits using this approach were 
characterized by acceptable (P > 0.05) lack-of-fit P values, however.  Visual inspection 
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of the data indicated that this was likely due to drastic changes in gene target quantities 
between time zero and the second sampling time for many soil microcosms.  Thus, the 
second model that was developed consisted of a single first-order kinetic model applied 
to all time series of gene target quantities with the time zero values removed.  Using this 
approach, 51 of a possible 59 (86%) fits were characterized by acceptable (P > 0.05) 
lack-of-fit P values.  Time series for which the second model was considered the better fit 
are described in terms of an initial percentage decrease between time zero and the second 
sampling time.     
Measures of Bacterial Biomass.  Trends in the quantities of 16S rRNA genes 
were largely similar for all experimental treatments (Figure 7.3, Figure 7.4, Figure 7.5, 
Figure 7.6, Figure 7.7, Figure 7.8, Figure 7.9, Figure 7.10, and Figure 7.11).  Quantities 
of 16S rRNA were constant (P > 0.05) throughout the experiment for all experimental 
treatments other than aerobically digested, pasteurized, and untreated residual solids.  
These constant 16S rRNA gene quantities varied between 1.5107 ± 3106 (alkali 
stabilized) and 9.3107 ± 7107 (anaerobically digested at 38°C) copies mg-1 dry mass 
(mean ± standard deviation).  Quantities of 16S rRNA genes in microcosms that received 
aerobically digested, pasteurized, or untreated residual solids declined (P ≤ 0.05) at 
relatively slow rates, with half-lives varying between 120 (aerobically digested) and 230 
(untreated) d.  
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Figure 7.3.  Quantities of 16S rRNA genes and AllBac in soil microcosms that 
received aerobically digested residual solids.  Values are the arithmetic mean of 
duplicate or triplicate samples; error bars represent one standard deviation. 
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Figure 7.4.  Quantities of 16S rRNA genes and AllBac in soil microcosms that 
received air-dried residual solids.  Values are the arithmetic mean of triplicate 
samples; error bars represent one standard deviation.  Dashed lines represent the 
maximum and minimum limits of quantification for data sets that contain one or 
more experimental observations below those limits. 
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Figure 7.5.  Quantities of 16S rRNA genes and AllBac in soil microcosms that 
received alkali stabilized residual solids.  Values are the arithmetic mean of 
duplicate or triplicate samples; error bars represent one standard deviation. 
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Figure 7.6.  Quantities of 16S rRNA genes and AllBac in soil microcosms that 
received anaerobically digested (38°C) residual solids.  Values are the arithmetic 
mean of triplicate samples; error bars represent one standard deviation. 
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Figure 7.7.  Quantities of 16S rRNA genes and AllBac in soil microcosms that 
received anaerobically digested (55°C) residual solids.  Values are the arithmetic 
mean of duplicate or triplicate samples; error bars represent one standard 
deviation. 
 
200 
 
 
Figure 7.8.  Quantities of 16S rRNA genes and AllBac in soil microcosms that 
received anaerobically digested (62°C) residual solids.  Values are the arithmetic 
mean of duplicate or triplicate samples; error bars represent one standard 
deviation.  Dashed lines represent the maximum and minimum limits of 
quantification for data sets that contain one or more experimental observations 
below those limits. 
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Figure 7.9.  Quantities of 16S rRNA genes and AllBac in soil microcosms that 
received anaerobically digested (69°C) residual solids.  Values are the arithmetic 
mean of duplicate or triplicate samples; error bars represent one standard 
deviation.  Dashed lines represent the maximum and minimum limits of 
quantification for data sets that contain one or more experimental observations 
below those limits. 
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Figure 7.10.  Quantities of 16S rRNA genes and AllBac in soil microcosms that 
received pasteurized residual solids.  Values are the arithmetic mean of triplicate 
samples; error bars represent one standard deviation.  Dashed lines represent the 
maximum and minimum limits of quantification for data sets that contain one or 
more experimental observations below those limits. 
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Figure 7.11.  Quantities of 16S rRNA genes, AllBac, and HF183 in soil microcosms 
that received untreated residual solids.  Values are the arithmetic mean of duplicate 
or triplicate samples; error bars represent one standard deviation.  Dashed lines 
represent the maximum and minimum limits of quantification for data sets that 
contain one or more experimental observations below those limits. 
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In contrast to 16S rRNA genes, AllBac quantities declined (P ≤ 0.05) in all 
microcosms regardless of the experimental treatment (Figure 7.3, Figure 7.4, Figure 7.5, 
Figure 7.6, Figure 7.7, Figure 7.8, Figure 7.9, Figure 7.10, and Figure 7.11).  The nature 
of the decline, however, varied somewhat based on the experimental treatment.  AllBac 
quantities in microcosms that received alkali stabilized residual solids, pasteurized 
residual solids, and residual solids digested anaerobically at temperatures of 55°C, 62°C, 
and 69°C decreased sharply within the first 32 d by between 98.77% ± 0.42% 
(anaerobically digested at 62°C) and 99.98% ± 0.01% (alkali stabilized) (mean ± standard 
deviation).  Following this initially sharp drop, AllBac quantities in these microcosms 
either remained constant (P > 0.05, anaerobically digested at 69°C and pasteurized) or 
decreased (P ≤ 0.05) slowly for the remainder of the experiment, with half-lives varying 
between 100 (alkali stabilized) and 170 (anaerobically digested at 60°C) d.  In contrast, 
AllBac quantities in microcosms that received aerobically digested, anaerobically 
digested at 38°C, and untreated residual solids tended to decrease throughout the 
experiment.  Initial decreases in these microcosms were between 91.1% ± 3.5% 
(anaerobically digested at 38°C) and 95.7% ± 2.2% (untreated) (mean ± standard 
deviation), and half-lives following this initial decrease varied between 29 (untreated) 
and 46 (anaerobically digested at 38°C) d.  Finally, AllBac was completely below 
quantification limits (8.2102 to 1.9103 copies mg-1 dry mass) in soil microcosms that 
received air-dried residual solids, and HF183 dropped below quantification limits 
(1.2103 to 3.1103 copies mg-1 dry mass) within the first 33 d in soil microcosms that 
received untreated residual solids, so it was not quantified in the remaining microcosms. 
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ARGs and intI1.  ARG and intI1 quantities in soil microcosms that received air-
dried residual solids or residual solids that were anaerobically digested at 38°C varied 
more with the specific gene target than with the experimental treatment (Figure 7.12 and 
Figure 7.13).  In the soil microcosms that received air-dried residual solids, erm(B) and 
tet(W) were mostly or completely below quantification limits (3.5103 to 8.2103 copies 
mg
-1
 dry mass for erm(B) and 2.7102 to 6.4102 copies mg-1 dry mass for tet(W)), while 
quantities of the remaining ARGs and intI1 either did not change (P > 0.05) or decreased 
(P ≤ 0.05) slowly, with half-lives on the order of 100 d.  For soil microcosms that 
received residual solids anaerobically digested at 38°C, tet(X) quantities are below 
quantification limits (range) by 33 d, while erm(B) and tet(W) quantities decreased by 
98.4% ± 0.4% and 97.4% ± 1.1% (mean ± standard deviation), respectively, within the 
first 33 d.  Quantities of erm(B) and tet(W) remain constant (P > 0.05) following this 
initial decrease.  In contrast, sul1 quantities decrease (P ≤ 0.05) throughout the 
experiment, with a half-life of on the order of 70 d.  Furthermore, intI1 and tet(A) 
quantities actually increase by factors of 2.2 ± 0.2 and 11.9 ± 3.0, respectively, within the 
first 33 d.  Following these initial increases, intI1 and tet(A) quantities decrease for the 
remainder of the experiment, with half-lives of 75 and 45 d, respectively.  
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Figure 7.12.  Quantities of ARGs and intI1 in soil microcosms that received air-
dried residual solids.  Values are the arithmetic mean of duplicate or triplicate 
samples; error bars represent one standard deviation.  Dashed lines represent the 
maximum and minimum limits of quantification for data sets that contain one or 
more experimental observations below those limits. 
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Figure 7.13.  Quantities of ARGs and intI1 in soil microcosms that received 
anaerobically digested (38°C) residual solids.  Values are the arithmetic mean of 
duplicate or triplicate samples; error bars represent one standard deviation.  
Dashed lines represent the maximum and minimum limits of quantification for data 
sets that contain one or more experimental observations below those limits.   
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For the remaining soil microcosms, ARG and intI1 quantities tended to decline in 
most microcosms, and the nature of the decline varied based on the experimental 
treatment (Figure 7.14, Figure 7.15, Figure 7.16, Figure 7.17, Figure 7.18, Figure 7.19, 
Figure 7.20, and Figure E.3).  With some exceptions, ARG and intI1 quantities declined 
sharply within the first 33 d in soil microcosms that received alkali stabilized residual 
solids, pasteurized residual solids, and residual solids digested anaerobically at 55°C, 
62°C, or 69°C.  In these microcosms, initial decreases varied between 53.2% ± 17.1% 
(intI1, anaerobically digested at 65°C) and 99.8% ± 0.1% (erm(B), alkali stabilized) 
(mean ± standard deviation), with a median initial decrease of 95.0% (tet(W), 
anaerobically digested at 55°C).  Following these initial decreases, ARG and intI1 
quantities in these microcosms either did not change (P > 0.05) or continued to decrease 
(P ≤ 0.05) relatively slowly, with half-lives varying between 44 (erm(B), pasteurized) 
and 330 (intI1, anaerobically digested at 60°C) d.  In contrast, ARG and intI1 quantities 
in soil microcosms that received aerobically digested or untreated residual solids 
decreased by between 42.9% ± 20.8% (tet(A), untreated) and 99.2% ± 0.003% (erm(B), 
untreated), with a median decrease of 65.4% (average of erm(B) and tet(X), aerobically 
digested), within the first 33 d.  Following these decreases, quantities of all ARGs and 
intI1 continued to decrease (P ≤ 0.02), with half-lives varying between 40 (tet(X), 
aerobically digested) and 120 (tet(A), aerobically digested) d.  Quantities of qnrA in soil 
microcosms that received untreated residual solids were low relative to other ARGs and 
were mostly below quantification limits (2.5 to 6.3 copies mg
-1
 dry mass) after 96 d, so 
qnrA was not quantified in the remaining soil microcosms.   
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Figure 7.14.  Quantities of ARGs and intI1 in soil microcosms that received 
aerobically digested residual solids.  Values are the arithmetic mean of triplicate 
samples; error bars represent one standard deviation.   
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Figure 7.15.  Quantities of ARGs and intI1 in soil microcosms that received alkali 
stabilized residual solids.  Values are the arithmetic mean of duplicate or triplicate 
samples; error bars represent one standard deviation.  Dashed lines represent the 
maximum and minimum limits of quantification for data sets that contain one or 
more experimental observations below those limits. 
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Figure 7.16.  Quantities of ARGs and intI1 in soil microcosms that received 
anaerobically digested (55°C) residual solids.  Values are the arithmetic mean of 
duplicate or triplicate samples; error bars represent one standard deviation.  
Dashed lines represent the maximum and minimum limits of quantification for data 
sets that contain one or more experimental observations below those limits. 
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Figure 7.17.  Quantities of ARGs and intI1 in soil microcosms that received 
anaerobically digested (62°C) residual solids.  Values are the arithmetic mean of 
duplicate or triplicate samples; error bars represent one standard deviation.  
Dashed lines represent the maximum and minimum limits of quantification for data 
sets that contain one or more experimental observations below those limits. 
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Figure 7.18.  Quantities of ARGs and intI1 in soil microcosms that received 
anaerobically digested (69°C) residual solids.  Values are the arithmetic mean of 
duplicate or triplicate samples; error bars represent one standard deviation.  
Dashed lines represent the maximum and minimum limits of quantification for data 
sets that contain one or more experimental observations below those limits. 
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Figure 7.19.  Quantities of ARGs and intI1 in soil microcosms that received 
pasteurized residual solids.  Values are the arithmetic mean of duplicate or 
triplicate samples; error bars represent one standard deviation.  Dashed lines 
represent the maximum and minimum limits of quantification for data sets that 
contain one or more experimental observations below those limits. 
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Figure 7.20.  Quantities of ARGs and intI1 in soil microcosms that received 
untreated residual solids.  Values are the arithmetic mean of duplicate or triplicate 
samples; error bars represent one standard deviation.  Dashed lines represent the 
maximum and minimum limits of quantification for data sets that contain one or 
more experimental observations below those limits. 
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Quantities of intI1 were relatively persistent compared to those of other gene 
targets during the first 33 d.  In four of the nine sets of microcosms, intI1 had the lowest 
percentage decrease among all ARGs and intI1.  These four values varied between 53.2% 
± 17.1% (anaerobically digested at 38°C) and 85.8% ± 8.9% (alkali stabilized) (mean ± 
standard deviation).  Furthermore, intI1 quantities during the first 33 d changed little in 
soil microcosms that received air-dried residual solids and increased by a factor of 2.2 ± 
0.2 (mean ± standard deviation) in microcosms that received residual solids that were 
anaerobically digested at 38°C.  The only other gene target that had the lowest percentage 
decrease during the first 33 d in more than one set of soil microcosms was tet(A), which 
decreased by 97.7% ± 0.3% and 42.9% ± 20.8% (mean ± standard deviation) in soil 
microcosms that received pasteurized and untreated residual solids, respectively.  As 
noted previously, quantities of tet(A) also increased during the first 33 d in soil 
microcosms that received residual solids that were anaerobically digested at 38°C.      
7.4 Discussion 
Upstream treatment units can have a substantial effect on the fate of ARGs and 
intI1 in residual municipal wastewater solids applied to soil.  Alkali stabilization, 
pasteurization, and anaerobic digestion at temperatures of 55°C, 62°C, and 69°C all 
caused sharp initial decreases in ARG and intI1 quantities in land-applied treated residual 
solids relative to alternative technologies.  These sharp decreases are important, because 
they lead to ARG and intI1 soil concentrations that are up to two orders of magnitude 
lower than initial concentrations after only approximately 30 d, as opposed to nearly 180 
d as has been shown for land-applied residual solids from a typical full-scale treatment 
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process (i.e. mesophilic anaerobic digestion) (Chapter 6).  Achieving lower ARG and 
intI1 concentrations in soil sooner should reduce the overall risk for off-site transport of 
ARGs and, eventually, exposure of ARGs to humans.  Thus, residual solids treatment 
technologies that can produce this effect should be preferable to alternatives that do not, 
because they hold the capacity to reduce the number of ARGs circulating in the 
environment.   
Future work should explicitly consider the fraction of ARGs present in 
environmental samples as extracellular DNA.  The results presented here demonstrate 
that at least one technology, alkali stabilization, appeared to produce a large fraction of 
extracellular DNA (which was separated from the residual solids during centrifugation 
prior to application to the soil microcosms).  This same technology was also among those 
that consistently produced a time series pattern in which ARG and intI1 quantities in soil 
microcosms decreased rapidly over the first 33 d.  It would seem likely that the other 
technologies that produced this effect, which included pasteurization and anaerobic 
digestion at 55°C, 62°C, and 69°C, also produce a large fraction of extracellular ARGs.  
This presumably exposes the ARGs to biodegradation and other extracellular DNA fate 
and transport mechanisms, and it could be a key factor in the fate of ARGs both in soil to 
which treated residual solids are applied and in the treatment units themselves.     
 This work adds to a growing body of evidence suggesting that the significance of 
integrons to the environmental spread of ARGs is in need of further scrutiny (198).  
Integrons enable both horizontal gene transfer and the accumulation of multiple ARGs in 
an individual bacterium (82).  As a result, they are typically assumed to be significant 
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with respect to the spread of antibiotic resistance, and, in fact, have been shown to 
contain multiple ARGs in environmental samples (126,133,145).  However, the 
discrepancy between the initial extents of intI1 removal and the initial extents of removal 
for many ARGs in this work would seem to suggest that the ARGs considered here are 
not strongly associated with class 1 integrons.  It may be that the integrons in these 
experiments contain ARGs not targeted in this work, or it may be that these integrons 
contain very few or no ARGs.  Confirmation of either result would be highly informative 
for efforts intended to mitigate the environmental spread of ARGs, and future work ought 
to consider the contents of integrons, in addition to the overall quantities, as well as the 
fate of individual gene cassettes. 
The approach used in this work is quantitative, culture-independent, and isolates 
mixtures of soil and residual solids in closed and reasonably homogenous experimental 
systems.  However, it is also subject to well-known limitations of molecular analytical 
methods as well as limitations related to the experimental design.  The real-time PCR 
protocol used in this work cannot distinguish gene targets in pathogens from those in 
non-pathogens, gene targets in living bacteria from those in dead bacteria or present as 
extracellular DNA in the soil matrix, full-length genes from gene fragments that happen 
to contain the primer annealing sites, or genes that can be transcribed in their hosts from 
those that cannot.  Also, the soil microcosms did not simulate the effects of direct 
sunlight, natural fluctuations in moisture content and temperature, or the presence of a 
full soil ecosystem on the rates at which ARG and intI1 quantities decline in soil.  
Furthermore, the fact that a large fraction of extracellular DNA from alkali stabilized and 
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pasteurized residual solids may have been excluded from the soil microcosms might have 
affected the results observed here.  It would be expected, however, that if the initially 
sharp decrease in gene target concentrations observed in some microcosms was due to the 
presence of extracellular DNA, that these effects would not be fundamentally different 
from those that were actually observed.  Finally, the work presented in this manuscript 
investigates only a small fraction of known ARGs.  For instance, there are at least 45 
genes known to encode resistance to macrolide, lincosamide, and streptogramin B 
(MLSB) antibiotics and at least 30 genes known to encode resistance to tetracycline 
antibiotics (73,74), yet this work considered only one MLSB resistance gene and three 
tetracycline resistance genes.        
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Chapter 8: Conclusions and Recommendations 
This work contributes significantly to our ability to optimize treatment and 
disposal of residual municipal wastewater solids for the removal of ARGs.  The primary 
conclusions can be summarized in seven points:   
Aerobic digestion, air drying, and hyperthermophilic (≥ 60°C) anaerobic 
digestion can effectively remove ARGs from residual municipal wastewater solids.  
Aerobic digestion, operated under different flow conditions, has been previously 
demonstrated to be largely ineffective at removing ARGs from residual solids (121), 
while air drying and hyperthermophilic anaerobic digestion have been previously 
unconsidered for their effects on ARG quantities in residual solids.  The results presented 
here (204,208) indicate that the many treatment plants already using aerobic digestion 
and air drying to treat (or dewater) residual municipal wastewater solids (186) could 
likely optimize their existing treatment systems to achieve significant ARG removal.  
Furthermore, hyperthermophilic anaerobic digestion was found to be the most effective 
treatment technology considered in this work based on kinetic analyses (Chapter 5).  
Future work ought to focus on optimizing this treatment process for removing ARGs 
from residual municipal wastewater solids, as it may represent the most effective 
currently available treatment option.   
The kinetic analyses presented in this work enable rational selection among 
alternative treatment technologies and management practices to optimize the entire 
residual municipal wastewater solids treatment and disposal process.  The selection 
and design of alternative treatment technologies to meet treatment objectives is governed 
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by operating costs (e.g. energy and chemical inputs and outputs) and capital costs (e.g. 
tank size).  Understanding these costs requires detailed process design, which relies on 
understanding the kinetics of the underlying biological, chemical, or physical processes.  
However, only one study prior to this work (121) has considered the kinetics of ARG 
removal during treatment of residual solids.  Thus, the identification of appropriate 
kinetic models (e.g. modified Collins-Selleck disinfection kinetics) (Chapter 5) and 
specific kinetic coefficients (Chapter 3, Chapter 4, Chapter 5, and Chapter 6) in this work 
significantly expands our ability to choose among alternative treatment technologies and 
management practices (e.g. frequency of land-application of treated residual solids) for 
optimizing the removal of ARGs from residual municipal wastewater solids.   
Batch and semi-batch operation of aerobic and anaerobic digestion may be 
an effective optimization of those technologies for enhancing ARG removal.  The 
effectiveness of ARG removal achieved by semi-continuous-flow aerobic digestion 
(121,204) differs considerably from that achieved by batch aerobic digestion (204).  
Furthermore, the superior performance of thermophilic and hyperthermophilic anaerobic 
digestion with regard to ARG removal is far more clear for semi-batch (121) (Chapter 5) 
than semi-continuous-flow (131) treatment systems.  Future work should be directed at 
optimizing the degree to which aerobic and anaerobic digestion can be operated in batch 
or semi-batch flow configurations while maintaining desirable treatment performance 
with respect to more traditional objectives (e.g. volatile solids destruction). 
The treatment environment imposed by a treatment technology can select for 
particular ARGs based on their ecological niche.  Semi-continuous-flow aerobic 
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digestion selected for increased quantities, relative to untreated residual solids, of an 
ARG that requires oxygen to function (tet(X)) (Chapter 3).  Air-drying beds selected for 
increased quantities of tet(X) as the treatment environment became presumably more 
aerobic (Chapter 4).  Selection of specific ARGs based on the relationship between 
treatment environment and the ecological niche of the ARG is important to the selection 
and design of individual treatment units depending on the ARG(s) of concern. 
Class 1 integrons are an early, promising candidate for consideration as a 
design gene.  Identification of a design gene or a set of design genes is an important step 
in formulating reasonable treatment objectives for treatment systems intended to remove 
ARGs from residual municipal wastewater solids.  An ideal design gene would be one 
that is both relevant to human health and that is relatively persistent in the treatment 
environments being considered.  Class 1 integrons appear to satisfy both of those 
requirements.  They enable both horizontal gene transfer and the accumulation of 
multiple ARGs (82).  They are also among the most persistent gene targets considered in 
this work (Chapter 3, Chapter 4, Chapter 5, Chapter 6, and Chapter 7).  The relationship 
between class 1 integron quantities (as represented by intI1) and quantities of the ARGs 
considered in this work, however, is frequently unclear.  Many ARGs considered here 
decrease in quantity even when intI1 quantities remain relatively constant.  Thus, future 
work should consider the gene cassette content of integrons in addition to their quantities 
(198).  Understanding the distribution of gene cassettes (whether ARGs, metabolic genes, 
or something else) on integrons in the environment would improve our understanding of 
the processes that determine their fate in those environments.   
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ARG quantities in treated residual municipal wastewater solids applied to 
soil decrease slowly.  ARGs in treated residual solids collected from full-scale treatment 
facilities exhibited half-lives on the order of months following land-application (Chapter 
6).  ARGs were more persistent in soil than in laboratory-scale residual solids treatment 
units, and they were more persistent than fecal microorganisms in the same soil (Chapter 
6).  This result is significant for several reasons.  First, it indicates that the best location to 
control the fate of ARGs in residual municipal wastewater solids may be during residual 
solids treatment in the treatment plant, because ARGs are relatively persistent once the 
residual solids are land-applied.  Second, the persistence of ARGs in land-applied 
residual solids in relatively high quantities likely provides the opportunity for their 
transport through the environment, and ultimately, for human exposure to ARGs.  This 
highlights our current lack of knowledge regarding the fate and transport of ARGs in the 
environment, and future work should focus on understanding the fate and transport of 
ARGs on regional or larger scales, the degree to which individuals tend to be exposed to 
ARGs in pathogens or in forms that permit horizontal gene transfer to pathogens, and the 
resultant risks associated with varying levels of exposure to ARGs in natural and 
engineered systems.  Finally, the specific kinetic coefficients determined in this work can 
be used to manage the frequency with which treated residual solids are land-applied at 
individual sites in order to control their quantities in receiving soils.   
Selection of residual solids treatment technology can affect the fate of ARGs 
in treated residual municipal wastewater solids applied to soil.  Approximately half of 
all treated residual solids in the United States are applied to soil for ultimate disposal 
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(186).  ARGs from these treated residual solids can persist in the soil in high quantities 
for months (Chapter 6), which likely provides the opportunity for transport of ARGs and 
human exposure to them.  Alkali stabilization, pasteurization, and anaerobic digestion at 
temperatures in the thermophilic and hyperthermophilic ranges cause ARG quantities to 
decrease much more rapidly immediately after land-application than alternative 
technologies.  Thus, selection of the residual solids treatment technology used in the 
treatment plant represents a useful control variable for reducing the quantity of ARGs in 
soil to which treated residual solids are applied. 
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Appendix A: Supporting Information for Chapter 3 
Table A.1.  Gene targets, resistance mechanisms, primer sequences, amplicon sizes, and annealing temperatures for real-time 
PCR assays. 
Gene Target 
Resistance 
Mechanism 
Primer Sequence (5’3’) 
Size 
(bp) 
Annealing Temp 
(°C) 
Reference 
16S rRNA gene NA 
F: CCT ACG GGA GGC AGC 
AG 
R: ATT ACC GCG GCT GCT 
GG 
202 60 (196) 
All Bacteroides spp. NA 
F: GAG AGG AAG GTC CCC 
CAC 
R: CGC TAC TTG GCT GGT 
116 60 (195) 
248 
 
TCA G 
Human-specific 
Bacteroides spp. 
NA 
F: ATC ATG AGT TCA CAT 
GTC CG 
R: TAC CCC GCC TAC TAT 
CTA ATG 
82 56 (194,203) 
erm(B) 
Ribosomal 
protection 
F: GAT ACC GTT TAC GAA 
ATT GG 
R: GAA TCG AGA CTT GAG 
TGT GC 
364 58 (200) 
intI1 Class 1 integron 
F: CCT CCC GCA CGA TGA TC 
R: TCC ACG CAT CGT CAG 
GC 
280 60 (201) 
249 
 
sul1 Target modification 
F: CCG TTG GCC TTC CTG 
TAA AG 
R: TTG CCG ATC GCG TGA 
AGT 
67 60 (151) 
tet(A) Efflux 
F: GCT ACA TCC TGC TTG 
CCT TC 
R: CAT AGA TCG CCG TGA 
AGA GG 
210 60 (202) 
tet(W) 
Ribosomal 
protection 
F: GAG AGC CTG CTA TAT 
GCC AGC 
R: GGG CGT ATC CAC AAT 
GTT AAC 
168 60 (95) 
250 
 
tet(X) 
Enzymatic 
modification 
F: AGC CTT ACC AAT GGG 
TGT AAA 
R: TTC TTA CCT TGG ACA 
TCC CG 
278 60 (24) 
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Table A.2.  Values of P for comparing the relative statistical significance of different kinetic coefficients determined using 
Welch’s t-test for unequal n and unequal sample variance. 
Gene 16S rRNA gene 
All  
Bacteroides spp. 
Human-specific  
Bacteroides spp. 
erm(B) intI1 sul1 tet(A) tet(W) tet(X) 
16S rRNA gene 1 310-5 0.6 0.02 0.3 0.06 0.03 710-4 0.8 
All  
Bacteroides spp. 
 1 210-4 110-4 210-5 510-5 610-5 610-4 310-5 
Human-specific  
Bacteroides spp. 
  1 0.4 0.4 1 0.9 0.1 0.6 
erm(B)    1 910-3 0.1 0.2 0.1 0.02 
252 
 
intI1     1 0.01 510-3 210-4 0.3 
sul1      1 0.6 410-3 0.02 
tet(A)       1 610-3 0.01 
tet(W)        1 610-4 
tet(X)         1 
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Appendix B: Supporting Information for Chapter 4 
Table B.1.  The primer sequences, expected amplicon size, and annealing temperature for each gene target considered in this 
work. 
Gene Target Primer Sequence (5’3’) Size (bp) Annealing Temp (°C) Reference 
16S rRNA gene 
(338F, 518R) 
F: CCT ACG GGA GGC AGC AG 
R: ATT ACC GCG GCT GCT GG 
202 60 (196) 
all Bacteroides spp. 16S rRNA gene 
(AllBac) 
F: GAG AGG AAG GTC CCC CAC 
R: CGC TAC TTG GCT GGT TCA G 
116 60 (195) 
human-specific Bacteroides spp. 16S 
rRNA gene (HF183) 
F: ATC ATG AGT TCA CAT GTC CG 
R: TAC CCC GCC TAC TAT CTA ATG 
82 56 (194,203) 
254 
 
erm(B) 
F: GAT ACC GTT TAC GAA ATT GG 
R: GAA TCG AGA CTT GAG TGT GC 
364 58 (200) 
intI1 
F: CCT CCC GCA CGA TGA TC 
R: TCC ACG CAT CGT CAG GC 
280 60 (201) 
sul1 
F: CCG TTG GCC TTC CTG TAA AG 
R: TTG CCG ATC GCG TGA AGT 
67 60 (151) 
tet(A) 
F: GCT ACA TCC TGC TTG CCT TC 
R: CAT AGA TCG CCG TGA AGA GG 
210 60 (202) 
tet(W) 
F: GAG AGC CTG CTA TAT GCC AGC 
R: GGG CGT ATC CAC AAT GTT AAC 
168 60 (95) 
255 
 
tet(X) 
F: AGC CTT ACC AAT GGG TGT AAA 
R: TTC TTA CCT TGG ACA TCC CG 
278 60 (24) 
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Appendix C: Supporting Information for Chapter 5 
Table C.1.  The primer sequences, expected amplicon size, and annealing temperature for each real-time PCR method used in 
this work. 
Gene Target Primer Sequence (5’3’) Size (bp) Ann. Temp. (°C) Reference 
16S rRNA gene 
(338F, 518R) 
F: CCT ACG GGA GGC AGC AG 
R: ATT ACC GCG GCT GCT GG 
202 60 (196) 
AllBac 
F: GAG AGG AAG GTC CCC CAC 
R: CGC TAC TTG GCT GGT TCA G 
116 60 (195) 
16S rRNA gene of methanogens 
(Met630F, Met803R) 
F: GGA TTA GAT ACC CSG GTA GT 
R: GTT GAR TCC AAT TAA ACC GCA 
82 56 (213) 
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intI1 
F: CCT CCC GCA CGA TGA TC 
R: TCC ACG CAT CGT CAG GC 
280 60 (201) 
qnrA 
F: AGG ATT TCT CAC GCC AGG ATT 
R: CCG CTT TCA ATG AAA CTG CA  
124 57 (8) 
repA 
F: TTC ATC AGC TCC AGC TTC TT 
R: CAG ATT CAT GAT CGA TTC GTT T 
126 60 This Study 
tet(W) 
F: GAG AGC CTG CTA TAT GCC AGC 
R: GGG CGT ATC CAC AAT GTT AAC 
168 60 (95) 
tet(X) 
F: AGC CTT ACC AAT GGG TGT AAA 
R: TTC TTA CCT TGG ACA TCC CG 
278 60 (24) 
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Table C.2.  The number of standards (n), slope, intercept, amplification efficiency determined from a dilution series of 
standards, r
2
, and quantification limit (QL, copies µL
-1
 template) for each real-time PCR assay conducted to generate the data 
presented in this work. 
Assay Name n Slope Intercept Amp. Eff. r
2
 QL 
qPCR An Dig Plate 1 (37C) 16S 091613 6 -3.21 36.72 105% 0.992 64,000 
qPCR An Dig Plate 1 (37C) AllBac 091713 8 -3.10 39.97 110% 0.993 520 
qPCR An Dig Plate 1 (37C) incAC 091613 8 -3.80 44.76 83% 0.988 630 
qPCR An Dig Plate 1 (37C) intI1 091613 7 -3.79 43.14 83% 0.999 2,300 
qPCR An Dig Plate 1 (37C) Methanogens 091813 9 -3.26 39.53 103% 0.993 230 
qPCR An Dig Plate 1 (37C) qnrA 091813 9 -3.48 39.88 94% 0.993 89 
qPCR An Dig Plate 1 (37C) tetW 091813 9 -3.33 40.37 100% 0.999 170 
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qPCR An Dig Plate 1 (37C) tetX 091613 9 -3.86 42.50 81% 0.995 71 
qPCR An Dig Plate 2 (55C) 16S 092413 7 -3.22 37.50 104% 0.991 6,400 
qPCR An Dig Plate 2 (55C) AllBac 092413 8 -3.00 39.10 115% 0.993 520 
qPCR An Dig Plate 2 (55C) incAC 092313 9 -3.74 42.65 85% 0.995 63 
qPCR An Dig Plate 2 (55C) intI1 092313 9 -3.51 40.70 93% 0.996 230 
qPCR An Dig Plate 2 (55C) Methanogens 091913 10 -3.14 38.08 108% 0.999 23 
qPCR An Dig Plate 2 (55C) qnrA 092313 10 -3.41 38.18 96% 0.993 8.9 
qPCR An Dig Plate 2 (55C) tetW 092313.Drift Corrected 10 -3.05 39.54 113% 0.997 17 
qPCR An Dig Plate 2 (55C) tetX 091913 9 -3.78 41.55 84% 0.996 71 
qPCR An Dig Plate 3 (60C) 16S 092613 7 -3.15 36.36 108% 0.989 6,400 
260 
 
qPCR An Dig Plate 3 (60C) AllBac 092713 9 -3.00 39.24 116% 0.992 52 
qPCR An Dig Plate 3 (60C) incAC 093013 9 -3.70 41.41 86% 0.998 63 
qPCR An Dig Plate 3 (60C) intI1 093013 8 -3.47 40.70 94% 0.999 2,300 
qPCR An Dig Plate 3 (60C) Methanogens 092713 10 -3.02 37.42 114% 0.992 23 
qPCR An Dig Plate 3 (60C) qnrA 093013 10 -3.39 38.33 97% 0.994 8.9 
qPCR An Dig Plate 3 (60C) tetW 092713.Drift Corrected 10 -3.06 39.29 112% 0.996 17 
qPCR An Dig Plate 3 (60C) tetX 092613 10 -3.38 39.03 98% 0.991 7.1 
qPCR An Dig Plate 4 (65C) 16S 091113 6 -3.32 38.31 100% 0.985 64,000 
qPCR An Dig Plate 4 (65C) AllBac 091313 8 -3.11 39.93 110% 0.997 520 
qPCR An Dig Plate 4 (65C) incAC 091213 8 -3.54 41.04 92% 0.991 630 
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qPCR An Dig Plate 4 (65C) intI1 091313 8 -3.60 41.49 89% 0.989 2,300 
qPCR An Dig Plate 4 (65C) Methanogens 091713 10 -3.12 38.12 109% 0.998 23 
qPCR An Dig Plate 4 (65C) qnrA 091113 9 -3.45 39.96 95% 0.995 89 
qPCR An Dig Plate 4 (65C) tetW 091113.Drift Corrected 8 -3.10 37.89 110% 0.998 1,700 
qPCR An Dig Plate 4 (65C) tetX 091113 9 -3.63 40.76 88% 0.996 71 
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Figure C.1.  The pH of anaerobic digesters operated at nominal temperatures of 
40°C, 56°C, 60°C, and 63°C. 
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Figure C.2.  The total solids content of untreated residual municipal wastewater 
solids and four anaerobic digesters operated at nominal temperatures of 40°C, 56°C, 
60°C, and 63°C.  Values are the arithmetic mean of triplicate samples; error bars 
represent one standard deviation.   
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Figure C.3.  The volume of gas produced during eight-day batch cycles by anaerobic 
digesters operated at nominal temperatures of 40°C, 56°C, 60°C, and 63°C. 
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Figure C.4.  The ratios of AllBac and methanogen 16S rRNA genes to 16S rRNA 
genes in untreated residual municipal wastewater solids.  Values are the arithmetic 
mean of triplicate samples; error bars represent one standard deviation. 
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Figure C.5.  The ratios of ARGs, intI1, and repA to 16S rRNA genes in untreated 
residual municipal wastewater solids.  Values are the arithmetic mean of duplicate 
or triplicate samples; error bars represent one standard deviation. 
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Figure C.6.  Quantities of 16S rRNA genes at the end of each of the first seven 
batches in anaerobic digesters operated at nominal temperatures of 40°C, 56°C, 
60°C, and 63°C.  Values are the arithmetic mean of triplicate samples; error bars 
represent one standard deviation.  
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Figure C.7.  Quantities of AllBac at the end of each of the first seven batches in 
anaerobic digesters operated at nominal temperatures of 40°C, 56°C, 60°C, and 
63°C.  Values are the arithmetic mean of triplicate samples; error bars represent 
one standard deviation.   
269 
 
 
Figure C.8.  The ratios of AllBac to 16S rRNA genes at the end of each of the first 
seven batches in anaerobic digesters operated at nominal temperatures of 40°C, 
56°C, 60°C, and 63°C.  Values are the arithmetic mean of triplicate samples; error 
bars represent one standard deviation.   
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Figure C.9.  The ratios of AllBac to 16S rRNA genes during the final three batches 
(green, orange, and red symbols represent unique batches) in anaerobic digesters 
operated at nominal temperatures of 40°C, 56°C, 60°C, and 63°C.  Values are the 
arithmetic mean of triplicate samples; error bars represent one standard deviation. 
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Figure C.10.  Quantities of methanogen 16S rRNA genes at the end of each of the 
first seven batches in anaerobic digesters operated at nominal temperatures of 40°C, 
56°C, 60°C, and 63°C.  Values are the arithmetic mean of triplicate samples; error 
bars represent one standard deviation.   
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Figure C.11.  The ratios of methanogen 16S rRNA genes to 16S rRNA genes at the 
end of each of the first seven batches in anaerobic digesters operated at nominal 
temperatures of 40°C, 56°C, 60°C, and 63°C.  Values are the arithmetic mean of 
triplicate samples; error bars represent one standard deviation.   
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Figure C.12.  The ratios of methanogen 16S rRNA genes to 16S rRNA genes during 
the final three batches (green, orange, and red symbols represent unique batches) in 
anaerobic digesters operated at nominal temperatures of 40°C, 56°C, 60°C, and 
63°C.  Values are the arithmetic mean of triplicate samples; error bars represent 
one standard deviation.   
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Figure C.13.  Quantities of intI1 at the end of each of the first seven batches in 
anaerobic digesters operated at nominal temperatures of 40°C, 56°C, 60°C, and 
63°C.  Values are the arithmetic mean of triplicate samples; error bars represent 
one standard deviation. 
275 
 
 
Figure C.14.  The ratios of intI1 to 16S rRNA genes at the end of each of the first 
seven batches in anaerobic digesters operated at nominal temperatures of 40°C, 
56°C, 60°C, and 63°C.  Values are the arithmetic mean of triplicate samples; error 
bars represent one standard deviation. 
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Figure C.15.  The ratios of intI1 to 16S rRNA genes during the final three batches 
(green, orange, and red symbols represent unique batches) in anaerobic digesters 
operated at nominal temperatures of 40°C, 56°C, 60°C, and 63°C.  Values are the 
arithmetic mean of triplicate samples; error bars represent one standard deviation. 
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Figure C.16.  Quantities of qnrA at the end of each of the first seven batches in 
anaerobic digesters operated at nominal temperatures of 40°C, 56°C, 60°C, and 
63°C.  Values are the arithmetic mean of duplicate or triplicate samples; error bars 
represent one standard deviation.  Dashed lines represent the limit of quantification 
for data sets that contain one or more experimental values below that limit. 
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Figure C.17.  The ratios of qnrA to 16S rRNA genes at the end of each of the first 
seven batches in anaerobic digesters operated at nominal temperatures of 40°C, 
56°C, 60°C, and 63°C.  Values are the arithmetic mean of duplicate or triplicate 
samples; error bars represent one standard deviation. 
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Figure C.18.  The ratios of qnrA to 16S rRNA genes during the final three batches 
(green, orange, and red symbols represent unique batches) in anaerobic digesters 
operated at nominal temperatures of 40°C, 56°C, 60°C, and 63°C.  Values are the 
arithmetic mean of duplicate or triplicate samples; error bars represent one 
standard deviation.   
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Figure C.19.  The ratios of repA to 16S rRNA genes during the final three batches 
(green, orange, and red symbols represent unique batches) in anaerobic digesters 
operated at nominal temperatures of 40°C, 56°C, 60°C, and 63°C.  Values are the 
arithmetic mean of duplicate or triplicate samples; error bars represent one 
standard deviation. 
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Figure C.20.  Quantities of tet(W) at the end of each of the first seven batches in 
anaerobic digesters operated at nominal temperatures of 40°C, 56°C, 60°C, and 
63°C.  Values are the arithmetic mean of triplicate samples; error bars represent 
one standard deviation. 
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Figure C.21.  The ratios of tet(W) to 16S rRNA genes at the end of each of the first 
seven batches in anaerobic digesters operated at nominal temperatures of 40°C, 
56°C, 60°C, and 63°C.  Values are the arithmetic mean of triplicate samples; error 
bars represent one standard deviation. 
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Figure C.22.  The ratios of tet(W) to 16S rRNA genes during the final three batches 
(green, orange, and red symbols represent unique batches) in anaerobic digesters 
operated at nominal temperatures of 40°C, 56°C, 60°C, and 63°C.  Values are the 
arithmetic mean of triplicate samples; error bars represent one standard deviation. 
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Figure C.23.  Quantities of tet(X) at the end of each of the first seven batches in 
anaerobic digesters operated at nominal temperatures of 40°C, 56°C, 60°C, and 
63°C.  Values are the arithmetic mean of duplicate or triplicate samples; error bars 
represent one standard deviation.  Dashed lines represent the limit of quantification 
for data sets that contain one or more experimental values below that limit. 
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Figure C.24.  The ratios of tet(X) to 16S rRNA genes at the end of each of the first 
seven batches in anaerobic digesters operated at nominal temperatures of 40°C, 
56°C, 60°C, and 63°C.  Values are the arithmetic mean of duplicate or triplicate 
samples; error bars represent one standard deviation. 
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Figure C.25.  The ratios of tet(X) to 16S rRNA genes during the final three batches 
(green, orange, and red symbols represent unique batches) in anaerobic digesters 
operated at nominal temperatures of 40°C, 56°C, 60°C, and 63°C.  Values are the 
arithmetic mean of duplicate or triplicate samples; error bars represent one 
standard deviation. 
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Table C.3.  The number of data points (n), r
2
, analysis of variance (ANOVA) P, lack-of-fit (LOF) P, and non-constant variance 
(NCV) P for an ordinary least squares fit of the first-order kinetic model to each time series of gene target quantities or ratios 
of gene target quantities to 16S rRNA gene quantities. 
Target Units (copies) Temperature n r
2
 ANOVA P LOF P NCV P 
16S rRNA gene mL
-1
 40°C 18 0.40 4.5×10
-3
 0.04 0.47 
16S rRNA gene mL
-1
 56°C 18 0.37 0.01 0.02 0.75 
16S rRNA gene mL
-1
 60°C 18 0.38 0.01 0.01 0.27 
16S rRNA gene mL
-1
 63°C 18 0.40 5.0×10
-3
 0.01 0.10 
AllBac mL
-1
 40°C 18 0.93 7.1×10
-11
 0.16 0.16 
AllBac mL
-1
 56°C 18 0.84 9.1×10
-8
 0.10 0.07 
AllBac mL
-1
 60°C 18 0.83 1.4×10
-7
 2.2×10
-8
 0.80 
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AllBac mL
-1
 63°C 18 0.82 2.1×10
-7
 1.6×10
-3
 0.55 
AllBac (16S rRNA gene)
-1
 40°C 18 0.92 2.4×10
-10
 0.14 0.67 
AllBac (16S rRNA gene)
-1
 56°C 18 0.86 2.7×10
-8
 0.50 0.01 
AllBac (16S rRNA gene)
-1
 60°C 18 0.88 1.0×10
-8
 5.2×10
-4
 0.42 
AllBac (16S rRNA gene)
-1
 63°C 18 0.85 5.8×10
-8
 0.02 0.39 
Methanogen 16S rRNA genes mL
-1
 40°C 18 0.01 0.78 0.72 0.60 
Methanogen 16S rRNA genes mL
-1
 56°C 18 0.70 1.6×10
-5
 0.25 0.57 
Methanogen 16S rRNA genes mL
-1
 60°C 18 0.57 2.7×10
-4
 0.34 0.30 
Methanogen 16S rRNA genes mL
-1
 63°C 18 0.68 2.5×10
-5
 0.93 0.20 
Methanogen 16S rRNA genes (16S rRNA gene)
-1
 40°C 18 0.09 0.23 0.26 0.48 
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Methanogen 16S rRNA genes (16S rRNA gene)
-1
 56°C 18 0.07 0.27 0.02 0.40 
Methanogen 16S rRNA genes (16S rRNA gene)
-1
 60°C 18 0.01 0.67 0.30 0.98 
Methanogen 16S rRNA genes (16S rRNA gene)
-1
 63°C 18 0.35 0.01 0.01 0.08 
intI1 mL
-1
 40°C 18 0.74 5.2×10
-6
 2.1×10
-3
 0.31 
intI1 mL
-1
 56°C 18 0.74 5.5×10
-6
 6.6×10
-6
 0.27 
intI1 mL
-1
 60°C 18 0.76 2.1×10
-6
 7.3×10
-6
 0.64 
intI1 mL
-1
 63°C 18 0.59 2.0×10
-4
 1.1×10
-3
 0.35 
intI1 (16S rRNA gene)
-1
 40°C 18 0.64 7.3×10
-5
 0.07 0.79 
intI1 (16S rRNA gene)
-1
 56°C 18 0.79 8.9×10
-7
 0.01 0.67 
intI1 (16S rRNA gene)
-1
 60°C 18 0.80 5.9×10
-7
 0.07 0.33 
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intI1 (16S rRNA gene)
-1
 63°C 18 0.60 1.5×10
-4
 3.6×10
-3
 0.67 
qnrA mL
-1
 40°C 4 0.61 0.22 ND
a
 0.41 
qnrA mL
-1
 56°C 18 0.20 0.06 0.01 0.23 
qnrA mL
-1
 60°C 8 0.25 0.20 0.01 0.27 
qnrA mL
-1
 63°C 9 0.37 0.08 0.03 0.54 
qnrA (16S rRNA gene)
-1
 40°C 4 0.56 0.25 ND
a
 0.41 
qnrA (16S rRNA gene)
-1
 56°C 18 0.04 0.45 0.20 0.73 
qnrA (16S rRNA gene)
-1
 60°C 8 0.03 0.67 0.08 0.29 
qnrA (16S rRNA gene)
-1
 63°C 9 0.18 0.25 0.13 0.68 
repA mL
-1
 40°C 0 ND
b
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repA mL
-1
 56°C 4 0.69 0.17 ND
a
 0.41 
repA mL
-1
 60°C 4 ND
b
 
repA mL
-1
 63°C 0 ND
b
 
repA (16S rRNA gene)
-1
 40°C 0 ND
b
 
repA (16S rRNA gene)
-1
 56°C 4 0.35 0.41 ND
a
 0.41 
repA (16S rRNA gene)
-1
 60°C 4 ND
b
 
repA (16S rRNA gene)
-1
 63°C 0 ND
b
 
tet(W) mL
-1
 40°C 18 0.38 0.01 0.08 0.03 
tet(W) mL
-1
 56°C 18 0.88 9.0×10
-9
 1.8×10
-4
 0.51 
tet(W) mL
-1
 60°C 18 0.79 6.8×10
-7
 1.1×10
-7
 0.60 
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tet(W) mL
-1
 63°C 18 0.73 6.4×10
-6
 0.01 0.48 
tet(W) (16S rRNA gene)
-1
 40°C 18 0.25 0.04 0.21 0.01 
tet(W) (16S rRNA gene)
-1
 56°C 18 0.92 2.1×10
-10
 0.03 0.78 
tet(W) (16S rRNA gene)
-1
 60°C 18 0.86 3.7×10
-8
 3.2×10
-5
 0.82 
tet(W) (16S rRNA gene)
-1
 63°C 18 0.78 1.2×10
-6
 0.02 0.65 
tet(X) mL
-1
 40°C 18 0.86 2.4×10
-8
 1.1×10
-3
 0.35 
tet(X) mL
-1
 56°C 18 0.86 2.4×10
-8
 2.1×10
-4
 0.56 
tet(X) mL
-1
 60°C 18 0.42 3.4×10
-3
 0.01 0.54 
tet(X) mL
-1
 63°C 11 0.75 6.0×10
-4
 0.01 0.58 
tet(X) (16S rRNA gene)
-1
 40°C 18 0.87 2.0×10
-8
 0.04 0.55 
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tet(X) (16S rRNA gene)
-1
 56°C 18 0.86 3.1×10
-8
 0.08 0.48 
tet(X) (16S rRNA gene)
-1
 60°C 18 0.31 0.02 0.30 0.01 
tet(X) (16S rRNA gene)
-1
 63°C 11 0.90 6.8×10
-6
 4.5×10
-3
 0.55 
a
Some time series lacked sufficient experimental replication to conduct a lack-of-fit test, and so LOF P was not determined 
(ND). 
b
Quantities of some gene targets were above quantification limits for only n ≤ 2 time points, so ordinary least squares fits of the 
model to the data were not determined (ND). 
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Table C.4.  The number of data points (n), r
2
, analysis of variance (ANOVA) P, lack-of-fit (LOF) P, and non-constant variance 
(NCV) P for an ordinary least squares fit of the second-order kinetic model to each time series of gene target quantities or 
ratios of gene target quantities to 16S rRNA gene quantities. 
Target Units (copies) Temperature n r
2
 ANOVA P LOF P NCV P 
16S rRNA gene mL
-1
 40°C 18 0.40 4.7×10
-3
 0.08 0.74 
16S rRNA gene mL
-1
 56°C 18 0.39 0.01 0.11 0.41 
16S rRNA gene mL
-1
 60°C 18 0.38 0.01 0.02 0.61 
16S rRNA gene mL
-1
 63°C 18 0.46 2.1×10
-3
 0.11 0.62 
AllBac mL
-1
 40°C 18 0.84 1.0×10
-7
 0.51 1.5×10
-5
 
AllBac mL
-1
 56°C 18 0.69 1.9×10
-5
 0.99 3.8×10
-8
 
AllBac mL
-1
 60°C 18 0.98 7.0×10
-15
 0.47 4.0×10
-4
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AllBac mL
-1
 63°C 18 0.88 1.2×10
-8
 0.88 4.7×10
-6
 
AllBac (16S rRNA gene)
-1
 40°C 18 0.91 1.2×10
-9
 0.30 3.6×10
-3
 
AllBac (16S rRNA gene)
-1
 56°C 18 0.77 1.5×10
-6
 0.98 1.3×10
-4
 
AllBac (16S rRNA gene)
-1
 60°C 18 0.95 1.4×10
-11
 0.04 0.06 
AllBac (16S rRNA gene)
-1
 63°C 18 0.86 3.5×10
-8
 0.95 3.0×10
-3
 
Methanogen 16S rRNA genes mL
-1
 40°C 18 0.01 0.67 0.67 0.23 
Methanogen 16S rRNA genes mL
-1
 56°C 18 0.71 1.2×10
-5
 0.17 0.04 
Methanogen 16S rRNA genes mL
-1
 60°C 18 0.62 1.1×10
-4
 0.44 0.79 
Methanogen 16S rRNA genes mL
-1
 63°C 18 0.75 3.5×10
-6
 0.30 0.14 
Methanogen 16S rRNA genes (16S rRNA gene)
-1
 40°C 18 0.10 0.19 0.21 0.23 
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Methanogen 16S rRNA genes (16S rRNA gene)
-1
 56°C 18 0.07 0.28 0.02 0.49 
Methanogen 16S rRNA genes (16S rRNA gene)
-1
 60°C 18 0.02 0.61 0.31 0.84 
Methanogen 16S rRNA genes (16S rRNA gene)
-1
 63°C 18 0.36 0.01 0.01 0.17 
intI1 mL
-1
 40°C 18 0.83 1.3×10
-7
 0.05 0.83 
intI1 mL
-1
 56°C 18 0.89 4.1×10
-9
 0.09 0.20 
intI1 mL
-1
 60°C 18 0.89 3.3×10
-9
 0.36 7.8×10
-4
 
intI1 mL
-1
 63°C 18 0.70 1.3×10
-5
 0.76 0.01 
intI1 (16S rRNA gene)
-1
 40°C 18 0.67 3.0×10
-5
 0.15 0.65 
intI1 (16S rRNA gene)
-1
 56°C 18 0.83 1.6×10
-7
 0.25 0.02 
intI1 (16S rRNA gene)
-1
 60°C 18 0.82 2.7×10
-7
 0.62 1.4×10
-4
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intI1 (16S rRNA gene)
-1
 63°C 18 0.59 2.2×10
-4
 0.15 0.06 
qnrA mL
-1
 40°C 4 0.70 0.17 ND
a
 0.41 
qnrA mL
-1
 56°C 18 0.21 0.06 0.06 0.67 
qnrA mL
-1
 60°C 8 0.15 0.35 0.06 0.28 
qnrA mL
-1
 63°C 9 0.39 0.07 0.02 0.74 
qnrA (16S rRNA gene)
-1
 40°C 4 0.66 0.19 ND
a
 0.41 
qnrA (16S rRNA gene)
-1
 56°C 18 0.05 0.35 0.32 0.47 
qnrA (16S rRNA gene)
-1
 60°C 8 0.00 0.95 0.12 0.31 
qnrA (16S rRNA gene)
-1
 63°C 9 0.15 0.31 0.20 0.31 
repA mL
-1
 40°C 0 ND
b
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repA mL
-1
 56°C 4 0.81 0.10 ND
a
 0.41 
repA mL
-1
 60°C 4 ND
b
 
repA mL
-1
 63°C 0 ND
b
 
repA (16S rRNA gene)
-1
 40°C 0 ND
b
 
repA (16S rRNA gene)
-1
 56°C 4 0.35 0.40 ND
a
 0.41 
repA (16S rRNA gene)
-1
 60°C 4 ND
b
 
repA (16S rRNA gene)
-1
 63°C 0 ND
b
 
tet(W) mL
-1
 40°C 18 0.46 1.9×10
-3
 0.47 2.4×10
-4
 
tet(W) mL
-1
 56°C 18 0.93 1.6×10
-10
 0.61 1.5×10
-5
 
tet(W) mL
-1
 60°C 18 0.96 2.8×10
-12
 0.82 1.8×10
-4
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tet(W) mL
-1
 63°C 18 0.75 3.7×10
-6
 1.00 2.6×10
-7
 
tet(W) (16S rRNA gene)
-1
 40°C 18 0.33 0.01 0.37 1.6×10
-3
 
tet(W) (16S rRNA gene)
-1
 56°C 18 0.97 3.5×10
-13
 0.97 0.18 
tet(W) (16S rRNA gene)
-1
 60°C 18 0.96 8.6×10
-13
 1.6×10
-3
 0.05 
tet(W) (16S rRNA gene)
-1
 63°C 18 0.81 3.4×10
-7
 0.85 5.8×10
-4
 
tet(X) mL
-1
 40°C 18 0.95 1.6×10
-11
 0.13 0.81 
tet(X) mL
-1
 56°C 18 0.94 2.2×10
-11
 0.85 1.3×10
-5
 
tet(X) mL
-1
 60°C 18 0.37 0.01 0.84 3.1×10
-6
 
tet(X) mL
-1
 63°C 11 0.94 8.4×10
-7
 0.02 0.09 
tet(X) (16S rRNA gene)
-1
 40°C 18 0.90 1.7×10
-9
 0.62 0.01 
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tet(X) (16S rRNA gene)
-1
 56°C 18 0.87 1.8×10
-8
 0.97 2.8×10
-4
 
tet(X) (16S rRNA gene)
-1
 60°C 18 0.29 0.02 0.96 3.7×10
-6
 
tet(X) (16S rRNA gene)
-1
 63°C 11 0.94 1.1×10
-6
 7.0×10
-5
 0.07 
a
Some time series lacked sufficient experimental replication to conduct a lack-of-fit test, and so LOF P was not determined 
(ND). 
b
Quantities of some gene targets were above quantification limits for only n ≤ 2 time points, so ordinary least squares fits of the 
model to the data were not determined (ND). 
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Table C.5.  The number of data points (n), r
2
, analysis of variance (ANOVA) P, lack-of-fit (LOF) P, and non-constant variance 
(NCV) P for an ordinary least squares fit of the modified Collins-Selleck kinetic model to each time series of gene target 
quantities or ratios of gene target quantities to 16S rRNA gene quantities. 
Target Units (copies) Temperature n r
2
 ANOVA P LOF P NCV P 
16S rRNA gene mL
-1
 40°C 15 0.34 0.02 0.35 0.46 
16S rRNA gene mL
-1
 56°C 15 0.35 0.02 0.41 0.24 
16S rRNA gene mL
-1
 60°C 15 0.45 0.01 0.17 1.00 
16S rRNA gene mL
-1
 63°C 15 0.24 0.07 0.55 0.96 
AllBac mL
-1
 40°C 15 0.90 6.0×10
-8
 0.03 0.90 
AllBac mL
-1
 56°C 15 0.85 1.1×10
-6
 0.61 0.01 
AllBac mL
-1
 60°C 15 0.98 2.0×10
-12
 1.00 0.75 
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AllBac mL
-1
 63°C 15 0.94 2.4×10
-9
 0.30 0.39 
AllBac (16S rRNA gene)
-1
 40°C 15 0.85 9.8×10
-7
 0.03 0.48 
AllBac (16S rRNA gene)
-1
 56°C 15 0.84 1.7×10
-6
 0.41 0.09 
AllBac (16S rRNA gene)
-1
 60°C 15 0.96 1.5×10
-10
 0.01 0.83 
AllBac (16S rRNA gene)
-1
 63°C 15 0.85 1.1×10
-6
 0.77 0.25 
Methanogen 16S rRNA genes mL
-1
 40°C 15 0.00 0.94 0.70 0.01 
Methanogen 16S rRNA genes mL
-1
 56°C 15 0.41 0.01 0.16 0.10 
Methanogen 16S rRNA genes mL
-1
 60°C 15 0.34 0.02 0.79 0.60 
Methanogen 16S rRNA genes mL
-1
 63°C 15 0.55 1.5×10
-3
 0.25 0.31 
Methanogen 16S rRNA genes (16S rRNA gene)
-1
 40°C 15 0.07 0.35 0.67 0.09 
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Methanogen 16S rRNA genes (16S rRNA gene)
-1
 56°C 15 0.15 0.15 0.13 0.60 
Methanogen 16S rRNA genes (16S rRNA gene)
-1
 60°C 15 0.02 0.65 0.14 0.82 
Methanogen 16S rRNA genes (16S rRNA gene)
-1
 63°C 15 0.53 2.1×10
-3
 0.31 0.31 
intI1 mL
-1
 40°C 15 0.90 8.3×10
-8
 0.70 0.77 
intI1 mL
-1
 56°C 15 0.90 6.1×10
-8
 0.75 0.10 
intI1 mL
-1
 60°C 15 0.96 2.3×10
-10
 0.61 0.35 
intI1 mL
-1
 63°C 15 0.74 3.4×10
-5
 0.99 0.44 
intI1 (16S rRNA gene)
-1
 40°C 15 0.58 9.9×10
-4
 0.28 0.65 
intI1 (16S rRNA gene)
-1
 56°C 15 0.81 5.1×10
-6
 0.60 0.15 
intI1 (16S rRNA gene)
-1
 60°C 15 0.83 2.5×10
-6
 0.58 0.07 
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intI1 (16S rRNA gene)
-1
 63°C 15 0.79 9.1×10
-6
 0.52 0.16 
qnrA mL
-1
 40°C 2 ND
a
 
qnrA mL
-1
 56°C 15 0.07 0.34 0.76 0.24 
qnrA mL
-1
 60°C 5 0.01 0.90 0.41 0.45 
qnrA mL
-1
 63°C 6 0.28 0.28 0.54 0.90 
qnrA (16S rRNA gene)
-1
 40°C 2 ND
a
 
qnrA (16S rRNA gene)
-1
 56°C 15 0.00 0.85 0.95 0.26 
qnrA (16S rRNA gene)
-1
 60°C 5 0.06 0.68 0.37 0.35 
qnrA (16S rRNA gene)
-1
 63°C 6 0.08 0.59 0.68 0.39 
repA mL
-1
 40°C 0 ND
a
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repA mL
-1
 56°C 2 ND
a
 
repA mL
-1
 60°C 0 ND
a
 
repA mL
-1
 63°C 0 ND
a
 
repA (16S rRNA gene)
-1
 40°C 0 ND
a
 
repA (16S rRNA gene)
-1
 56°C 2 ND
a
 
repA (16S rRNA gene)
-1
 60°C 0 ND
a
 
repA (16S rRNA gene)
-1
 63°C 0 ND
a
 
tet(W) mL
-1
 40°C 15 0.44 0.01 0.79 3.6×10
-3
 
tet(W) mL
-1
 56°C 15 0.92 1.2×10
-8
 0.22 0.11 
tet(W) mL
-1
 60°C 15 0.98 1.4×10
-12
 0.99 0.19 
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tet(W) mL
-1
 63°C 15 0.93 8.9×10
-9
 0.51 0.69 
tet(W) (16S rRNA gene)
-1
 40°C 15 0.21 0.09 0.74 0.03 
tet(W) (16S rRNA gene)
-1
 56°C 15 0.91 2.6×10
-8
 0.16 0.54 
tet(W) (16S rRNA gene)
-1
 60°C 15 0.90 5.7×10
-8
 0.26 0.62 
tet(W) (16S rRNA gene)
-1
 63°C 15 0.95 4.6×10
-10
 0.27 0.87 
tet(X) mL
-1
 40°C 15 0.92 1.9×10
-8
 0.13 0.81 
tet(X) mL
-1
 56°C 15 0.92 2.2×10
-8
 0.39 0.66 
tet(X) mL
-1
 60°C 15 0.38 0.01 0.73 0.01 
tet(X) mL
-1
 63°C 8 0.92 1.8×10
-4
 0.54 0.46 
tet(X) (16S rRNA gene)
-1
 40°C 15 0.83 2.2×10
-6
 0.17 0.34 
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tet(X) (16S rRNA gene)
-1
 56°C 15 0.86 6.2×10
-7
 0.31 0.53 
tet(X) (16S rRNA gene)
-1
 60°C 15 0.25 0.06 0.94 4.5×10
-3
 
tet(X) (16S rRNA gene)
-1
 63°C 8 0.90 3.4×10
-4
 0.01 0.35 
a
Quantities of some gene targets were above quantification limits for only n ≤ 2 time points, so ordinary least squares fits of the 
model to the data were not determined (ND). 
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Table C.6.  Fitted values of k and calculated initial half-lives (t1/2) from an ordinary least squares fit of the second-order kinetic 
model to each time series of gene target quantities or ratios of gene target quantities to 16S rRNA genes.  Error terms 
represent the standard error of the mean. 
Target Units (copies) Temperature k
a,b
 (mL copy
-1
 day
-1
) Initial t1/2
c
 (days) 
16S rRNA gene mL
-1
 40°C -2.4×10
-13
 ± 7.2×10
-14
 22.8 
16S rRNA gene mL
-1
 56°C -5.2×10
-13
 ± 1.6×10
-13
 14.0 
16S rRNA gene mL
-1
 60°C -1.2×10
-12
 ± 3.7×10
-13
 11.3 
16S rRNA gene mL
-1
 63°C -1.4×10
-12
 ± 3.9×10
-13
 7.9 
AllBac mL
-1
 40°C -1.9×10
-11
 ± 2.1×10
-12
 -0.3 
AllBac mL
-1
 56°C -8.0×10
-12
 ± 1.3×10
-12
 0.9 
AllBac mL
-1
 60°C -1.3×10
-11
 ± 4.6×10
-13
 0.6 
309 
 
AllBac mL
-1
 63°C -3.4×10
-11
 ± 3.2×10
-12
 0.0 
AllBac (16S rRNA gene)
-1
 40°C -2.5×10
0
 ± 2.0×10
-1
 0.0 
AllBac (16S rRNA gene)
-1
 56°C -6.3×10
-1
 ± 8.5×10
-2
 2.0 
AllBac (16S rRNA gene)
-1
 60°C -5.7×10
-1
 ± 3.4×10
-2
 1.4 
AllBac (16S rRNA gene)
-1
 63°C -1.5×10
0
 ± 1.5×10
-1
 0.7 
Methanogen 16S rRNA genes mL
-1
 40°C -6.3×10
-12
 ± 1.4×10
-11
 85.9 
Methanogen 16S rRNA genes mL
-1
 56°C -1.9×10
-10
 ± 3.0×10
-11
 7.5 
Methanogen 16S rRNA genes mL
-1
 60°C -4.3×10
-10
 ± 8.5×10
-11
 8.5 
Methanogen 16S rRNA genes mL
-1
 63°C -9.5×10
-10
 ± 1.4×10
-10
 1.9 
Methanogen 16S rRNA genes (16S rRNA gene)
-1
 40°C 3.7×10
0
 ± 2.7×10
0
 -28.0 
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Methanogen 16S rRNA genes (16S rRNA gene)
-1
 56°C -5.4×10
0
 ± 4.8×10
0
 38.9 
Methanogen 16S rRNA genes (16S rRNA gene)
-1
 60°C -2.9×10
0
 ± 5.7×10
0
 101.2 
Methanogen 16S rRNA genes (16S rRNA gene)
-1
 63°C -2.5×10
1
 ± 8.4×10
0
 8.1 
intI1 mL
-1
 40°C -4.1×10
-11
 ± 4.6×10
-12
 6.5 
intI1 mL
-1
 56°C -2.8×10
-10
 ± 2.5×10
-11
 2.8 
intI1 mL
-1
 60°C -3.9×10
-10
 ± 3.4×10
-11
 1.7 
intI1 mL
-1
 63°C -6.7×10
-10
 ± 1.1×10
-10
 1.7 
intI1 (16S rRNA gene)
-1
 40°C -4.2×10
0
 ± 7.3×10
-1
 12.0 
intI1 (16S rRNA gene)
-1
 56°C -2.2×10
1
 ± 2.5×10
0
 5.0 
intI1 (16S rRNA gene)
-1
 60°C -1.6×10
1
 ± 1.9×10
0
 3.4 
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intI1 (16S rRNA gene)
-1
 63°C -2.5×10
1
 ± 5.2×10
0
 4.3 
qnrA mL
-1
 40°C -6.2×10
-7
 ± 2.9×10
-7
 0.5 
qnrA mL
-1
 56°C -2.5×10
-7
 ± 1.2×10
-7
 12.3 
qnrA mL
-1
 60°C -4.1×10
-7
 ± 4.1×10
-7
 6.5 
qnrA mL
-1
 63°C -1.3×10
-7
 ± 5.9×10
-8
 3.0 
qnrA (16S rRNA gene)
-1
 40°C -1.4×10
5
 ± 6.9×10
4
 0.5 
qnrA (16S rRNA gene)
-1
 56°C -1.1×10
4
 ± 1.1×10
4
 36.3 
qnrA (16S rRNA gene)
-1
 60°C -2.6×10
3
 ± 3.7×10
4
 101.1 
qnrA (16S rRNA gene)
-1
 63°C -4.6×10
3
 ± 4.2×10
3
 8.2 
repA mL
-1
 40°C ND
d
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repA mL
-1
 56°C -1.3×10
-6
 ± 4.6×10
-7
 0.3 
repA mL
-1
 60°C ND
d
 
repA mL
-1
 63°C ND
d
 
repA (16S rRNA gene)
-1
 40°C ND
d
 
repA (16S rRNA gene)
-1
 56°C -1.1×10
5
 ± 1.0×10
5
 0.8 
repA (16S rRNA gene)
-1
 60°C ND
d
 
repA (16S rRNA gene)
-1
 63°C ND
d
 
tet(W) mL
-1
 40°C -3.9×10
-11
 ± 1.1×10
-11
 5.9 
tet(W) mL
-1
 56°C -1.4×10
-9
 ± 9.6×10
-11
 0.5 
tet(W) mL
-1
 60°C -2.1×10
-9
 ± 1.1×10
-10
 0.6 
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tet(W) mL
-1
 63°C -1.6×10
-9
 ± 2.3×10
-10
 0.2 
tet(W) (16S rRNA gene)
-1
 40°C -4.1×10
0
 ± 1.4×10
0
 10.6 
tet(W) (16S rRNA gene)
-1
 56°C -1.2×10
2
 ± 5.5×10
0
 1.2 
tet(W) (16S rRNA gene)
-1
 60°C -9.5×10
1
 ± 4.7×10
0
 1.2 
tet(W) (16S rRNA gene)
-1
 63°C -6.5×10
1
 ± 7.8×10
0
 1.0 
tet(X) mL
-1
 40°C -4.4×10
-9
 ± 2.6×10
-10
 2.6 
tet(X) mL
-1
 56°C -4.1×10
-8
 ± 2.5×10
-9
 0.2 
tet(X) mL
-1
 60°C -2.9×10
-8
 ± 9.4×10
-9
 2.2 
tet(X) mL
-1
 63°C -3.0×10
-7
 ± 2.5×10
-8
 -0.1 
tet(X) (16S rRNA gene)
-1
 40°C -5.5×10
2
 ± 4.5×10
1
 4.0 
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tet(X) (16S rRNA gene)
-1
 56°C -3.7×10
3
 ± 3.5×10
2
 0.7 
tet(X) (16S rRNA gene)
-1
 60°C -1.3×10
3
 ± 4.9×10
2
 3.8 
tet(X) (16S rRNA gene)
-1
 63°C -1.8×10
4
 ± 1.6×10
3
 -0.1 
a
See Table C.4 for ANOVA P values, which are equal to values of P for k, as well as other summary metrics that describe the 
quality of fit of the model to the data. 
b
Alternatively, units may be 16S rRNA genes copy
-1
 day
-1
. 
c
Initial half-lives (t1/2) were calculated using fitted values of k and C0.  
d
Quantities of some gene targets were above quantification limits for only n ≤ 2 time points, so k was not determined (ND). 
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Appendix D: Supporting Information for Chapter 6 
Table D.1.  The primer sequences, expected amplicon size, and annealing temperature for each real-time PCR method used in 
this work. 
Gene Target Primer Sequence (5’3’) Size (bp) Ann. Temp. (°C) Reference 
16S rRNA gene 
(338F, 518R) 
F: CCT ACG GGA GGC AGC AG 
R: ATT ACC GCG GCT GCT GG 
202 60 (196) 
all Bacteroides spp. 16S rRNA gene 
(AllBac) 
F: GAG AGG AAG GTC CCC CAC 
R: CGC TAC TTG GCT GGT TCA G 
116 60 (195) 
human-specific Bacteroides spp. 16S 
rRNA gene (HF183) 
F: ATC ATG AGT TCA CAT GTC CG 
R: TAC CCC GCC TAC TAT CTA ATG 
82 56 (194,203) 
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erm(B) 
F: GAT ACC GTT TAC GAA ATT GG 
R: GAA TCG AGA CTT GAG TGT GC 
364 58 (200) 
intI1 
F: CCT CCC GCA CGA TGA TC 
R: TCC ACG CAT CGT CAG GC 
280 60 (201) 
qnrA 
F: AGG ATT TCT CAC GCC AGG ATT 
R: CCG CTT TCA ATG AAA CTG CA  
124 57 (8) 
repA 
F: TTC ATC AGC TCC AGC TTC TT 
R: CAG ATT CAT GAT CGA TTC GTT T 
126 60 This Study 
sul1 
F: CCG TTG GCC TTC CTG TAA AG 
R: TTG CCG ATC GCG TGA AGT 
67 60 (151) 
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tet(A) 
F: GCT ACA TCC TGC TTG CCT TC 
R: CAT AGA TCG CCG TGA AGA GG 
210 60 (202) 
tet(W) 
F: GAG AGC CTG CTA TAT GCC AGC 
R: GGG CGT ATC CAC AAT GTT AAC 
168 60 (95) 
tet(X) 
F: AGC CTT ACC AAT GGG TGT AAA 
R: TTC TTA CCT TGG ACA TCC CG 
278 60 (24) 
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Table D.2.  The number of standards (n), slope, intercept, amplification efficiency determined from a dilution series of 
standards, r
2
, and quantification limit (QL, copies µL
-1
 template) for each real-time PCR assay conducted to generate the data 
presented in this work. 
Assay Name n Slope Intercept Amp. Eff. r
2
 QL               
qPCR Soil Microcosms 13-16 16S 061313 7 -3.06 35.86 112% 0.994 23,000 
qPCR Soil Microcosms 17-20 16S 061413 5 -3.10 37.28 110% 0.998 23,000 
TRB 16S rRNA Gene qPCR 21-24 and C 040111 7 -3.09 36.14 111% 0.999 16,000 
qPCR Soil Microcosms A1-A3 16S rRNA gene 010313 5 -3.32 38.67 100% 0.997 69,000 
qPCR Soil Microcosms B1-C2-3.122911 16S 012913 5 -3.52 41.28 92% 0.999 690,000 
qPCR Soil Microcosms 13-15 AllBac 071112 8 -2.95 37.47 118% 0.995 630 
qPCR Soil Microcosms 16-18 AllBac 071812 8 -3.51 42.52 93% 0.976 630 
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qPCR Soil Microcosms 19-21 AllBac 062812 8 -3.16 40.25 107% 0.995 630 
qPCR Soil Microcosms 22-24 AllBac 080112 8 -2.99 38.36 116% 0.999 630 
qPCR Soil Microcosms A1-A3 AllBac 122712 9 -3.09 38.62 111% 0.998 63 
qPCR Soil Microcosms B1-C2.122911 AllBac 121212 9 -3.16 39.53 107% 0.997 63 
qPCR Soil Microcosms 13-15 HF183 071112 8 -3.18 38.83 106% 0.998 730 
qPCR Soil Microcosms 16-18 HF183 071812 8 -3.22 39.32 104% 0.994 730 
qPCR Soil Microcosms 19-21 HF183 062812 8 -3.35 40.82 99% 0.995 730 
qPCR Soil Microcosms 22-24 HF183 080112 7 -3.50 40.82 93% 0.993 730 
qPCR Soil Microcosms B1-C2-3.122911 HF183 121812 8 -3.21 38.90 105% 0.999 730 
qPCR Soil Microcosms 13-15 ermB 071012 9 -3.59 43.47 90% 0.992 220 
320 
 
qPCR Soil Microcosms 16-18 ermB 071212 10 -3.58 42.90 90% 0.996 22 
qPCR Soil Microcosms 19-21 ermB 062512 8 -3.50 42.24 93% 0.994 220 
qPCR Soil Microcosms 22-24 ermB 073112 9 -3.50 41.87 93% 0.993 22 
qPCR Soil Microcosms A1-A3 ermB 122712 9 -3.88 45.30 81% 0.998 220 
qPCR Soil Microcosms B1-C2.122912 ermB 121112 9 -3.62 43.95 89% 0.996 220 
qPCR Soil Microcosms B1-C2.122911 IncAC 121212 9 -3.56 41.86 91% 0.994 63 
qPCR Soil Microcosms K1-Startups incAC 012513 8 -3.80 46.01 83% 0.992 630 
TRB IntI1 qPCR 13-16 051611 9 -3.03 32.36 114% 0.992 10 
TRB IntI1 qPCR 17-20 041311 8 -3.13 34.62 109% 0.994 980 
TRB IntI1 qPCR 21-24 and C 041811 9 -3.40 38.09 97% 0.998 98 
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qPCR Soil Microcosms A1-A3 intI1 122012 9 -3.17 37.54 107% 0.998 190 
qPCR Soil Microcosms B1-C2.122912 intI1 121012 9 -3.49 39.78 93% 0.991 190 
qPCR Soil Microcosms B1-C2.122911 qnrA 121112 8 -3.25 36.88 103% 0.993 150 
qPCR Soil Microcosms K1-Startups qnrA 012513 10 -3.06 35.85 112% 0.995 1.5 
qPCR Soil Microcosms 13-15 sul1 071012 9 -2.98 36.92 117% 0.994 25 
qPCR Soil Microcosms 16-18 sul1 071812 8 -3.05 38.21 113% 0.993 250 
qPCR Soil Microcosms 19-21 sul1 062512 7 -3.17 39.14 107% 0.993 25 
qPCR Soil Microcosms 22-24 sul1 080112 7 -3.22 40.09 104% 0.995 2,500 
qPCR Soil Microcosms A1-A3 sul1 122712 10 -3.07 38.33 112% 0.996 25 
qPCR Soil Microcosms B1-C2.122912 sul1 121112 8 -3.19 39.01 106% 0.998 250 
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qPCR Soil Microcosms 13-15 tetA 071012 9 -3.15 36.45 108% 0.994 17 
qPCR Soil Microcosms 16-18 tetA 071212 8 -3.13 36.85 109% 0.992 170 
qPCR Soil Microcosms 19-21 tetA 062212 9 -3.14 37.26 108% 0.994 17 
qPCR Soil Microcosms 22-24 tetA 073112 9 -3.20 37.55 105% 0.997 17 
qPCR Soil Microcosms A1-A3 tetA 122612 10 -3.12 37.78 109% 0.999 17 
qPCR Soil Microcosms B1-C2.122912 tetA 121012 9 -3.28 39.17 102% 0.998 170 
TRB tetW qPCR 13-16 042711 9 -3.16 36.83 107% 0.996 110 
TRB tetW qPCR 17-20 042911 8 -3.21 36.36 105% 0.995 11 
TRB tetW qPCR 21-24 and C 050611 8 -2.90 34.48 121% 0.996 1,100 
qPCR Soil Microcosms A1-A3 tetW 122612 9 -3.14 37.82 108% 0.998 170 
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qPCR Soil Microcosms B1-C2-3.122911 tetW 010313 9 -3.22 38.30 104% 0.993 170 
TRB tetx qPCR 13-16 040211 10 -3.38 37.55 98% 0.993 13 
TRB tetx qPCR 17-20 040411 10 -3.49 39.73 93% 0.993 13 
TRB tetx qPCR 21-24 and C 040511 9 -3.68 40.52 87% 0.996 130 
qPCR Soil Microcosms A1-A3 tetX 122112 10 -3.44 40.09 95% 0.997 20 
qPCR Soil Microcosms B1-C2.122912 tetX 121012 9 -3.57 41.06 91% 0.996 200 
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Figure D.1.  The quantities of ARGs and intI1 in three replicate soil microcosms 
(closed circles, open circles, and closed triangles represent unique experimental 
units) at a loading rate of 20 g residual solids kg
-1
 soil for Experiment 1.  Values are 
the arithmetic mean of duplicate or triplicate samples; error bars represent one 
standard deviation. 
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Figure D.2.  The quantities of ARGs and intI1 in three replicate soil microcosms 
(closed circles, open circles, and closed triangles represent unique experimental 
units) at a loading rate of 100 g residual solids kg
-1
 soil for Experiment 1.  Values are 
the arithmetic mean of duplicate or triplicate samples; error bars represent one 
standard deviation. 
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Figure D.3.  The ratios of ARGs and intI1 to 16S rRNA genes in three replicate soil 
microcosms (closed circles, open circles, and closed triangles represent unique 
experimental units) at a loading rate of 20 g residual solids kg
-1
 soil for Experiment 
1.  Values are the arithmetic mean of duplicate or triplicate samples; error bars 
represent one standard deviation. 
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Figure D.4.  The ratios of ARGs and intI1 to 16S rRNA genes in three replicate soil 
microcosms (closed circles, open circles, and closed triangles represent unique 
experimental units) at a loading rate of 40 g residual solids kg
-1
 soil for Experiment 
1.  Values are the arithmetic mean of duplicate or triplicate samples; error bars 
represent one standard deviation. 
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Figure D.5.  The ratios of ARGs and intI1 to 16S rRNA genes in three replicate soil 
microcosms (closed circles, open circles, and closed triangles represent unique 
experimental units) at a loading rate of 100 g residual solids kg
-1
 soil for Experiment 
1.  Values are the arithmetic mean of duplicate or triplicate samples; error bars 
represent one standard deviation. 
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Figure D.6.  The ratios of ARGs and intI1 to 16S rRNA genes in three replicate soil 
microcosms (closed circles, open circles, and closed triangles represent unique 
experimental units) at a loading rate of 40 g residual solids kg
-1
 soil for Experiment 
2.  Values are the arithmetic mean of duplicate or triplicate samples; error bars 
represent one standard deviation. 
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Appendix E: Supporting Information for Chapter 7 
Table E.1.  The temperatures, hydraulic residence times (HRT), total solids (TS) destruction, volatile solids (VS) destruction, 
gas methane content, and dissolved oxygen (DO) concentrations in an aerobic digester and anaerobic digesters operated at 
four temperatures during the 70 days prior to sampling for residual solids.  Values are arithmetic means; error terms 
represent one standard deviation. 
Digester 
Temperature 
(°C) 
HRT (days) TS Destruction VS Destruction 
Gas Methane 
Content 
DO (mg L
-1
) 
Aerobic 14.8 ± 1.0 12.4 ± 0.8 35% 45% NA
a
 5.6 ± 1.7 
Anaerobic, 38°C 38.1 ± 2.4 16.2 ± 1.3 25% 39% 36.8% ± 8.9% NA
a
 
Anaerobic, 55°C 54.7 ± 2.1 15.3 ± 1.6 28% 41% 24.1% ± 10.9% NA
a
 
Anaerobic, 62°C 61.5 ± 1.7 16.3 ± 1.1 27% 43% 20.0% ± 10.2% NA
a
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Anaerobic, 69°C 69.0 ± 1.8 16.1 ± 1.2 23% 36% 7.6% ± 2.0% NA
a
 
a
Some operating variables are not applicable (NA) depending on digester operating conditions.
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Figure E.1.  The temperature of untreated residual solids undergoing pasteurization and the pH of untreated residual solids 
undergoing alkali stabilization prior to application to soil microcosms. 
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Table E.2.  The number of standards (n), slope, intercept, amplification efficiency determined from a dilution series of 
standards, r
2
, and quantification limit (QL, copies µL
-1
 template) for each real-time PCR assay conducted to generate the data 
presented in this work.  Assays for “Soil Microcosms A1-A3” are also listed in Table D.2. 
Assay Name n Slope Intercept Amp. Eff. r
2
 QL 
qPCR Soil Microcosms A1-A3 16S rRNA gene 010313 5 -3.32 38.67 100% 0.997 69,000 
qPCR Soil Microcosms A1-A3 AllBac 122712 9 -3.09 38.62 111% 0.998 63 
qPCR Soil Microcosms A1-A3 ermB 122712 9 -3.88 45.30 81% 0.998 220 
qPCR Soil Microcosms A1-A3 intI1 122012 9 -3.17 37.54 107% 0.998 190 
qPCR Soil Microcosms A1-A3 sul1 122712 10 -3.07 38.33 112% 0.996 25 
qPCR Soil Microcosms A1-A3 tetA 122612 10 -3.12 37.78 109% 0.999 17 
qPCR Soil Microcosms A1-A3 tetW 122612 9 -3.14 37.82 108% 0.998 170 
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qPCR Soil Microcosms A1-A3 tetX 122112 10 -3.44 40.09 95% 0.997 20 
qPCR Soil Microcosms C2.013112-D3 16S 032713 6 -3.07 36.01 112% 0.997 23,000 
qPCR Soil Microcosms C2.013112-D3 AllBac 032713 8 -3.02 38.47 114% 0.991 520 
qPCR Soil Microcosms C2.013112-D3 ermB 032713 8 -3.54 43.40 92% 0.998 220 
qPCR Soil Microcosms C2.013112-D3 intI1 032513 9 -3.59 40.59 90% 0.993 23 
qPCR Soil Microcosms C2.013112-D3 sul1 032713 9 -3.15 39.35 108% 0.998 25 
qPCR Soil Microcosms C2.013112-D3 tetA 032513 9 -3.65 39.32 88% 0.980 150 
qPCR Soil Microcosms C2.013112-D3 tetW 040213 9 -3.13 38.11 109% 0.998 170 
qPCR Soil Microcosms C2.013112-D3 tetX 031813 9 -3.70 42.46 86% 0.997 110 
qPCR Soil Microcosms E1-F2.122911 16S 041113 5 -3.23 37.83 104% 0.996 230,000 
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qPCR Soil Microcosms E1-F2.122911 AllBac 041613 11 -2.93 36.99 119% 0.994 5.2 
qPCR Soil Microcosms E1-F2.122911 ermB 043013 8 -3.87 43.84 81% 0.998 220 
qPCR Soil Microcosms E1-F2.122911 intI1 041613 10 -3.66 41.51 88% 0.998 230 
qPCR Soil Microcosms E1-F2.122911 sul1 041113 10 -3.42 40.83 96% 0.992 25 
qPCR Soil Microcosms E1-F2.122911 tetA 040913 9 -3.64 40.95 88% 0.990 150 
qPCR Soil Microcosms E1-F2.122911 tetW 040913 11 -3.03 37.48 114% 0.994 17 
qPCR Soil Microcosms E1-F2.122911 tetX 041613 10 -3.51 40.83 93% 0.985 11 
qPCR Soil Microcosms F2.013112-G3 16S 041713 5 -3.21 37.66 105% 0.999 230,000 
qPCR Soil Microcosms F2.013112-G3 AllBac 041713 10 -2.80 36.39 127% 0.997 5.2 
qPCR Soil Microcosms F2.013112-G3 ermB 042913 8 -3.95 45.06 79% 0.995 220 
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qPCR Soil Microcosms F2.013112-G3 intI1 050113 8 -3.50 39.12 93% 0.995 230 
qPCR Soil Microcosms F2.013112-G3 sul1 042913 9 -3.00 37.75 115% 0.997 25 
qPCR Soil Microcosms F2.013112-G3 tetA 042413 7 -4.10 42.51 75% 0.980 1,500 
qPCR Soil Microcosms F2.013112-G3 tetW 042413 10 -3.13 37.74 109% 0.996 17 
qPCR Soil Microcosms F2.013112-G3 tetX 050113 8 -3.46 39.45 94% 0.994 200 
qPCR Soil Microcosms H1-I2.013112 16S 031213 6 -3.01 35.39 115% 0.998 23,000 
qPCR Soil Microcosms H1-I2.013112 AllBac  040213 8 -2.95 37.93 118% 0.991 520 
qPCR Soil Microcosms H1-I2.013112 ermB 031113 8 -3.87 45.12 81% 0.999 2,200 
qPCR Soil Microcosms H1-I2.013112 intI1 031113 9 -3.67 42.05 87% 0.997 230 
qPCR Soil Microcosms H1-I2.013112 sul1 031213 9 -3.62 43.78 89% 0.989 250 
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qPCR Soil Microcosms H1-I2.013112 tetA 031113 8 -3.44 39.32 95% 0.993 150 
qPCR Soil Microcosms H1-I2.013112 tetW 030713 9 -3.00 36.89 116% 0.998 170 
qPCR Soil Microcosms H1-I2.013112 tetX 030713 9 -3.87 43.44 81% 0.990 110 
qPCR Soil Microcosms I2.022812-J3 16S 030613 6 -3.01 34.83 115% 0.991 23,000 
qPCR Soil Microcosms I2.022812-J3 AllBac 030613 9 -3.04 38.84 113% 0.998 63 
qPCR Soil Microcosms I2.022812-J3 ermB 021913 8 -4.07 46.49 76% 1.000 220 
qPCR Soil Microcosms I2.022812-J3 intI1 022213 8 -3.31 39.08 101% 0.998 230 
qPCR Soil Microcosms I2.022812-J3 sul1 021913 10 -3.02 38.12 115% 0.998 25 
qPCR Soil Microcosms I2.022812-J3 tetA 022013 8 -3.38 39.64 98% 0.999 150 
qPCR Soil Microcosms I2.022812-J3 tetW 021213 9 -3.23 38.97 104% 0.996 170 
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qPCR Soil Microcosms I2.022812-J3 tetX 021213 9 -3.71 42.71 86% 0.999 110 
qPCR Soil Microcosms K1-Startups 16S gene 020413 5 -3.77 43.34 84% 0.998 690,000 
qPCR Soil Microcosms K1-Startups AllBac 012813 8 -3.12 40.04 109% 0.997 630 
qPCR Soil Microcosms K1-Startups HF183 012813 8 -3.21 38.96 105% 0.995 730 
qPCR Soil Microcosms K1-Startups ermB 012313 8 -4.07 47.21 76% 0.996 220 
qPCR Soil Microcosms K1-Startups intI1 012313 9 -3.61 41.48 89% 0.994 230 
qPCR Soil Microcosms K1-Startups qnrA 012513 10 -3.06 35.85 112% 0.995 1.5 
qPCR Soil Microcosms K1-Startups sul1 012813 10 -3.11 39.26 110% 0.999 25.0 
qPCR Soil Microcosms K1-Startups tetA 012313 9 -3.34 39.82 99% 0.999 170 
qPCR Soil Microcosms K1-Startups tetW 012213 8 -3.45 40.40 95% 0.996 170 
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qPCR Soil Microcosms K1-Startups tetX 012213 10 -3.41 40.19 96% 0.997 20 
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Table E.3.  The quantities of 16S rRNA genes, intI1, and sul1 in soil used to initiate 
microcosms that received aerobically digested, air-dried, anaerobically digested, or 
untreated residual solids (10/27/11) vs. alkali stabilized or pasteurized residual 
solids (12/1/11).  Values are the arithmetic mean of at least five of nine positive 
samples (for 10/27/11) or two of three positive samples (for 12/1/11); error terms 
represent one standard deviation.  All other gene targets were below quantification 
limits in at least six of nine samples (for 10/27/11) or in all three samples (for 
12/1/11). 
Gene Target 
Gene Copies (mg
-1
 dry mass) 
P
a
 
10/27/11 12/1/11 
16S rRNA gene 4.2107 ± 2107 1.0108 ± 1107 110-3 
intI1 1.0103 ± 4102 5.0103 ± 4102 910-5 
sul1 4.8102 ± 3102 1.2103 ± 2102 210-3 
aWelch’s t-test (two-sample, unequal variance) 
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Table E.4.  First-order kinetic coefficients (k), P, r
2
, and half-lives (t1/2) from first-order kinetic models of gene target quantities 
in residual municipal wastewater solids undergoing pasteurization or alkali stabilization.  Error terms for k represent one 
standard error; all values of k were regressed from eight data points. 
Gene Target Treatment k (min
-1
) P r
2
 t1/2 (min) 
16S rRNA gene Pasteurization -4.510-3 ± 310-3 0.21 0.25 160 
intI1 Pasteurization -3.410-3 ± 310-3 0.35 0.15 200 
tet(X) Pasteurization -1.010-2 ± 310-3 0.02 0.60 68 
intI1/16S rRNA gene Pasteurization 1.310-3 ± 210-3 0.48 0.09 -540 
tet(X)/16S rRNA gene Pasteurization -5.710-3 ± 210-3 0.01 0.68 120 
16S rRNA gene Alkali Stabilization -3.610-3 ± 110-3 0.02 0.61 190 
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intI1 Alkali Stabilization -2.710-3 ± 110-3 0.12 0.36 260 
tet(X) Alkali Stabilization -2.810-3 ± 110-3 0.03 0.58 250 
intI1/16S rRNA gene Alkali Stabilization 9.110-4 ± 510-4 0.14 0.32 -760 
tet(X)/16S rRNA gene Alkali Stabilization 8.610-4 ± 410-4 0.10 0.38 -810 
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Table E.5.  Evaporation rates and cumulative evaporation in all sets of soil microcosms.  Error terms for evaporation rates 
represent one standard error.  Error terms for fraction of initial microcosm mass lost to evaporation and final moisture 
content represent one standard deviation. 
Residual Solids 
Evaporation Rate
a
                   
(mm H2O day
-1
) 
Fraction of Initial 
Microcosm Mass 
Lost to Evaporation 
Final Moisture Content 
Aerobically Digested 110-3 ± 110-4 4.1% ± 1.0% 10.0% ± 1.6% 
Air-dried 210-3 ± 210-4 6.9% ± 1.7% 4.5% ± 1.5% 
Alkali Stabilized 210-3 ± 210-4 6.2% ± 1.0% 7.6% ± 0.8% 
Anaerobically Digested, 38°C 210-3 ± 210-4 8.1% ± 1.6% 5.2% ± 1.1% 
Anaerobically Digested, 55°C 210-3 ± 110-4 7.0% ± 0.6% 7.0% ± 0.5% 
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Anaerobically Digested, 62°C 210-3 ± 210-4 7.4% ± 2.3% 6.2% ± 2.2% 
Anaerobically Digested, 69°C 210-3 ± 310-4 7.3% ± 2.4% 5.7% ± 1.6% 
Pasteurized 210-3 ± 310-4 5.9% ± 2.0% 7.8% ± 2.2% 
Untreated 210-3 ± 810-5 6.0% ± 0.7% 8.5% ± 0.5% 
a
Evaporation rates were determined using linear regression (R 2.15.0).  The predictor was time, and the cumulative mass of 
water lost from each group of replicate soil microcosms (i.e. three values at each time point) was used as the response variable.  
All evaporation rates are statistically significant (P < 0.05).  
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Figure E.2.  The quantities of 16S rRNA genes, intI1, and tet(X) in residual solids 
undergoing pasteurization or alkali stabilization.  Values are the arithmetic mean of 
triplicate samples; error bars represent one standard deviation.
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Table E.6.  First-order kinetic coefficients (k), number of data points (n), r
2
, P, lack-of-fit P (LOF P), and half-lives (t1/2) from 
first-order kinetic models applied to full time series of gene target quantities in triplicate soil microcosms that received 
different residual municipal wastewater solids.  Error terms for k represent the standard error of the mean.   
Residual Solids Target k (day
-1
) n r
2
 P LOF P t1/2 (days) 
Aerobically Digested 16S rRNA genes -6.0×10
-3
 ± 8×10
-4
 18 0.77 2×10
-6
 4×10
-4
 120 
Aerobically Digested AllBac -2.6×10
-2
 ± 4×10
-3
 18 0.72 9×10
-6
 2×10
-8
 26 
Aerobically Digested erm(B) -1.7×10
-2
 ± 2×10
-3
 18 0.78 1×10
-6
 0.01 40 
Aerobically Digested intI1 -1.2×10
-2
 ± 2×10
-3
 18 0.77 2×10
-6
 1×10
-3
 57 
Aerobically Digested sul1 -1.0×10
-2
 ± 1×10
-3
 18 0.78 1×10
-6
 0.02 68 
Aerobically Digested tet(A) -9.1×10
-3
 ± 1×10
-3
 18 0.71 1×10
-5
 3×10
-3
 76 
Aerobically Digested tet(W) -2.1×10
-2
 ± 3×10
-3
 18 0.82 3×10
-7
 8×10
-6
 32 
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Aerobically Digested tet(X) -2.1×10
-2
 ± 2×10
-3
 18 0.91 1×10
-9
 5×10
-4
 34 
Air-dried 16S rRNA genes 2.7×10
-4
 ± 1×10
-3
 18 0.00 0.78 0.18 -2,500 
Air-dried AllBac ND
a
 
Air-dried erm(B) ND
a
 
Air-dried intI1 -7.2×10
-3
 ± 3×10
-3
 18 0.29 0.02 0.95 96 
Air-dried sul1 -7.1×10
-3
 ± 3×10
-3
 18 0.23 0.04 0.87 97 
Air-dried tet(A) -4.6×10
-3
 ± 4×10
-3
 11 0.11 0.33 0.90 150 
Air-dried tet(W) ND
a
 
Air-dried tet(X) -6.5×10
-3
 ± 4×10
-3
 18 0.15 0.11 0.85 110 
Alkali Stabilized 16S rRNA genes -1.2×10
-3
 ± 7×10
-4
 18 0.17 0.09 0.02 560 
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Alkali Stabilized AllBac -3.8×10
-2
 ± 1×10
-2
 18 0.45 2×10
-3
 1×10
-11
 18 
Alkali Stabilized erm(B) -3.4×10
-2
 ± 8×10
-3
 18 0.53 6×10
-4
 2×10
-11
 21 
Alkali Stabilized intI1 -1.2×10
-2
 ± 3×10
-3
 18 0.53 6×10
-4
 1×10
-5
 57 
Alkali Stabilized sul1 -1.8×10
-2
 ± 5×10
-3
 18 0.49 1×10
-3
 5×10
-8
 38 
Alkali Stabilized tet(A) -1.3×10
-2
 ± 4×10
-3
 13 0.44 0.01 5×10
-4
 53 
Alkali Stabilized tet(W) -2.6×10
-2
 ± 8×10
-3
 14 0.49 0.01 2×10
-7
 27 
Alkali Stabilized tet(X) -1.1×10
-1
 ± 1×10
-2
 4 0.97 0.02 ND
b
 6.3 
Anaerobically Digested, 38°C 16S rRNA genes -3.4×10
-3
 ± 3×10
-3
 18 0.06 0.31 0.89 200 
Anaerobically Digested, 38°C AllBac -2.3×10
-2
 ± 3×10
-3
 18 0.77 2×10
-6
 4×10
-4
 30 
Anaerobically Digested, 38°C erm(B) -2.1×10
-2
 ± 9×10
-3
 13 0.35 0.03 0.01 32 
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Anaerobically Digested, 38°C intI1 -5.6×10
-3
 ± 2×10
-3
 18 0.35 0.01 7×10
-4
 120 
Anaerobically Digested, 38°C sul1 -1.0×10
-2
 ± 2×10
-3
 18 0.69 2×10
-5
 0.06 67 
Anaerobically Digested, 38°C tet(A) -4.7×10
-3
 ± 4×10
-3
 18 0.07 0.28 2×10
-3
 150 
Anaerobically Digested, 38°C tet(W) -1.8×10
-2
 ± 5×10
-3
 16 0.45 4×10
-3
 1×10
-6
 39 
Anaerobically Digested, 38°C tet(X) ND
a
 
Anaerobically Digested, 55°C 16S rRNA genes -7.9×10
-4
 ± 8×10
-4
 18 0.05 0.36 0.47 880 
Anaerobically Digested, 55°C AllBac -2.4×10
-2
 ± 6×10
-3
 18 0.50 1×10
-3
 8×10
-8
 29 
Anaerobically Digested, 55°C erm(B) ND
a
 
Anaerobically Digested, 55°C intI1 -7.3×10
-3
 ± 1×10
-3
 18 0.66 4×10
-5
 5×10
-3
 94 
Anaerobically Digested, 55°C sul1 -1.3×10
-2
 ± 3×10
-3
 18 0.55 4×10
-4
 5×10
-6
 52 
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Anaerobically Digested, 55°C tet(A) -5.4×10
-2
 ± 5×10
-3
 5 0.97 2×10
-3
 ND
b
 13 
Anaerobically Digested, 55°C tet(W) -1.6×10
-2
 ± 6×10
-3
 12 0.45 0.02 2×10
-5
 43 
Anaerobically Digested, 55°C tet(X) ND
a
 
Anaerobically Digested, 62°C 16S rRNA genes 1.2×10
-3
 ± 6×10
-4
 18 0.19 0.07 2×10
-3
 -560 
Anaerobically Digested, 62°C AllBac -2.0×10
-2
 ± 5×10
-3
 16 0.48 3×10
-3
 1×10
-6
 35 
Anaerobically Digested, 62°C erm(B) -1.8×10
-2
 ± 8×10
-3
 7 0.50 0.08 0.01 38 
Anaerobically Digested, 62°C intI1 -5.0×10
-3
 ± 1×10
-3
 18 0.51 9×10
-4
 0.01 140 
Anaerobically Digested, 62°C sul1 -7.9×10
-3
 ± 3×10
-3
 18 0.37 0.01 1×10
-5
 88 
Anaerobically Digested, 62°C tet(A) -1.5×10
-2
 ± 4×10
-3
 5 0.81 0.04 0.15 47 
Anaerobically Digested, 62°C tet(W) -1.2×10
-2
 ± 4×10
-3
 18 0.32 0.01 5×10
-6
 58 
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Anaerobically Digested, 62°C tet(X) 5.1×10
-3
 ± 8×10
-3
 5 0.13 0.55 0.52 -140 
Anaerobically Digested, 69°C 16S rRNA genes 1.3×10
-3
 ± 9×10
-4
 18 0.10 0.20 0.03 -550 
Anaerobically Digested, 69°C AllBac -2.0×10
-2
 ± 6×10
-3
 17 0.45 3×10
-3
 8×10
-6
 35 
Anaerobically Digested, 69°C erm(B) -2.6×10
-2
 ± 1×10
-2
 8 0.44 0.07 2×10
-3
 26 
Anaerobically Digested, 69°C intI1 -8.6×10
-3
 ± 4×10
-3
 17 0.26 0.04 0.91 81 
Anaerobically Digested, 69°C sul1 -1.2×10
-2
 ± 4×10
-3
 18 0.35 0.01 0.43 60 
Anaerobically Digested, 69°C tet(A) ND
a
 
Anaerobically Digested, 69°C tet(W) -1.4×10
-2
 ± 4×10
-3
 18 0.45 2×10
-3
 2×10
-4
 50 
Anaerobically Digested, 69°C tet(X) ND
a
 
Pasteurized 16S rRNA gene -4.4×10
-3
 ± 2×10
-3
 18 0.34 0.01 0.79 160 
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Pasteurized AllBac -4.4×10
-2
 ± 1×10
-2
 11 0.60 0.01 4×10
-5
 16 
Pasteurized erm(B) -3.5×10
-2
 ± 8×10
-3
 11 0.66 2×10
-3
 2×10
-5
 20 
Pasteurized intI1 -1.9×10
-2
 ± 5×10
-3
 18 0.42 3×10
-3
 4×10
-4
 37 
Pasteurized sul1 -2.4×10
-2
 ± 8×10
-3
 18 0.38 0.01 0.03 28 
Pasteurized tet(A) -1.7×10
-2
 ± 6×10
-3
 15 0.42 0.01 3×10
-6
 40 
Pasteurized tet(W) -3.2×10
-2
 ± 8×10
-3
 10 0.65 0.01 1×10
-4
 22 
Pasteurized tet(X) -2.0×10
-2
 ± 2×10
-3
 4 0.97 0.01 ND
b
 35 
Untreated 16S rRNA gene -3.0×10
-3
 ± 8×10
-4
 18 0.46 2×10
-3
 0.22 230 
Untreated AllBac -3.6×10
-2
 ± 5×10
-3
 18 0.78 1×10
-6
 8×10
-5
 19 
Untreated erm(B) -3.7×10
-2
 ± 8×10
-3
 16 0.63 2×10
-4
 1×10
-6
 19 
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Untreated intI1 -1.2×10
-2
 ± 2×10
-3
 18 0.80 5×10
-7
 0.31 57 
Untreated sul1 -1.7×10
-2
 ± 2×10
-3
 18 0.81 4×10
-7
 0.32 41 
Untreated tet(A) -1.4×10
-2
 ± 2×10
-3
 18 0.79 7×10
-7
 0.13 51 
Untreated tet(W) -2.9×10
-2
 ± 4×10
-3
 18 0.75 4×10
-6
 1×10
-6
 24 
Untreated tet(X) -2.0×10
-2
 ± 4×10
-3
 17 0.61 2×10
-4
 0.01 35 
a
Quantities of some gene targets were above quantification limits for only n ≤ 2 time points, so k was not determined (ND). 
b
Quantities of some gene targets did not provide sufficient experimental replication to conduct the lack-of-fit test, so LOF P 
was not determined (ND). 
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Table E.7.  First-order kinetic coefficients (k), number of data points (n), r
2
, P, lack-of-fit P (LOF P), and half-lives (t1/2) from 
first-order kinetic models applied to time series of gene target quantities with time zero values removed in triplicate soil 
microcosms that received different residual municipal wastewater solids.  Error terms for k represent the standard error of 
the mean.   
Residual Solids Target k (day
-1
) n r
2
 P LOF P t1/2 (days) 
Aerobically Digested 16S rRNA gene -3.9×10
-3
 ± 5×10
-4
 15 0.81 6×10
-6
 0.01 180 
Aerobically Digested AllBac -1.5×10
-2
 ± 3×10
-3
 15 0.70 1×10
-4
 4×10
-5
 45 
Aerobically Digested erm(B) -1.4×10
-2
 ± 3×10
-3
 15 0.66 2×10
-4
 0.04 50 
Aerobically Digested intI1 -8.0×10
-3
 ± 1×10
-3
 15 0.77 2×10
-5
 0.12 87 
Aerobically Digested sul1 -7.5×10
-3
 ± 1×10
-3
 15 0.72 7×10
-5
 0.17 93 
Aerobically Digested tet(A) -5.6×10
-3
 ± 1×10
-3
 15 0.64 4×10
-4
 0.26 120 
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Aerobically Digested tet(W) -1.5×10
-2
 ± 2×10
-3
 15 0.86 7×10
-7
 0.01 48 
Aerobically Digested tet(X) -1.8×10
-2
 ± 2×10
-3
 15 0.88 3×10
-7
 5×10
-3
 40 
Air-dried 16S rRNA gene -1.4×10
-3
 ± 1×10
-3
 15 0.12 0.20 0.60 510 
Air-dried AllBac ND
a
 
Air-dried erm(B) ND
a
 
Air-dried intI1 -7.4×10
-3
 ± 4×10
-3
 15 0.25 0.06 0.88 93 
Air-dried sul1 -7.4×10
-3
 ± 4×10
-3
 15 0.19 0.11 0.77 94 
Air-dried tet(A) -4.6×10
-3
 ± 5×10
-3
 9 0.12 0.37 0.67 150 
Air-dried tet(W) ND
a
 
Air-dried tet(X) -9.7×10
-3
 ± 4×10
-3
 15 0.27 0.04 0.95 71 
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Alkali Stabilized 16S rRNA gene -2.5×10
-3
 ± 7×10
-4
 15 0.46 0.01 0.16 280 
Alkali Stabilized AllBac -6.8×10
-3
 ± 1×10
-3
 15 0.63 4×10
-4
 1.00 100 
Alkali Stabilized erm(B) -1.1×10
-2
 ± 2×10
-3
 15 0.71 8×10
-5
 0.02 64 
Alkali Stabilized intI1 -4.3×10
-3
 ± 1×10
-3
 15 0.40 0.01 0.50 160 
Alkali Stabilized sul1 -4.9×10
-3
 ± 2×10
-3
 15 0.40 0.01 0.13 140 
Alkali Stabilized tet(A) -2.2×10
-3
 ± 2×10
-3
 10 0.11 0.36 0.41 310 
Alkali Stabilized tet(W) -4.0×10
-3
 ± 2×10
-3
 11 0.31 0.08 0.08 170 
Alkali Stabilized tet(X) ND
a
 
Anaerobically Digested, 38°C 16S rRNA gene -5.2×10
-3
 ± 4×10
-3
 15 0.10 0.24 0.88 130 
Anaerobically Digested, 38°C AllBac -1.5×10
-2
 ± 2×10
-3
 15 0.74 3×10
-5
 0.23 46 
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Anaerobically Digested, 38°C erm(B) 9.3×10
-5
 ± 5×10
-3
 10 0.00 0.99 0.78 -7,500 
Anaerobically Digested, 38°C intI1 -9.3×10
-3
 ± 2×10
-3
 15 0.62 5×10
-4
 0.01 75 
Anaerobically Digested, 38°C sul1 -1.0×10
-2
 ± 2×10
-3
 15 0.58 1×10
-3
 0.05 68 
Anaerobically Digested, 38°C tet(A) -1.5×10
-2
 ± 3×10
-3
 15 0.64 3×10
-4
 0.54 45 
Anaerobically Digested, 38°C tet(W) -2.9×10
-3
 ± 2×10
-3
 13 0.19 0.14 0.57 240 
Anaerobically Digested, 38°C tet(X) ND
a
 
Anaerobically Digested, 55°C 16S rRNA gene -1.9×10
-3
 ± 9×10
-4
 15 0.23 0.07 0.78 370 
Anaerobically Digested, 55°C AllBac -6.0×10
-3
 ± 2×10
-3
 15 0.47 5×10
-3
 0.89 120 
Anaerobically Digested, 55°C erm(B) ND
a
 
Anaerobically Digested, 55°C intI1 -4.0×10
-3
 ± 9×10
-4
 15 0.59 9×10
-4
 0.96 170 
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Anaerobically Digested, 55°C sul1 -4.6×10
-3
 ± 1×10
-3
 15 0.51 3×10
-3
 0.89 150 
Anaerobically Digested, 55°C tet(A) ND
a
 
Anaerobically Digested, 55°C tet(W) -5.9×10
-4
 ± 2×10
-3
 9 0.01 0.81 0.06 1,200 
Anaerobically Digested, 55°C tet(X) ND
a
 
Anaerobically Digested, 62°C 16S rRNA gene -3.6×10
-4
 ± 5×10
-4
 15 0.04 0.47 0.30 1,900 
Anaerobically Digested, 62°C AllBac -4.1×10
-3
 ± 2×10
-3
 13 0.30 0.05 0.19 170 
Anaerobically Digested, 62°C erm(B) 5.9×10
-4
 ± 4×10
-3
 4 0.01 0.90 ND
b
 -1,200 
Anaerobically Digested, 62°C intI1 -2.1×10
-3
 ± 9×10
-4
 15 0.28 0.04 0.67 330 
Anaerobically Digested, 62°C sul1 -6.1×10
-4
 ± 1×10
-3
 15 0.03 0.55 0.53 1,100 
Anaerobically Digested, 62°C tet(A) ND
a
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Anaerobically Digested, 62°C tet(W) 5.8×10
-4
 ± 2×10
-3
 15 0.01 0.73 0.71 -1,200 
Anaerobically Digested, 62°C tet(X) ND
a
 
Anaerobically Digested, 69°C 16S rRNA gene -5.7×10
-4
 ± 1×10
-3
 15 0.02 0.58 0.32 1,200 
Anaerobically Digested, 69°C AllBac -3.8×10
-3
 ± 3×10
-3
 14 0.12 0.22 0.14 180 
Anaerobically Digested, 69°C erm(B) 2.0×10
-3
 ± 5×10
-3
 5 0.04 0.73 0.14 -350 
Anaerobically Digested, 69°C intI1 -7.4×10
-3
 ± 5×10
-3
 14 0.17 0.14 0.83 93 
Anaerobically Digested, 69°C sul1 -6.5×10
-3
 ± 4×10
-3
 15 0.14 0.17 0.73 110 
Anaerobically Digested, 69°C tet(A) ND
a
 
Anaerobically Digested, 69°C tet(W) -3.2×10
-3
 ± 2×10
-3
 15 0.18 0.12 0.75 210 
Anaerobically Digested, 69°C tet(X) ND
a
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Pasteurized 16S rRNA gene -3.1×10
-3
 ± 2×10
-3
 15 0.19 0.11 0.90 220 
Pasteurized AllBac -3.9×10
-3
 ± 2×10
-3
 8 0.33 0.14 0.64 180 
Pasteurized erm(B) -1.6×10
-2
 ± 2×10
-3
 9 0.91 7×10
-5
 0.15 44 
Pasteurized intI1 -4.4×10
-3
 ± 3×10
-3
 15 0.12 0.20 0.99 160 
Pasteurized sul1 -7.4×10
-3
 ± 7×10
-3
 15 0.08 0.30 0.90 93 
Pasteurized tet(A) -1.8×10
-3
 ± 2×10
-3
 12 0.08 0.36 0.43 380 
Pasteurized tet(W) -4.6×10
-3
 ± 3×10
-3
 7 0.30 0.21 0.20 150 
Pasteurized tet(X) ND
a
 
Untreated 16S rRNA gene -2.5×10
-3
 ± 1×10
-3
 15 0.28 0.04 0.21 280 
Untreated AllBac -2.4×10
-2
 ± 4×10
-3
 15 0.77 2×10
-5
 0.05 29 
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Untreated erm(B) -1.3×10
-2
 ± 3×10
-3
 13 0.64 1×10
-3
 0.18 52 
Untreated intI1 -9.8×10
-3
 ± 2×10
-3
 15 0.70 9×10
-5
 0.86 71 
Untreated sul1 -1.5×10
-2
 ± 3×10
-3
 15 0.71 7×10
-5
 0.39 46 
Untreated tet(A) -1.1×10
-2
 ± 2×10
-3
 15 0.68 1×10
-4
 0.23 61 
Untreated tet(W) -1.7×10
-2
 ± 2×10
-3
 15 0.83 3×10
-6
 0.07 42 
Untreated tet(X) -1.2×10
-2
 ± 4×10
-3
 14 0.37 0.02 0.17 60 
a
Quantities of some gene targets were above quantification limits for only n ≤ 2 time points, so k was not determined (ND). 
b
Quantities of some gene targets did not provide sufficient experimental replication to conduct the lack-of-fit test, so LOF P 
was not determined (ND). 
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Figure E.3.  Quantities of qnrA in soil microcosms that received untreated residual 
solids.  Values are the arithmetic mean of duplicate or triplicate samples; error bars 
represent one standard deviation.  Dashed lines represent the maximum and 
minimum limits of quantification for data sets that contain one or more 
experimental observations below those limits. 
 
 
 
 
 
